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ABSTRACT
Src-family kinases (SFKs) control a wide variety of biological processes, from cell 
proliferation and differentiation to cytoskeletal rearrangements. Abnormal SFK 
activation has been implicated in a wide variety of cancers and is associated with 
metastatic behaviour. SFKs are maintained in an inactive state by inhibitory 
phosphorylation of their C-terminal region by C-terminal Src kinase (CSK). In this 
study, Drosophila ASPP (dASPP) has been characterized and identified as a regulator 
of dCsk activity. dASPP is the homolog of the mammalian ASPP proteins, which are 
known to bind to and specifically stimulate the pro-apoptotic function of p53. dASPP is 
a positive dCsk regulator. Firstly, dASPP mutants show similar phenotypes to dCsk 
mutants, which are partially rescued by dSrc64B loss of function. Secondly, dASPP loss 
of function enhances the specific phenotypes of dCsk mutants in wing epithelial cells. 
Thirdly, dASPP physically interacts with dCsk to potentiate the inhibitory 
phosphorylation of dSrc42A. Taken together, these results suggest that dASPP has a 
role in maintaining epithelial integrity through dCsk regulation (Langton et al., 2007).
This work also provides the initial characterization of Boa (Binder of dASPP). Boa 
physically interacts with dASPP and is important for maintaining high levels o f dASPP 
at the apical membrane. This may be achieved by regulating the stability or localization 
of dASPP. The data suggests that Boa is important for dASPP function as it also 
genetically interacts with dCsk. dASPP or Boa loss of function results in similar 
phenotypes, although there are important differences indicating that Boa has other roles 
besides dASPP regulation.
In another project, I have examined the transcriptional control of DIAP1 (.Drosophila 
Inhibitor of Apoptosis 1) by the Ras pathway. Preliminary results suggest that the Ras 
pathway up-regulates DIAP1 transcription and this may be mediated by the Ttk69 
transcription factor.
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CHAPTER 1 Introduction
1.1 Introduction overview
As several broad topics are covered in this introduction I give here a brief overview to 
orient the reader and explain why each topic is being introduced. Firstly, I start out with 
a general introduction to Drosophila as a model system and discuss some o f the 
techniques available to researchers. Secondly, I include a section about the control of 
growth (accumulation of mass) in Drosophila, as this is the main research interest o f the 
lab. Thirdly, I provide a comprehensive introduction to the Hippo pathway. The 
majority of work in our lab is focused on understanding the Hippo pathway, which is a 
potent growth regulatory network in Drosophila and mammals. The Hippo pathway was 
the starting point for my project as I carried out a screen for novel components. 
Fourthly, I introduce Src-family kinases (SFKs) and their regulation in Drosophila and 
mammals. SFKs are introduced because I subsequently found that dASPP, which was 
identified in my screen, is likely to function upstream of SFKs rather than in the Hippo 
pathway. This is followed by an introduction to what is currently known about ASPP 
family proteins in mammals, which have been described as p53 regulators. Finally, I 
finish with a brief introduction to the Ras pathway in Drosophila, as I carried out a 
separate project investigating the transcriptional regulation o f DIAP1 by the Ras 
pathway.
1.2 An introduction to Drosophila melanogaster
1.2.1 Drosophila as a model organism
Drosophila melanogaster, commonly known as the fruit fly, is small two-winged flies 
of the order diptera. Drosophila melanogaster is one of the major model organisms in 
biological research and has been studied for over a hundred years, yielding many 
advances in our understanding o f genetics, disease, immunity, development and 
evolution. There are several reasons why Drosophila is such a valuable organism to
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biologists. Firstly, they are small, easy and relatively inexpensive to maintain in the 
laboratory. Secondly, the generation time is short (10 days at 25°C), which allows for 
comparatively rapid genetic experiments. Thirdly, Drosophila has only 4 pairs of 
chromosomes, comprising one sex chromosome and three autosomes, facilitating 
mapping of loci o f interest. Finally, recombination does not occur in males, this greatly 
facilitated the generation of early genomic maps as recombination events could be 
easily scored in females.
Further facilitating Drosophila research is the abundance of available resources 
including several large stock centres, online databases, and established protocols 
covering many techniques. The sequencing of the genome in 2000 has greatly advanced 
all aspects o f research including comparative genomics and the identification of 
homologs of human disease related genes. Drosophila is a suitable system for the 
analysis of human disease related genes in a genetically tractable organism as 62% of 
such genes are conserved in the fly (Rubin et al., 2000). In addition Drosophila genetic 
transformation is now routine allowing the introduction of transgenes, and the 
development of many subsequent techniques.
1.2.2 The life cycle of Drosophila melanogaster
The Drosophila melanogaster life cycle (see figure 1) at 25°C is about 10 days from 
egg to adult, although this varies considerably with temperature, for example the life 
cycle at 18°C is about 19 days. Fertilised females can lay hundreds o f eggs per day and 
in the wild they are laid onto rotting vegetation such as decaying fruit or fungus. The 
embryos develop over a period of 12-15 hours at 25°C before hatching as first-instar 
larvae. The larvae feed on the food source and increase in mass by about 400X during 
the 4-day larval growth phase. Moulting occurs at 24h and 48h after hatching, defining 
the second and third larval instars respectively, which are easily identified by the 
morphology of the mouth hooks. Roughly 5 days after egg laying (AEL) third-instar 
larvae leave the food source (the ‘wandering’ phase) in response to a pulse o f the steroid 
hormone Ecdysone, and pupate. The pupal stage lasts a further 4.5-5 days and during 
this time the majority of larval tissues are broken down, one exception being the 
imaginal discs, which undergo extensive morphological changes and develop into adult
16
Figure 1: The Drosophila melanogaster life cycle. The life cycle of Drosophila melano­
gaster lasts about 10 days at 25°C. Embryos laid by fertilised females develop over a 
period of 12-15 hours before hatching. The larval phase of the life cycle lasts 4 days 
during which time larvae increase in mass by 400x. Moulting occurs at 24h and 48h, 
defining the second and third instar phases. Roughly 5 days after egg laying, larvae leave 
the food source and pupate. The pupal stage of the life cycle lasts another 4-5 days and 
during this time extensive morphological changes occur. After emerging from the pupal 
case female flies are receptive to mating attempts after about 8 hours. Image taken from 
Flymove: http://flymove.uni-muenster.de.
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structures such as legs and wings. Upon completion of pupariation adult flies emerge 
and females are receptive to male mating attempts after about 8 hours.
1.3 Imaginal disc development
Imaginal discs are epithelial sheets that develop during the larval and pupal stages o f the 
life cycle and undergo extensive morphological changes during pupariation to give rise 
to the adult organs. The eye-antennal disc and the wing disc (see figure 2) are the most 
frequently studied tissues and provide a system for the interrogation of many biological 
processes including tissue patterning, cell growth, proliferation, apoptosis, cell polarity 
and differentiation.
The eye-antennal disc develops from a group of roughly 20 cells allocated during 
embryonic development. The eye disc cells divide during the first and second larval 
instars giving rise to the majority of the cells that will form the adult eye. A 
differentiation front known as the morphogenetic furrow (MF) passes from posterior to 
anterior during the third larval instar (Held, 2002). Cells anterior to the MF actively and 
asynchronously proliferate, and those within the furrow are arrested in G l. Patterning 
begins as cells exit the MF with groups of cells forming evenly spaced preclusters, 
which will differentiate into photoreceptor cells (see figure 2 A). Non precluster cells 
posterior to the MF undergo a final, synchronous round of entry into S-phase, followed 
by staggered divisions, a phenomenon known as the second mitotic wave (SMW) (see 
figure 2 B). This precise temporal and spatial control of proliferation and differentiation 
makes the eye a good system in which to study these processes.
The wing imaginal disc initially contains roughly 40 cells, which actively proliferate 
during the larval stages to produce a tissue of about 50,000 cells. Cell division stops at 
the onset of pupariation, and adult structures such as the longitudinal veins and notum 
bristles differentiate. Wing discs are divided into discrete anterior and posterior 
compartments and signalling initiated at the boundary sets up a gradient of the 
Decapentaplegic (Dpp) morphogen, which promotes proliferation and is involved in 
patterning the disc. Cellular interactions initiated at the dorsal / ventral boundary 
establishes a perpendicular Wingless (Wg) gradient that is also crucial for wing
18
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Figure 2: Drosophila eye and wing imaginal discs. (A and B) Schematics of third larval 
instar eye-antennal imaginal discs. During the third instar a wave of differentiation 
known as the morphogenetic furrow (MF) (blue region, arrow indicates direction of 
progression) sweeps across the eye disc from posterior to anterior. (A) Differentiation 
begins as cells exit the MF; groups of cells form evenly spaced preclusters, which will 
differentiate into photoreceptors (photoreceptor clusters in green). The position of the 
dorsal / ventral boundary is indicated. (B) A schematic showing the pattern of mitoses 
(dividing cells in red). Anterior to the MF, cells actively and asynchronously proliferate. 
Cells within the MF are arrested in G l. Uncommitted cells posterior to the MF undergo 
one final, synchronous round of S-phases, followed by staggered divisions, this is known 
as the second mitotic wave (SMW) (red arrowhead). (C and D) Schematics of third instar 
wing imaginal discs. Images taken and modified from (Butler, 2003). (C) Cells within the 
wing pouch (green) will form the adult wing. The hinge region (yellow) will form a struc­
ture that connects the wing to the body wall (blue). The anterior / posterior and dorsal / 
ventral boundaries are indicated. Signalling initiated at these boundaries has important 
roles in wing patterning. (D) A cross section through a wing disc along the anterior / 
posterior boundary indicating the three layers of cells: the peripodial membrane, the 
columnar epithelium, and the adepithelium.
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patterning and development (Held, 2002) (see figure 2 C). The wing disc contains cells 
that will go on to form the adult wing (those within the wing pouch), hinge region and 
the notum. The disc has three layers: the columnar epithelium, which will become the 
adult epidermis; the peripodial membrane, which has important roles during 
metamorphosis, and the adepithelium, a layer of myoblasts that will become the adult 
flight muscles (Butler et al., 2003) (see figure 2 D).
1.4 P-elements in Drosophila
Transposable elements are pieces of DNA that can integrate into genomic DNA and 
have the ability to move around the genome by ‘jumping’ from location to location 
(Engels, 1992). Transposable elements are thought to constitute 10-20% of the 
Drosophila melanogaster genome. P-elements are just one family o f transposable 
element found in Drosophila, they are roughly 2.9kb in length and consist o f a four 
exon gene encoding the transposase enzyme and 31 bp perfect inverted terminal repeats.
Interestingly, it is believed that P-elements have only recently become part o f the 
Drosophila genome and were acquired by a horizontal transmission event from another 
Drosophila species. This is thought to have occurred less than 100 years ago as only 
laboratory stocks established in the early 1900s have escaped P-element invasion. In the 
wild, P-elements are ubiquitous and are thought to have rapidly spread through heredity 
and transposition (Engels, 1992). When P-elements jump to new genomic sites they 
leave behind a double strand DNA break, which is usually repaired by homologous 
recombination using the sister chromatid as a template. This replaces the original P- 
element with a copy form the sister chromatid, meaning that after transposition, one 
extra P-element copy is present in the genome. This is thought to be responsible for the 
rapid increase in P-element number observed when P-elements are introduced to M 
strains (those without P-elements) under experimental conditions (Good et al., 1989).
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1.5 Genetic techniques in Drosophila
The identification of P-elements has allowed the development of many molecular and 
genetic techniques including the generation of transgenics, mutagenesis, analysis o f 
gene expression patterns, clonal analysis and gene replacement.
1.5.1 Germline transformation using P-element vectors
One of the most important Drosophila genetic techniques developed is the generation of 
transgenic animals using P-elements as vectors (Rubin and Spradling, 1982; Spradling 
and Rubin, 1982). The gene o f interest is inserted into the P-element sequence within a 
plasmid, which is microinjected into pre-blastoderm embryos in the presence of 
functional transposase. The P-element then transposes from the plasmid to a random 
chromosomal site. If the P-element integrates into the germline then a percentage of the 
progeny o f the injected flies will be transformants. Screening for transformants is 
possible if a second gene containing a dominant marker, such as an eye colour marker, 
is also inserted into the P-element sequence prior to injection (Rubin and Spradling, 
1982). The source of transposase may be genetically supplied by another transgenic 
insertion or supplied by co-injection of a transposase expressing helper plasmid. The 
ability to transform Drosophila allows the development of many subsequent techniques 
based on integration of DNA, some of which are described below.
1.5.2 Mutagenesis by P-element insertion
P-elements have been particularly useful tools for generating mutants; the insertion of a 
P-element into the region of a gene can result in a loss o f function (LOF) phenotype. A 
sufficient number of single insertion P-element lines have been generated and are 
available such that one can obtain a P-element insertion near a gene of interest for most 
Drosophila genes (Bellen et al., 2004).
These collections were created by crossing a P-element bearing line to a transposase 
expressing line. The P-element is mobilised in the germline o f the FI progeny and the 
F2 generation is screened for flies with new insertions, and which lack the transposase-
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expressing chromosome. The engineered transposase gene used to mobilize P-elements 
lacks the 2-3 intron (A 2-3), as the presence of this intron is known to be inhibitory to 
mobilization. The A 2-3 transposase is inserted within an element, which cannot itself 
transpose due to deletion of the terminal repeats (Robertson et al., 1988). The 
transposase-expressing chromosome is often also marked with a dominant marker such 
as stubble to allow it to be selected against in the F2 generation.
New insertions are identifiable if the P-element being mobilized contains an eye colour 
marker; the intensity of eye colour will depend on the local chromatin status and P- 
element copy number. New insertions may be mapped by inverse PCR whereby the 
genomic DNA is digested, circularised and sequenced using P-element specific primers 
(Sentry and Kaiser, 1994). This allows identification o f the sequence flanking new P- 
element insertions and the identification of the disrupted gene.
1.5.3 Mutagenesis by imprecise P-element excision
Once a P-element near a gene of interest has been obtained it is possible to create 
further mutations in that gene by re-supplying transposase (A2-3) (Salz et al., 1987; 
Tsubota and Schedl, 1986). P-element stocks are normally generated in a white (w) 
mutant background and P-elements are marked with the mini-white (mw) gene, which 
gives an orange eye colour. When crossed to the transposase expressing line the FI flies 
show an orange/white mosaic eye phenotype as the P-element is mobilising in the 
somatic and germ cells. The FI flies are crossed to balancer stocks, which are 
chromosomes with large inversions to prevent homologous recombination and contain 
lethal mutations that prevent them from overtaking a stock. The F2 generation will 
contain mutant flies as a result o f mobilisation of the P-element; males are crossed to 
balancer stocks to retain putative mutant chromosomes and then extracted from the 
cross and screened.
The F2 generation will contain various genotypes. Progeny that have orange eyes and 
thus retained the P-element insertion are discarded. Progeny that have white eyes have 
lost the P-element are kept for PCR screening. The majority of the white-eyed F2 
generation will be the result o f precise excision of the P-element where the surrounding
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DNA is left in tact. However, a small proportion (roughly 2%, depending on the 
insertion site) will have deletions o f the genomic DNA on either one or both sides of the 
insertion site. Using genomic primers that generate a PCR product spanning the P- 
element insertion site it is possible to recognise these imprecise excisions.
Precise excision events will give the expected PCR product size, as a deletion was not 
generated at the locus. Imprecise excision events will give one band of the expected size 
(from the balancer chromosome) and one band of reduced size corresponding to the size 
of the deletion. This band can then be extracted from the gel and sequenced to define 
the exact breakpoints. Imprecise excisions will only be recognisable using this method 
if the deletion breakpoints are within the range of the PCR primers used for screening. 
For technical reasons this limits the size of deletions that can be obtained by PCR 
screening to about 3kb, however P-elements have preferential insertion sites including 
in the promoters o f genes, so often one needs only a small deletion to disrupt a gene. 
Once a mutant male has been identified by PCR, the cross to the balancer stock is kept 
and the offspring are mated inter se to obtain the mutant stock. It is also possible to 
generate large deficiencies between two P-elements located in cis on the same 
chromosome (Cooley et al., 1990).
1.5.4 Enhancer trapping to visualise expression patterns
Enhancer trapping is another technique that takes advantage o f Drosophila 
transformation techniques. This involves mobilizing a P-element containing the LacZ 
gene under the control of a weak promoter and selecting single re-insertion lines. 
Enhancer elements present in the local chromatin near the reintegration site affect 
expression of the LacZ gene. Therefore this technique can be used to identify genes with 
interesting expression patterns during development (O'Kane and Gehring, 1987). One is 
example o f an enhancer trap line is the DIAP-LacZ line used in this work (see figure 
16), which contains a P(lacZ) insertion in the first intron of the thread (th) gene.
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1.5.5 Generating mosaics in Drosophila tissues
Genetic mosaic techniques are widely used in Drosophila research and are highly useful 
in the analysis of genes during development. These techniques are particularly useful 
for studying the function of genes that result in embryonic or larval lethality when 
mutated. Inducing LOF of such genes in small areas (clones) bypasses the early lethality 
and the phenotype can be assessed (Perrimon, 1998). Genetic mosaics have also been 
used to answer questions about the cell autonomy of gene function and to trace cell 
lineages in tissues (Blair, 2003).
A commonly used method for generating mosaic flies relies on the site-specific 
recombination between FRTs (FLPase recombination targets) catalysed by expression 
of the yeast FLP recombinase (FLPase) (see figure 3). It was first shown that this 
system could be used in Drosophila in 1989; expression of FLP from one transgene 
could induce recombination between two FRTs flanking the white gene on another 
transgene, leading to mosaic eyes (Golic and Lindquist, 1989). P-elements containing 
FRTs have been inserted at the base of all major chromosomal arms to allow clonal 
analysis of about 95% of Drosophila genes (Xu and Rubin, 1993). A cell automomous 
marker is present distally to the FRT site to allow identification of clonal tissue (Xu and 
Rubin, 1993).
In order to generate clones o f a mutation of interest one must first recombine the 
mutation onto a chromosome bearing an FRT site at the base of the chromosome arm. 
This recombinant is then crossed to a line containing the same FRT site and a distal cell 
marker (typically GFP or LacZ), as well as a transgene expressing FLP under the 
control o f a heat shock promoter (Xu and Rubin, 1993). When a heat shock is applied to 
developing FI animals, a mitotic recombination event occurs between the FRT sites in a 
small percentage o f cells. This event can result (depending on chromosome segregation) 
in the production of one daughter cell, which is homozygous for the mutation and one 
daughter cell, which is homozygous for the cell marker (see figure 3). Therefore the 
homozygous mutant cells are marked by the absence of the cell marker. The 
surrounding cells that have not undergone recombination also express the marker, as 
they are heterozygous for both mutation and marker. Provided that the mutation is not 
cell lethal, the unmarked mutant cell divides and produces a clone, the phenotype of
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Figure 3: Generating mosaics by homologous recombination. Animals are generated 
that have the same FRT site on homologous chromosomes (a). One chromosome carries 
a ubiquitously expressed marker (such as GFP) distal to the FRT site. The other chromo­
some carries the mutation of interest (*) distal to the FRT site. Expression of Flipase (Flp) 
is induced by heat-shock or is under the control of a tissue specific promoter. Flp cataly­
ses recombination between FRT sites on homologous chromosomes during interphase in 
a small percentage of cells (b). Following recombination, mitosis may lead to the genera­
tion of two homozygous daughter cells (outcome A). One daughter cell is homozygous 
for the marker; the progeny o f this cell give rise to a clone called the twinspot that 
expresses 2X GFP. The progeny of the other daughter cell produces a mutant clone that is 
homozygous for the mutation o f interest and does not express GFP.
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which can be analysed at a later developmental stage. The marked sibling cell also 
divides to produce a clone known as the twin-spot, which expresses two copies of the 
marker (see figure 3). If GFP is used as a marker the twin-spot is easily identifiable as 
the brightest cells.
The major advantage of generating mosaics is that the behaviour of mutant and wild- 
type cells can be directly compared in the same tissue preparation (Xu and Rubin, 
1993). The internal control provided by the wild-type tissue is extremely useful when 
assessing levels of another protein or reporter in mutant tissue. Mutant clones may also 
be generated in specific tissues if a tissue specific driver drives FLPase expression. For 
example, ey-FLP is commonly used to generate mosaics only in the eye. This has been 
used to study photoreceptor axon guidance as it provides a system where mutant axons 
project into a wild-type brain (Newsome et al., 2000).
A useful adaptation to the FLP/FRT system is the MARCM (mosaic analysis with a 
repressible marker) technique. The Gal4 inhibitor, Gal80, is ubiquitously expressed 
from an FRT chromosome (not the FRT chromosome carrying the mutation of interest), 
and when homologous recombination is induced only the homozygous mutant cells lack 
Gal80. This allows expression o f UAS-GFP or UAS-LacZ in the mutant cells leading to 
the generation of positively marked clones (Lee and Luo, 1999). The MARCM system 
can also be used to express any UAS construct o f interest within the labelled mutant 
clones (Blair, 2003).
1.5.6 The Gal4-UAS system for gain or loss of function analysis
Another Drosophila tool adapted from yeast is the Gal4-UAS system (see figure 4), 
which has been extensively used to study both over-expression phenotypes and LOF 
phenotypes. The Gal4-UAS system is a two-part system. One transgene expresses the 
Gal4 transcription factor under the control of specific promoters. Another transgene 
contains UAS (upstream activating sequences) sequences upstream of the gene of 
interest. When the two are bought together, Gal4 is expressed in a specific pattern and 
binds to the UAS sequences to drive expression of the genes of interest (see figure 4).
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Figure 4: The Gal4-UAS system and the FLPout technique. (A) The Gal4-UAS 
system. Gal4 is expressed from one transgene. Gal4 expression may be under the control 
of endogenous enhancer elements or a specific promoter that is cloned upstream of the 
Gal4 coding sequence in a transposon vector. A second transgene contains UAS 
sequences placed upstream of gene X. Gal4 binds to the UAS sequences and drives 
expression of gene X  wherever Gal4 is expressed. Figure adapted from (Perrimon, 1998). 
(B) The Flp-out technique: This method of mosaic analysis combines the Gal4-UAS 
system and the Flp-FRT system and is used to make positively marked clones that may be 
either loss of function or gain of function. The Gal4 gene is separated from a constitutive 
promoter by two FRT sites and a ‘stuffer’ containing a transcription termination signal. 
Flp expression is usually induced by heatshock and catalyses recombination between the 
FRT sites in a small percentage of cells. This removes the ‘stuffer’ and Gal4 is expressed. 
Gal4 drives transcription of gene X  and GFP and the descendants of these cells become 
the positively labelled gain of function clones. Loss o f function clones may also be gener­
ated using this system by replacing gene X  with an RNAi construct. Figure adapted from 
(Blair, 2003).
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If a UAS-GFP or UAS-LacZ transgene is also present areas o f gene expression can be 
marked (Brand and Perrimon, 1993).
Placing Gal4 under the control of different promoters allows for tissue specific 
expression of genes. This may be achieved by cloning the promoters o f genes with 
known expression patterns upstream of the Gal4 sequence or by enhancer trapping to 
place the Gal4 transgene under the control of endogenous promoters. The Gal4-UAS 
system may also be used for LOF analysis either by expressing dominant negatives or 
by expressing RNAi constructs. The recent availability of a genome-wide library of 
transgenic stocks containing RNAi constructs under UAS control provides a novel 
platform for the analysis of gene function in specific tissues (Dietzl et al., 2007).
1.5.7 The FLPout technique can be used to positively mark clones
The FLPout technique combines the FLP/FRT system and the Gal4-UAS system and 
can be used to generate positively marked clones. FLPout constructs have been 
generated; the Gal4 gene is separated from a constitutive promoter by a ‘stuffer’ 
comprising two FRT sites and a transcription termination codon (see figure 4). Flp 
expression is usually under the control of a heatshock promoter. When induced Flp 
catalyses recombination between the FRT sites leading to removal of the ‘stuffer’ in a 
small percentage of cells. This allows heritable Gal4 expression in the descendants of 
these cells and expression of transgenes under the control of UAS sequences (see figure 
4). UAS-GFP is usually present on the same chromosome as the FLPout construct 
allowing clones to be positively marked (Blair, 2003).
1.6 Control of growth in Drosophila
How the size of an animal or organ is determined is a fundamental question in 
developmental biology. For example, our arms develop independently but reach a near 
identical final size. This suggests that mechanisms exist to sense the size of organs 
during development and instruct them when to stop growing when appropriate. The size 
of an organ or animal is controlled by the relative contributions of three cell behaviours: 
cell proliferation, cell growth and cell death (Conlon and Raff, 1999). These processes
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may be regulated by systemic or intrinsic cues and the importance of these different 
types of growth cues varies from organ to organ (Conlon and Raff, 1999).
1.6.1 Humoral control of growth
Drosophila growth (accumulation of mass) is controlled at both the humoral and 
intrinsic level. Humoral growth is regulated by a network of secretory tissues including 
the larval fat body, which is an endoreplicating tissue involved in fat and glycogen 
storage, the oenocytes, the ring gland and various neuronal populations The fat body 
senses nutrient availability using amino acid transporters (for example, Slimfast) and 
accordingly governs global insulin signalling and the growth rate of peripheral tissues 
(Colombani et al., 2003). This positive regulation of humoral growth by insulin 
signalling is antagonized by 20-hydroxyecdysone (ecdysone) signalling. Peaks o f 
ecdysone levels are known to determine transitions between developmental stages. It 
was shown that ecdysone signalling also negatively regulates growth by affecting the 
localization of dFOXO, a negative regulator o f translation that responds to levels of 
insulin signalling (Colombani et al., 2005). Interestingly, inhibiting Slimfast in the fat 
body results in a larval growth defect and a reduction in the size of endoreplicating 
tissues. However, the size of the mitotic imaginal discs is largely unaffected due to an 
extension of larval development time, suggesting that the growth of these tissues is less 
sensitive to nutrient conditions (Colombani et al., 2003).
1.6.2 Intrinsic control of growth
Similar to most mammalian organs, the growth of Drosophila imaginal discs is 
controlled largely by intrinsic signals from within the discs themselves. Several 
signalling pathways are implicated in controlling imaginal disc growth including the 
Decapentaplegic (Dpp), Wingless (Wg), Notch (N), Phosphoinositide 3-kinase (PI3K), 
Mitogen-activated protein kinase (MAPK), and Hippo (Hpo) pathways. Final disc size 
is determined by the combined action of these pathways and there is considerable 
crosstalk between them.
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These pathways may regulate cell proliferation, cell growth, cell death or a combination 
of these processes to exert control over final disc size. Evidence supporting the 
existence of a sensor of organ size comes from studies showing that perturbation o f one 
o f these processes is not sufficient to alter final organ size. For example, accelerating 
proliferation in one compartment of the wing disc by expressing the cell cycle 
regulators cyclinE and cdc25/string does not lead to an increase in final compartment or 
wing size, rather the compartment contains more cells o f a smaller size (Neufeld et al., 
1998). In another example, cell death in the wing disc can be compensated for by 
increased proliferation, allowing apoptosis to be tolerated without affecting final disc 
size. It is thought that dying cells secrete the Wg and Dpp morphogens to induce 
compensatory proliferation of neighbouring cells (Huh et al., 2004; Perez-Garijo et al., 
2004; Ryoo et al., 2004). If cell death pathways are stimulated but cells are 
simultaneously prevented from dying (by expression of the Caspase inhibitor p35) then 
considerable non-autonomous proliferation is observed (Huh et al., 2004; Perez-Garijo 
et al., 2004; Ryoo et al., 2004). These results show that proliferation, cell growth and 
cell death are tightly linked processes in developing organs and perturbation of one of 
these processes can be compensated for by the actions of another to maintain constant 
tissue size.
The organ size sensing mechanism can however be overridden by modulating pathways 
that control more than one o f the processes affecting organ growth. For example, 
expression of activated Ras (Rasvl2) overrides size control mechanisms as Ras 
simultaneously drives cell division and cell growth, through regulation of dMyc and 
activation of PI3K signalling (Prober and Edgar, 2002). Ras also promotes cell survival 
by inhibiting the pro-apoptotic protein, Hid (Head Involution Defective) (Bergmann et 
al., 1998; Kurada and White, 1998). Additionally, loss of some members o f the Hippo 
pathway, including Hippo itself, results in a dramatic increase in organ size. This occurs 
because Hippo signalling regulates proliferation, growth and apoptosis (Harvey and 
Tapon, 2007). Below, a general introduction to the cellular behaviours regulating organ 
growth will be given, with the exception o f cellular growth, which is not relevant to the 
genes characterized in this work. In a later section (section 1.7) the effects of the Hippo 
pathway on these processes will be discussed, with emphasis on how the pathway may 
be part of the organ size sensing mechanism.
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1.6.3 Proliferation
Cell division is the mechanism by which a mother cell gives rise to two daughter cells. 
For cell division to succeed, a cell must faithfully replicate its DNA and transmit a copy 
of the genome to each of the two daughter cells. Following division the daughter cells 
enter a growth phase, which must be completed before they can divide again. The cycle 
of growth, duplication and division is known as the cell cycle and the amount o f time 
taken to complete the cell cycle varies from organism to organism. Eukaryotic cells 
have developed complex regulatory mechanisms dictating progression through the cell 
cycle. This ensures faithful replication as one stage of the cell cycle cannot proceed 
until the previous stages are complete (Malumbres and Barbacid, 2001). The same 
mechanisms can also prevent cells from dividing if they are damaged, thus ensuring that 
potentially harmful mutations are not passed on to daughter cells. The cell cycle 
regulation machinery enables cells to respond to extracellular signals (mitogens and 
nutrients) and divide accordingly, this is crucial for controlling cell numbers within 
tissues. Importantly, deregulation of cell cycle control is a necessary step for 
tumourigenesis.
1.6.3.1 The cell cycle and its regulators
The cell cycle consists of four main phases, G1 phase, S phase, G2 phase and M phase 
(see figure 5 A). During S phase the DNA is replicated, this phase lasts about 10-12 
hours for a typical mammalian cell. M phase is much shorter, lasting about an hour, 
during which time the cellular contents are partitioned between the daughter cells, 
followed by cytokinesis. The G1 and G2 phases that separate S phase and M phase 
allow time for cell growth so that cell size within a population in constant (Malumbres 
and Barbacid, 2001). These phases also allow time for cells to assess whether 
intracellular and extracellular conditions are suitable before committing to division. 
During G1 the cell will receive both positive and negative inputs from cell cycle control 
pathways and the balance of these inputs determines whether it divides. If  conditions 
are unfavourable, cells can delay entry into S phase or even enter a quiescent state (GO) 
and resume the cell cycle some time later (see figure 5 A). Cells can also arrest in G1 or 
G2 in response to DNA damage, allowing DNA repair to take place and preventing
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Figure 5: Cyclin-Cdk complexes regulate the cell cycle. (A) A simplified schematic of 
a typical eukaryotic cell cycle and some of its regulators. The cell cycle can be divided 
into four stages. During S-phase, the cell replicates its DNA content. During M-phase the 
cellular components are partitioned between two daughter cells and cytokinesis occurs. 
S-phase and M-phase are separated by two ‘gap’ phases, G1 and G2, during which time 
cells receive both extracellular and intracellular signals that regulate progression to the 
next stage. Many such signals determine the activity of Cyclin-Cdk complexes, central 
players in the cell cycle control machinery. The G1 to S-phase transition is highly regu­
lated and progression requires the activities of CyclinD-Cdk4/6 and CyclinE-Cdk2 com­
plexes. Entry into M-phase requires the activity of CyclinB-Cdkl complexes, which are 
positively regulated by the Cdc25 (String in Drosophila) phosphatase. Schematic modi­
fied from (Malumbres, 2005). (B) An example of how extracellular growth factors 
(mitogens) influence the cell cycle. The proto-oncogene, c-Myc, is a target o f the 
EGFR/Ras pathway and promotes entry into S-phase by several mechanisms. c-Myc 
ultimately leads to increased CyclinD-Cdk4/6 and CyclinE-Cdk2 activity, which phos- 
phorylate pRb and promote E2F release. Liberated E2F then upregulates expression of 
genes required for DNA replication. Schematic adapted from (Zomig, 1996).
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potentially harmful mutations from being passed on to their progeny. Another 
checkpoint exists in M phase and prevents cytokinesis if chromosome segregation has 
not been completed.
Central players in the cell cycle control system are the Cyclin-dependent kinases (Cdks) 
(Malumbres and Barbacid, 2005) (see figure 5A). When active, Cdks phosphorylate 
target proteins involved in controlling crucial cell cycle steps such as DNA replication 
or mitosis. Cdks only become activated at the relevant stage of the cell cycle and this 
activity is regulated by the abundance of their binding partners, the Cyclins (Morgan, 
1997). Expression of Cyclins oscillates during the cell cycle ensuring that Cdks are only 
active at the relevant stage. For example, the expression of S phase specific Cyclins, 
such as Cyclin E, is induced during late G l. This allows for the assembly and activation 
o f Cdk-Cyclin complexes, which act on proteins controlling entry into S phase. Once S 
phase is initiated these Cyclin molecules are degraded. Similar cyclic expression and 
degradation is observed for the M phase-specific Cyclins.
In addition to their regulation by the abundance of Cyclins, Cdks are regulated by 
phosphorylation and by binding of other proteins. For example, the Weel kinase and 
the Cdc25 phosphatase regulate Cdks that control entry into M phase, through 
inhibitory Cdk phosphorylation. The binding of proteins such as p21 and p27 inhibits 
the Cdk-Cyclin complexes controlling entry into S phase (Morgan, 1997) (see figure 5 
A). The activity of Cdks is highly regulated, allowing inputs from several different 
signalling pathways to be processed and ensuring that cells only divide when necessary.
Complex regulatory mechanisms exist to control the activity of Cdk4/6-CyclinD 
complexes and Cdk2-CyclinE complexes, which promote progression from Gl to S 
phase (Malumbres and Barbacid, 2005). These Cdk-Cyclin complexes act to relieve 
inhibition of a transcription factor called E2F, which transcribes genes required for S 
phase entry. In non-dividing cells E2F is bound to Retinoblastoma protein (Rb) and 
inactive. When cells are instructed to divide, Cdk4/6-CyclinD and Cdk2-CyclinE 
complexes are activated and hyperphosphorylate Rb; E2F is released and can transcribe 
target genes (Morgan, 1997). Several positive feedback mechanisms exist to ensure that 
S phase is robustly initiated once E2F is liberated, for example E2F activates its own 
transcription and that of CyclinE (see figure 5 B).
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1.6.3.2 Mitogens regulate cell cycle progression
One important pathway positively regulating cell division is the MAPK (Mitogen 
activated protein kinase) pathway. This pathway responds to extracellular signals 
(mitogens), and transmits signals to the nucleus that regulate the cell cycle control 
machinery. Typically, mitogen signalling promotes cell cycle progression by regulating 
the Gl to S phase transition. Certain mitogens, such as Platelet-derived growth factor 
(PDGF) and Epidermal growth factor (EGF), can stimulate proliferation o f a wide 
variety o f cell types, whereas others are more specific. Mitogens bind to receptor 
tyrosine kinases (RTKs) leading to their activation and the initiation of downstream 
signalling events. The small GTPase Ras proteins are heavily implicated in the 
signalling events downstream of RTK activation. When GTP bound, Ras proteins 
activate a MAP kinase cascade that ultimately leads to MAPK activation, which enters 
the nucleus and phosphorylates target genes. Several transcription factors are targeted 
by MAPK and this affects the transcription of genes that regulate entry into S-phase.
One consequence of mitogen stimulation is increased transcription of c-Myc proto­
oncogene. c-Myc can promote entry into Gl by several mechanisms (see figure 5 B). 
Firstly, it increases transcription o f CyclinD leading to formation of Cdk4/6-CyclinD 
complexes (Daksis et al., 1994), a necessary step in the Gl to S phase transition. 
Secondly, c-Myc increases transcription of cul-1, a gene encoding a subunit of the SCF 
ubiquitin ligase (O'Hagan et al., 2000). SCF is responsible for degrading the Cdk2- 
CyclinE inhibitory protein p27, and thus promotes S phase entry. Lastly, c-Myc directly 
regulates the transcription of the cdc25 gene, which produces a phosphatase that 
activates Cdk2 and Cdk4 (Zornig and Evan, 1996). This example illustrates how 
mitogens can influence cell division, though the complete picture is vastly more 
complex. Cell division is also regulated by intracellular signals including by adhesion 
molecules, damage sensing pathways and metabolic pathways. A more detailed 
description of the EGFR-Ras mitogenic signalling pathway in Drosophila is given in a 
later section (section 1.11).
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1.6.4 Apoptosis
Apoptosis is a type of cell death, which plays vital roles during both the development 
and adult life of animals (Hay et al., 2004). Apoptosis may be triggered by intracellular 
or extracellular cues, which ultimately lead to the activation of proteases called 
Caspases. Caspase activation beyond a certain threshold leads to the irreversible death 
of a cell. Several morphological changes occur during apoptosis, including cell 
shrinkage, loss of contact with neighbouring cells, chromatin condensation and 
membrane blebbing. These features are a consequence of the cleavage o f Caspase 
targets including proteins involved in DNA fragmentation (for example, Inhibitor of 
Caspase activated DNase) (Nagata, 2005) and cytoskeletal regulation (for example, 
beta-catenin) (Van de Craen et al., 1999). Eventually apoptotic cells form compact 
structures known as apoptotic bodies, which are subsequently engulfed by phagocytes 
or neighbouring cells. Consumption by other cells prevents the damage to surrounding 
cells and inflammation associated with necrosis, another form of cell death.
One function o f apoptosis during development is to shape organs, for example cell 
death is responsible for creating the gaps between the digits of vertebrate limbs 
(Zuzarte-Luis and Hurle, 2002). Another function is to remove excess cells such as the 
supplementary neurons generated during development of the vertebrate nervous system. 
Tissues that are no longer needed may also be destroyed by apoptosis, such as the 
amphibian tadpole tail (Meier et al., 2000a).
In adults, the balance between cell division and apoptosis is instrumental in regulating 
organ size (Hay et al., 2004). Apoptosis also provides a protection mechanism that 
prevents the propagation of abnormal or damaged cells. For example, cells infected by 
pathogens or those with damaged DNA are eliminated and tissue integrity is 
maintained. Apoptosis is tightly linked to the cell cycle and can be utilised to remove 
cells that are dividing aberrantly. This is an important cellular defence against cancer 
and suppression of cell death is a necessary step for oncogenic transformation. 
Conversely, inappropriate apoptosis can lead to disease; it is a feature of 
neurodegenerative disorders and compromises the immune system in patients with 
AIDS (Hay et al., 2004).
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1.6.4.1 The cell death machinery
Many of the molecules required for cell death were identified in the nematode, 
C.elegans. O f the 1090 cells generated during C.elegans development, invariably 131 
are eliminated by apoptosis. Screening for mutations that alter the number of cells dying 
during development identified the C.elegans Caspase (CED-3), its adaptor (CED-4) and 
the CED-4 inhibitor (CED-9) (Meier et al., 2000a).
The cell death machinery is conserved in Drosophila but is more complex, with 7 
identified Caspases. When the apical Caspase DRONC becomes activated, it cleaves 
and activates effector Caspases such as DRICE, which execute the apoptotic program 
(Hay et al., 2004) (see figure 6). In mammals 14 Caspases have been identified and 
include the apical Caspases 8 and 9, and the effector Caspases 3 and 7 (Hay et al.,
2004). Apoptosis can occur in the absence of gene transcription and is controlled by the 
post-translational regulation of Caspases. Caspases are expressed as inactive precursors, 
which become activated following death stimuli. Active Caspases cleave substrates, 
including other Caspases, at aspartic acid residues, leading to an amplification of the 
cell death signal.
In Drosophila and mammals Caspase activity is kept low by IAPs (Inhibitor of 
Apoptosis Proteins), which bind to and inhibit both apical and effector Caspases by 
several mechanisms (Hay et al., 2004). Expression of DIAP1 {Drosophila Inhibitor of 
Apoptosis 1) is able to block cell death phenotypes induced by expression of Caspases 
(Meier et al., 2000b). Furthermore, loss of DIAP1 induces cell death in many different 
contexts, highlighting its crucial role as an apoptosis inhibitor (Hay and Guo, 2006). 
The mechanisms by which DIAP1 inhibits Caspases are complex and still under 
investigation. DIAP1 has been shown to bind to the apical Caspase DRONC, and 
mediate DRONC ubiquitination and inactivation (Wilson et al., 2002). DIAP1 also 
ubiquitinates itself, leading to its proteasome-mediated degradation. DIAP1 stability is 
also controlled by the Caspases themselves via and N-terminal cleavage event, which 
exposes an asparaginyl (Asn) residue targeted by the ‘N-end rule’ degradative pathway 
(Ditzel et al., 2003). Paradoxically, the short half life of DIAP1 (~30 minutes) appears 
to be crucial to its ability to block cell death, leading to the hypothesis that DIAP1 
degradation concurrently leads to degradation of bound Caspases such as DRONC
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Figure 6: Caspase dependent cell death in Drosophila. Pro-apoptotic proteins are in 
red/orange and anti-apoptotic proteins are in blue. DIAP1 is crucial for keeping Caspase 
activity low and does so by inhibiting both apical Caspases such as Drone and effector 
Caspases such as Drice (the Caspase 3 homolog). The pro-apoptotic Hid, Grim and Rpr 
proteins bind to and inhibit DIAP1. Binding of Rpr to DIAP1 also leads to dTrafl stabili­
zation, and subsequent activation of the JNK pathway. Rpr and Grim can also promote 
apoptosis independently of DIAP1 though global inhibition of translation. Hid pro- 
apoptotic activity is negatively regulated by the EGF/Ras pathway and positively regu­
lated by the Hippo signalling via Yki and the microRNA bantam. Rpr induces cell death 
in response to Ecdysone and cellular stresses such as DNA damage - the Rpr promoter 
contains a p53-binding site. Figure adapted from (Hay, 2006).
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(Ditzel et al., 2003). DIAP1 can also prevent apoptosis by inhibiting TRAF1, which 
functions upstream of the JNK signalling pathway (Hay et al., 2004) (see figure 6).
Apoptosis in Drosophila is commonly induced by the Hid, Grim, Reaper proteins, 
which can bind to DIAP1 and displace bound Caspases thus relieving their inhibition 
(Hay et al., 2004) (see figure 6). It seems that Hid, Grim and Rpr can also reduce 
DIAP1 protein levels through distinct alternative mechanisms. Hid binding stimulates 
DIAP1 self-ubiquitination and degradation, whereas Rpr and Grim induce DIAP1 
downregulation by another mechanism. This activity does not require DIAP1 ubiquitin 
ligase activity and in the case o f Grim may be through a general suppression of 
translation (Yoo et al., 2002). A deficiency (H99) removing the hid, grim and rpr genes 
blocks nearly all cell death in the Drosophila embryo, suggesting the proteins they 
encode are essential death regulators (White et al., 1994). Hid, Grim and Rpr 
themselves are subject to regulation by several different signalling pathways. For 
example, their translation is subject to control by micro-RNAs including the Hippo 
pathway target bantam , which represses Hid translation (Brennecke et al., 2003; Nolo et 
al., 2006; Thompson and Cohen, 2006). Further, Hid is negatively regulated by the 
MAPK signalling pathway via phosphorylation and transcriptional control (Bergmann 
et al., 1998; Kurada and White, 1998) (see figure 6).
1.6.4.2 The intrinsic cell death pathway
In mammals, the apical Caspase 9 (functionally equivalent to Drosophila DRONC) is 
positively regulated by its adaptor protein APAF-1. Activation of APAF-1 and Caspase 
9 is regulated by the actions of pro-apoptotic Bcl2 family members such as Bax and 
Bak. Death-inducing signals can lead to Bax and Bak mediated mitochondrial 
membrane permeabalization and release o f Cytochrome c. Cytochrome c then associates 
with APAF-1 and promotes the aggregation and activation of Caspase 9 molecules, 
leading to the formation of a complex known as the apoptosome (Hay et al., 2004). This 
pathway is sometimes referred to as the intrinsic pathway as it is mediated by signals 
from within the cell. The intrinsic pathway may be activated following cellular stresses, 
which compromise the integrity of the mitochondrial membrane. For example, DNA
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damage leads to p53 activation and subsequent transcriptional upregulation o f the Bcl2 
family member Bax (Samuels-Lev et al., 2001).
Although some of the components of the intrinsic pathway are conserved in Drosophila, 
the relationship between them is far from understood. Drosophila has an APAF-1 
homolog called dARK, which functions in an analogous manner as an adaptor of 
DRONC. Drosophila also has Bcl2 family members, DEBCL and Buffy, but it is not 
clear whether they function to activate dARK (Hay et al., 2004) (see Figure 6). The role 
of Cytochrome c in Drosophila apoptosis remains controversial. Cytochrome c was 
shown to be dispensable for Caspase function and apoptosis in Drosophila cells and in 
vivo (Dorstyn et al., 2004). However, it is also reported that one of the Drosophila 
Cytochrome c genes, cyt-c-d, is required for Caspase activation during spermatid 
differentiation (Arama et al., 2006) and for developmental apoptosis in the pupal retina 
(Mendes et al., 2006). Taken together, the data suggests that an intrinsic pathway does 
exist in Drosophila. In support of a mitochondrial role in Drosophila apoptosis it was 
recently shown that Hid and Reaper localize to the mitochondria and bring about 
membrane permeabalization (Abdelwahid et al., 2007).
1.6.4.3 The extrinsic cell death pathway
Mammalian and Drosophila cell death may also be induced by the extrinsic pathway, 
which responds to death stimuli coming from outside the cell. For example, mammalian 
lymphocytes can kill cells by expressing the TNF ligand, Fas, which binds to tumour 
necrosis factor (TNF) receptors on the target cell. Ligand binding causes the recruitment 
and aggregation of various intracellular adaptor proteins and inactive pro-Caspase 8 
molecules. Following recruitment, Caspase 8 molecules are cleaved and go on to initiate 
the Caspase cascade in the target cell. Drosophila possesses a single TNF ligand 
homolog, Eiger, which is a potent inducer of cell death. In contrast to the mammalian 
extrinsic pathway Eiger does not induce apoptosis through the Caspase 8 homolog, 
DREDD, but instead activates the Jun-N-terminal kinase (JNK) pathway to induce 
apoptosis (Moreno et al., 2002).
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1.7 An introduction the Hippo signalling pathway
1.7.1 Discovery of a novel pathway controlling Drosophila growth
During development, cell proliferation, apoptosis and cell size must be tightly regulated 
in a coordinated manner to ensure that organisms reach the correct final adult size. A 
fundamental question in developmental biology is: how do organs stop growing when 
they reach the appropriate size? Drosophila adult organs such as the eyes, wings and 
legs are derived from imaginal discs; small epithelial sacs, which develop during the 
larval and pupal stages of the life cycle. The Hippo signalling pathway (see figure 7), 
recently identified in Drosophila melanogaster, acts to restrict the size of imaginal discs 
and organs by carrying out the dual functions of promoting apoptosis and exit from the 
cell cycle (Harvey and Tapon, 2007). LOF mutations in upstream ‘core’ Hippo pathway 
components lead to severely overgrown adult structures, therefore the Hippo pathway is 
part o f the mechanism that limits the size organs can reach.
The Hippo pathway was first identified in clonal screens for overgrowth phenotypes, 
which were carried out by several different groups. These screens involved randomly 
mutagenising chromosomes carrying FRT recombination sites, generating homozygous 
mutant clones in the eye and screening FI adults visually for aberrations that give 
mutant tissue (marked white) a growth advantage over wild-type tissue (marked red). 
One benefit of screening for overgrowth genes in this way is that mutations in tumour 
suppressor genes are often lethal at an early stage, precluding analysis o f the phenotype 
in adults. This lethality is bypassed by generating clones of mutant tissue in a non- 
essential organ such as the eye.
1.7.2 The ‘core’ components of the Hippo pathway
1.7.2.1 Warts / Lats (Wts)
The first member of the Hippo pathway to be identified was Warts / LATS (Wts) (see 
figure 7), which was recovered in a screen for overgrowth phenotypes in mosaic 
animals with clones of X-ray or P-element induced mutations (Justice et al., 1995; Xu et
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al., 1995). Loss of wts in clones causes severe overgrowth phenotypes in imaginal discs 
and epithelial tumours in the corresponding adult structures (Justice et al., 1995; Xu et 
al., 1995). In Drosophila Wts and Tricomered (Trc) are members o f the nuclear DBF2- 
related (NDR) family of serine/threonine kinases. Trc is not a growth regulator but 
instead functions to regulate Furry (Fry) and this interaction is required for normal wing 
hair development (He et al., 2005) and dendritic tiling (Emoto et al., 2004). Much of 
what is known about NDR kinases comes from studies in yeast, which show that NDR 
kinases, including the Wts homolog Dbf2, play roles in the mitotic exit network and 
cytokinesis (Hergovich et al., 2006). The human genome encodes 4 NDR family 
kinases; NDR1, NDR2, LATS1 and LATS2. The functions of mammalian NDR1 and 
NDR2 are not clear but mammalian LATS1 functions analogously to Wts as a tumour 
suppressor; LATS1 deficient mice develop ovarian and soft tissue tumours (St John et 
al., 1999).
1.7.2.2 Salvador / Shar-pei (Sav)
Several years later Salvador (Sav) / Shar-pei (Shrp) was identified in clonal screens for 
EMS induced mutations that cause overgrowth of mutant tissue in the eye (Kango- 
Singh et al., 2002; Tapon et al., 2002) (see figure 7). The main findings o f these studies 
will be summarized below, as they were the first comprehensive analysis of the 
characteristic Hippo pathway phenotype.
sav clones induced in the eye, notum or haltere display tumour-like outgrowths of 
tissue. Interestingly, it was shown that clones of sav cells in the eye contain many more 
inter-ommatidial cells than wild-type tissue and this abnormal cell number results from 
both delayed cell cycle exit and reduced apoptosis (Kango-Singh et al., 2002; Tapon et 
al., 2002).
In wild-type discs, a synchronous, final round of S-phases followed by staggered 
divisions occurs posterior to the MF. This is known as the second mitotic wave (SMW) 
and very little proliferation occurs posterior to the SMW. In sav mutant cells ectopic 
cell division is visualised posterior to the SMW using BrdU labelling to mark cells in S- 
phase. This data suggests that sav mutant cells do not exit from the cell cycle in a timely
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Figure 7: The Drosophila Hippo signalling pathway. The Hippo pathway was identi­
fied in Drosophila and is an important regulator of tissue size. The Hippo pathway nega­
tively regulates the size of organs by carrying out the dual functions of promoting apopto­
sis and exit from the cell cycle. The ‘core’ components of the pathway are in red and 
consist of the kinases Hpo and Wts, their adaptor proteins Sav and MATS, and the tran­
scriptional co-activator Yki. Hpo phosphorylates Wts, which in turn phosphorylates Yki 
leading to its exclusion from the nucleus. Yki binds to as yet unidentified transcription 
factors) (X) to promote the expression of cyclinE, DIAP1, bantam, merlin and expanded. 
Expanded and Merlin function upstream of Hpo but the mechanism by which Hpo is 
activated remains elusive. The atypical Cadherin Fat functions in the Hippo pathway, it is 
thought that Fat is required for Expanded membrane localization. Fat has also been 
proposed to regulate Wts protein levels by inhibiting Dachs. RASSF antagonizes the 
pathway by competing with Sav for binding to Hpo. Figure adapted from (Harvey, 2007).
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fashion leading to ectopic cell divisions. Furthermore sav mutant cells were found to 
contain elevated levels o f cyclinE, a critical regulator o f entry into S-phase (Kango- 
Singh et al., 2002; Tapon et al., 2002).
In wild-type eyes, an excess o f inter-ommatidial cells are generated during development 
and these are eliminated by a burst of apoptosis between 24 and 40 hours APF (after 
puparium formation). In pupal retinas containing sav clones, apoptosis is largely 
confined to the wild-type tissue suggesting that sav is required for developmental 
apoptosis (Kango-Singh et al., 2002; Tapon et al., 2002). In agreement with sav acting 
as a pro-apoptotic gene, levels of DIAP1, the Drosophila Inhibitor o f Apoptosis, are 
elevated in sav clones (Tapon et al., 2002). Taken together this suggests that the excess 
inter-ommatidial cell number in sav mutant cells is due to both delay in exit from cell 
cycle and reduced apoptosis.
Tapon et al. also made a connection between sav and wts, two genes now known to 
encode members of the Hippo pathway. Further analysis of wts mutant cells showed 
that, like sav mutant cells, wts clones show excess inter-ommatidial cells, BrdU 
incorporation posterior to the furrow and reduced apoptosis at 38h APF. Additionally, 
co-expression of sav and wts gives a stronger phenotype than expression o f each alone. 
A physical interaction between Sav and Wts was also observed; the WW domain o f Sav 
is capable of binding to Wts (Tapon et al., 2002).
1.7.2.3 Hippo (Hpo)
Hippo (Hpo) (see figure 7) was also identified in mosaic screens and hpo mutant clones 
have similar phenotypes to wts or sav clones, namely, excess inter-ommatidial cells, 
increased cyclin E and DIAP1 levels and proliferative advantage over wild-type cells 
(Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003). Hpo is 
a serine/threonine kinase of the Sterile-20 group and the Drosophila ortholog of human 
Mstl and Mst2. Mammalian Mstl and Mst2 have been shown to have roles in 
promoting apoptosis through phosphorylation o f histone H2B (Cheung et al., 2003) and 
FOXO transcription factors (Lehtinen et al., 2006). Recently a role for M stl and Mst2
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in the mammalian Hippo pathway has been confirmed (Chan et al., 2005; Dong et al., 
2007).
Hpo shows strong binding to Sav by co-immunoprecipitation and yeast two-hybrid 
(Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) suggesting that Hpo can 
complex with Sav. Hpo and Sav interact via their C-terminal regions; in two-hybrid 
studies the C-terminus o f Hpo binds to the C-terminus of Sav (Wu et al., 2003). 
Moreover, in-vitro translated C-terminal domains of Sav and Hpo can bind by co- 
immunoprecipitation (Udan et al., 2003). It is now known that the C-terminal region o f 
Hpo and Sav contains a unique 30-40 amino acid coiled-coil domain known as the 
SARAH domain (Scheel and Hofmann, 2003), which is crucial for binding of Hpo to 
either Sav or RASSF (Polesello et al., 2006) (See below).
When Hpo and Sav are co-expressed, a Sav mobility shift is observed suggesting that 
Sav is a phosphorylation target of Hpo. In support of this notion the mobility shift can 
be suppressed by phosphatase treatment (Pantalacci et al., 2003; Wu et al., 2003). 
Binding to Hpo stabilises Sav protein levels but this is not a consequence o f 
phosphorylation as kinase-dead Hpo also stabilizes Sav (Pantalacci et al., 2003).
Hpo is also able to phosphorylate Wts in kinase assays and co-transfection of Hpo and 
Wts in S2 cells leads to a Wts bandshift. Interestingly this bandshift is greater in the 
presence of Sav suggesting that Sav functions to enhance Hpo kinase activity (Wu et al., 
2003). Therefore, Sav and Hpo function upstream of Wts; Sav binds to Hpo and this 
interaction promotes signalling to Wts.
Hpo also phosphorylates DIAP1 in in-vitro kinase assays presumably leading to 
downregulation o f DIAP1 protein levels (Harvey et al., 2003; Pantalacci et al., 2003). 
However, another group provided evidence that regulation of DIAP1 by Hpo is also 
transcriptional by examining the response of a DIAP1 transcriptional reporter (DIAP- 
LacZ) in hpo mutant tissue (Wu et al., 2003).
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1.7.2.4 Mob as tumour suppressor (Mats)
Mob as tumour suppressor (Mats) (see figure 7) also functions in growth regulation and 
Mats mutant clones show characteristic Hippo pathway phenotypes. Mats is able to 
physically associate with Wts and this increases the kinase activity of Wts (Lai et al.,
2005). It was recently shown that Mats functions downstream of Hpo genetically. Mats 
is a phosphorylation target o f Hpo and that this phosphorylation increases its affinity for 
Wts (Wei et al., 2007). The S.cerevisiae homolog of Mats (M oblp) is an important 
regulator of the mitotic exit network kinase Dbf2p, the homolog of Wts, suggesting that 
the interaction between Mats and Wts is evolutionarily conserved (Hergovich et al.,
2006).
In summary, these findings indicate that Wts, Sav, Hpo and Mats function in the same 
signalling pathway and are required to limit organ growth. Hpo binds to its adapter Sav 
and this interaction promotes the phosphorylation of Wts and Mats. Wts phosphorylates 
target proteins. As Wts is downstream of Hpo and Sav it could integrate signals from 
other pathways, which offers an explanation for its stronger LOF phenotype.
1.7.2.5 Yorkie (Yki)
Yorkie (Yki) (see figure 7) is a transcriptional co-activator and functions downstream of 
Wts in the Hippo pathway (Huang et al., 2005). The discovery of Yki was important in 
the field as it provided a link between Hpo signalling and transcriptional control and is 
to date the most downstream ‘core’ component of the pathway. Yki was identified in a 
yeast 2-hybrid screen for Wts interactors and is homologous to the mammalian Yes- 
associated proteins (YAP1 and YAP2). Interestingly has the opposite phenotype to 
wts, sav, hpo or mats in that over-expression of yki results in similar overgrowth 
phenotypes to LOF of other Hippo pathway components (Huang et al., 2005). 
Conversely, only small yki LOF clones can be recovered and these clones are negative 
for DIAP-LacZ. This provides further evidence that the Hippo pathway can regulate 
DIAP1 at the transcriptional level (Huang et al., 2005).
45
Several lines of evidence place Yki downstream of Hpo and Wts. Firstly, in a cell-based 
assay, the activity o f Yki as a transcriptional co-activator is suppressed by co-expression 
of Hpo, Sav and Wts. Secondly, Yki is epistatic to Hippo pathway components. For 
example, yki hpo double mutant clones are phenotypically similar to yki clones (small) 
rather than hpo clones (large). Thirdly, Yki is phosporylated by Wts and the observed 
Yki mobility shift is enhanced in the presence o f Hpo and Sav (Huang et al., 2005). 
This is an inhibitory phosphorylation as signalling from Wts reduces Yki activity in the 
transcription assay. As Yki does not contain DNA binding sequences it is thought that 
Yki binds to an as yet unidentified transcription factor to activate Hippo pathway 
targets.
Recently, S I68 was identified as the critical Yki residue targeted by Wts for growth 
inhibition and its phosphorylation leads to exclusion of Yki from the nucleus, an event 
mediated by the 14-3-3 proteins (Dong et al., 2007). The translocation o f Yki to the 
cytoplasm in the presence of Hippo signalling is visualized in S2 cells by 
immunofluorescence and cell fractionation, and in vivo using a Yki antibody (Dong et 
al., 2007). Mutation of this residue alleviates inhibition by Hippo signalling and leads to 
constitutive Yki activation; inducible expression under the control of the tubulin 
promoter of mutant but not wild-type yki drives overgrowth (Dong et al., 2007). 
Moreover, it was shown that the equivalent YAP residue, S I27, is targeted by the 
mammalian Hippo pathway and relocalizes YAP to the cytoplasm (Dong et al., 2007). 
Yki is believed to be a co-activator and would therefore need to interact with a DNA- 
binding transcription factor. The identity of such factor(s) remains unknown, therefore 
none of the Hippo pathway targets have been formally demonstrated to be directly 
under Yki transcriptional control.
1.7.3 Other components of the Hippo pathway
1.7.3.1 bantam -  a transcriptional target of the Hippo pathway
The first identified Hippo pathway targets, CyclinE and DIAP1, although important 
regulators of cell division and apoptosis could not account for the extreme severity of 
Hippo pathway mutations; the discovery of the microRNA bantam as a target of Hippo
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signalling helped to reconcile this. Over-expression of bantam in the eye causes an 
increase in the number of inter-ommatidial cells (Nolo et al., 2006; Thompson and 
Cohen, 2006) and this phenotype is more severe than over-expression of cyclinE or 
DIAP1 (Nolo et al., 2006).
A GFP sensor containing bantam target sites was used as a measure of bantam 
expression, wherever bantam is expressed GFP expression is inhibited (Brennecke et 
al., 2003). The bantam sensor responds to changes in Hpo signalling and the fact that 
yki expression can affect the sensor provides evidence that bantam is a target o f the 
Hippo pathway (Nolo et al., 2006; Thompson and Cohen, 2006). Importantly, bantam is 
required for Yki to induce overproliferation; yki over-expression clones are much larger 
than controls but if bantam is absent these clones are not overgrown (Thompson and 
Cohen, 2006). Conversely, over-expression of bantam is able to rescue the small size of 
yki mutant clones (Nolo et al., 2006; Thompson and Cohen, 2006). This suggests that 
bantam is a target of the Hippo pathway and acts to promote cell division. It is likely 
that bantam also mediates some o f the pro-apoptotic effects of the Hippo pathway as 
Hid is known to be a bantam target (Brennecke et al., 2003). The mRNA(s) bantam 
binds to for cell cycle control have yet to be identified and unlike many other Hippo 
pathway members there are no clear mammalian bantam homologs.
1.7.3.2 Expanded (Ex) and Merlin (Mer) function upstream of Hippo
Merlin is a FERM domain containing protein homologous to Neurofibramatosis type-2 
gene (NF2). NF2 is a tumour suppressor gene and mutations in NF2 are the cause o f a 
familial form of cancer associated with the development o f tumours of the skin and the 
nervous system. Merlin has been shown to have tumour suppressor roles in flies and 
functions redundantly with a related FERM domain containing protein, Expanded, to 
regulate tissue growth and differentiation (McCartney et al., 2000). A role in the Hippo 
pathway was proposed due to merlin, expanded double mutant phenotypic similarities; 
clones show many excess inter-ommatidial cells in the pupal retina and tissue 
outgrowths (Hamaratoglu et al., 2006). Mutations in merlin or expanded alone cause 
only mild overgrowth phenotypes suggesting that they can at least partially replace each 
other.
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Merlin and Expanded were the first reported examples of proteins functioning upstream 
of Hpo (see figure 7) and several key experiments suggest that this is the case. Firstly, 
over-expression of expanded is rescued by loss of wts but over-expression o f hpo is not 
rescued by loss of expanded and merlin. Secondly, transcriptional upregulation elicited 
by loss of expanded is suppressed by over-expression of hpo. It was also shown that 
Merlin and Expanded are able to act together to induce Wts phosphorylation 
(Hamaratoglu et al., 2006). Interestingly, Merlin and Expanded are also transcriptional 
targets o f the Hippo pathway and this may provide a negative feedback control 
mechanism to regulate the pathway (Hamaratoglu et al., 2006). The mechanism by 
which Merlin and Expanded regulate the Hippo pathway is still unclear but may involve 
transducing a signal from an as yet unknown receptor. Alternatively, since Merlin has 
been reported to mediate contact inhibition in mammals, Merlin/Expanded signalling 
may respond to cell-cell contacts (Zhao et al., 2007).
Another group reported that Merlin and Expanded are required for the efficient 
membrane clearance of several different transmembrane receptors, merlin expanded 
double mutant clones show elevated levels of EGF receptor, Notch, Patched, 
Smoothened, Fat and DE-Cadherin (Maitra et al., 2006). Pulse-chase experiments using 
an extracellular Notch antibody showed that Notch is removed form the cell surface 
more quickly in wild-type than expanded!merlin mutant cells, suggesting a role for 
Merlin and Expanded in endocytosis o f membrane receptors (Maitra et al., 2006). This 
data raises the possibility that Merlin and Expanded only indirectly regulate the Hippo 
pathway as a consequence o f their effects on other signalling pathways.
1.7.3.3 Fat (Ft) functions upstream of Hippo
One putative receptor for the Hippo pathway is the atypical cadherin Fat. Fat is known 
to play important roles in the generation o f planar cell polarity (PCP) and control o f 
organ growth. Fat had long been known to function as a tumour suppressor in 
Drosophila but the pathways downstream of Fat were elusive. Closer examination 
revealed that fa t  mutant cells upregulate Hippo pathway targets such as cyclin E, DIAP- 
LacZ and expanded-LacZ (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 
2006). Genetic experiments suggest that Fat functions apically in the Hippo pathway
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upstream of Expanded, for example, mutations fail to rescue the small eye caused by 
over-expression of expanded (Bennett and Harvey, 2006; Willecke et al., 2006). Since 
Fat is a transmembrane protein and functions upstream of Expanded, it has been 
proposed that Fat functions as a receptor for the Hippo pathway. However, fa t  mutant 
phenotypes are significantly weaker than Hippo pathway phenotypes suggesting that, 
like Expanded and Merlin, Fat may function redundantly. In agreement with this, Fat is 
required for the apical localization of Expanded but not Merlin (Bennett and Harvey, 
2006; Silva et al., 2006; Willecke et al., 2006). As Fat is required for Expanded 
localization/function, it also acts redundantly with Merlin, fa t expanded double mutant 
clones do not show many excess inter-ommatidial cells whereas fa t merlin double 
mutant clones show the characteristic Hippo pathway phenotype (Silva et al., 2006; 
Willecke et al., 2006).
An alternative and not mutually exclusive model of the role of Fat in the Hippo pathway 
has been proposed whereby Fat acts through the unconventional myosin Dachs to 
regulate the levels of Wts protein. Epistasis experiments suggest that Fat functions 
upstream of Dachs and Dachs functions upstream of Wts (Cho et al., 2006). In 
agreement with a role for Dachs in Hippo signalling it was shown that DIAP1 levels are 
elevated in dachs overexpressing cells (Cho et al., 2006). Interestingly, in fa t  mutant 
clones levels of Wts protein (but not levels of other Hippo pathway members) are 
downregulated, and in dachs fa t  double mutant clones Wts levels are unaffected (Cho et 
al., 2006). This suggests that Fat acts to inhibit the function of Dachs, which itself is 
required to reduce levels of Wts. This work provided an alternative mechanism for the 
regulation of the Hippo pathway by Fat, which is independent of Expanded and Hpo. 
Fat activity is known to be positively regulated by another protocadherin, Dachsous 
(Ds), raising the possibility that Ds is a ligand for the Hippo pathway. In support o f this 
view ds over-expression clones show upregulation of the Hippo pathway target DIAP1 
within the clones and also in surrounding wild-type cells (Cho et al., 2006).
1.7.3.4 dRASSF antagonises Hippo signalling
Several upstream positive regulators of Hpo and Wts have now been described however 
the only known antagonists are Dachs and dRASSF, the Drosophila ortholog of the
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mammalian RASSF proteins. There are 8 RASSF family members in humans 
(RASSF1-8), which have been proposed to function as tumour suppressors. Silencing of 
RASSF 1A by promoter methylation is one of the most frequent alterations in human 
tumours (van der Weyden and Adams, 2007). RASSF proteins are characterized by an 
RA domain and RASSF 1-6, which are the most closely related to dRASSF, also possess 
a SARAH domain.
dRASSF or Sav are able to physically interact with Hpo via their SARAH domains, a 
unique domain found in all three proteins. It is thought that dRASSF and Sav compete 
for binding to the Hpo SARAH domain as in cells dRASSF and Sav are never detected 
in the same Hpo complex. Also, adding increasing amounts of Sav disrupts the binding 
of Hpo and dRASSF (Polesello et al., 2006). Therefore dRASSF can inhibit Hippo 
signalling by binding to Hpo and sequestering it away from its adapter and positive 
regulator, Sav. dRASSF is also thought to have a tumour suppressor function aside from 
its oncogenic role in the Hippo pathway as dRASSF mutation can partially rescue the 
poor growth of ras clones (Polesello et al., 2006).
1.7.4 The Hippo pathway has other functions besides growth regulation
Aside from its crucial role in the control of organ growth the Hippo pathway has been 
shown to have other functions during development. For example, Wts has been shown 
to antagonize another growth regulator, Melted, to control the fates o f R8 
photoreceptors in the developing eye (Mikeladze-Dvali et al., 2005). Colour vision in 
Drosophila is achieved by a random distribution of p and y sub-types of ommatidia, 
which respond to different wavelengths of light by expressing different rhodopsins. Wts 
and Melted are required to respond to signals from the R7 photoreceptor that specify 
which rhodopsin is expressed in the R8 (Mikeladze-Dvali et al., 2005).
In addition to this post-mitotic role in photoreceptor development the Hippo pathway 
has been shown to be required for neurogenesis during the larval stages. In wts, hpo or 
sav mutants the number and length of dendritic branches is greatly reduced (Emoto et 
al., 2006). This is a late defect as initially wts mutant neurons have similar dendritic 
arbors to wild-type neurons but at later developmental stages the complexity o f wts
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mutant arbours is reduced suggesting a role for Hpo and Wts in the maintenance of 
dendrites (Emoto et a l, 2006).
The Hippo pathway also has a role in responding to DNA damage by mediating 
apoptosis downstream of Dmp53. Ionizing radiation induces an apoptotic response to 
DNA damage, which is dependent on Dmp53, the Drosophila ortholog of the 
mammalian p53 tumour suppressor. This response also requires Hippo signalling as 
hpo, sav or wts mutant clones contain fewer apoptotic cells than the surrounding tissue 
(Colombani et al., 2006). Additionally Hpo phosphorylation is induced in response to 
ionizing radiation in wild-type but not Dmp53 mutant ovaries suggesting that Dmp53 
activates the Hippo pathway in response to DNA damage (Colombani et al., 2006).
Recently the Hippo pathway has been shown to have an early developmental role in 
establishing oocyte polarity. During mid-oogenesis gurken (grk) mRNA becomes 
localized to a region between the oocyte nucleus and the membrane of the presumptive 
posterior follicle cells (PFCs). Grk is an EGFR ligand and provides a signal that 
specifies the PFCs. The PFCs are then thought to signal back to the oocyte which 
reorganizes the microtubule network and establishes anterior-posterior polarity via an 
unknown signal. If the PFCs are mutant for ‘core’ Hippo pathway components, then the 
posterior determinants Staufen and Oskar do not localize to the posterior end of the egg 
chamber. This only occurs when the PFCs, rather than other follicle cells, are mutant, 
suggesting that Hippo signalling is specifically required in the PFCs to control anterior 
posterior body axis formation (Meignin et al., 2007; Polesello and Tapon, 2007).
1.7.5 The Hippo pathway and cancer
Given that most of the Hippo pathway members discussed above have clear mammalian 
homologs and that they carry out such potent growth regulatory functions in 
Drosophila, it is reasonable to expect that a similar pathway plays a role in human 
tumourigenesis. Strong evidence for functional conservation is provided by the data 
showing that the human MATS1, MST2 and YAP genes can rescue the corresponding 
Drosophila mutants in vivo (Huang et al., 2005; Lai et al., 2005; Wu et al., 2003). The 
homolog of sav, hWW45, is deleted in renal cancer cell lines (Tapon et al., 2002) and a
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MATS homolog is disrupted in cell lines derived from human melanomas (Lai et al.,
2005). Studies in mice have identified LATS1 (one o f two Wts homolgs) as a tumour 
suppressor; knockout mice developed soft tissue sarcomas and ovarian cancer and are 
extremely sensitive to carcinogenic treatments (St John et al., 1999).
The homologue of yki (known as YAP) has oncogenic properties and has also been 
implicated in cancer. The genomic locus 9qAl contains the mouse equivalents of yki 
and D1AP1 ( YAP and cIAP) and is often duplicated in a mouse model of hepatocellular 
carcinoma (Zender et al., 2006) and in mouse mammary tumours (Overholtzer et al.,
2006). It was further shown that YAP and cIAPl act synergistically and are the driving 
force behind tumourigenesis associated with this genomic amplification (Zender et al.,
2006). Importantly, the genomic region containing YAP is also amplified in some 
human hepatocellular carcinoma samples and esophageal cancers (Zender et al., 2006). 
Over-expression of YAP results in cellular changes required for tumourigenesis such as 
epithelial to mesenchymal transitions, increased proliferation and resistance to apoptosis 
(Overholtzer et al., 2006). The fact that the merlin homolog NF2 is a known mammalian 
tumour suppressor and its deletion is the cause of neurofibromatosis type 2, also 
strongly implicates the Hippo pathway in human cancer.
Despite the links between many Hippo pathway orthologs and tumourigenesis a clearly 
defined mammalian Hippo pathway has only recently been described to regulate tissue 
growth. The characterization of a mammalian Hippo pathway benefited from the 
identification of S I27 as the YAP phosphorylation site. Using phospho-specific 
antibodies it was demonstrated that YAP is targeted by M stl/2 and Latsl/2 in 
mammalian cells leading to its exclusion from the nucleus (Dong et al., 2007; Zhao et 
al., 2007). Furthermore, conditional activation of YAP in mouse livers leads to a 
dramatic increase in organ size as a result of increased cell numbers, much like the 
phenotypes seen when yki is expressed in Drosophila organs (Dong et al., 2007). RT- 
PCR analysis of transgenic livers revealed that both cell cycle regulators and apoptosis 
inhibitors are upregulated by YAP. The cell-death inhibitor BIRC5/survivin was 
strongly induced and shown to be functionally important as BIRC5 RNAi inhibited the 
transforming capability of YAP (Dong et al., 2007). It has also been recently shown that 
the Hippo pathway inhibits YAP via S I27 phosphorylation to achieve contact inhibition 
of growth in mammalian cells. Inhibition of YAP rescues the contact inhibition defect
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in a WW45 (Sav) deleted cancer cell line (Zhao et al., 2007). This suggests that the 
Hippo pathway can respond to the density of cells within a tissue and regulate growth 
accordingly. Thus, it seems that the Hippo pathway functions analogously in 
Drosophila and mammals to restrict organ growth by inhibiting Yki/YAP dependent 
transcription of genes involved in the control of proliferation and apoptosis. Therefore, 
although much work still needs to be done to assess the role of the Hippo pathway in 
mammalian systems, there are clear indications that this conserved signalling cassette 
contributes to tumourigenesis.
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1.8 An introduction to the regulation and function of SFKs
1.8.1 Mammalian SRC family kinases
Cellular SRC (c-SRC) is a member of the SRC family kinases (SFKs), which include 
SRC, FYN and YES. c-SRC is heavily implicated in cancer and in the progression of 
the disease leading to metastasis. c-SRC is either overexpressed or activated in a wide 
variety of tumours and this reflects its roles in promoting proliferation, loss of adhesion 
and increased cell motility and invasiveness (Yeatman, 2004) (see figure 8). Intensive 
research is currently underway to understand the cellular consequences o f c-SRC 
activation and to develop c-SRC inhibitors for cancer treatment. c-SRC is a tyrosine 
kinase and contains a C-terminal regulatory region and four SH (SRC homology) 
domains. The SHI domain is the kinase domain. The SH2 and SH3 domains bind to 
other proteins and are involved in the intramolecular interaction that inactivates c-SRC. 
The SH4 domain contains a myristoylation site, which allows c-SRC to dock to the 
plasma membrane (Cole et al., 2003).
1.8.2 Regulation of c-SRC
Viral SRC (v-SRC) of the avian Rous sarcoma virus (RSV) was the first viral oncogene 
to be identified and, unlike c-SRC, is capable of transforming infected cells. It was 
subsequently discovered that v-SRC is derived from vertebrate c-SRC and was 
incorporated by the virus by recombination. v-SRC transformed fibroblasts have a 
visibly altered morphology, they disaggregate from each other and float in the medium 
as a consequence of loss o f cell-cell and cell-substratum adhesions. The cells have 
increased motility and are able to invade a basement matrix. v-SRC transformed cells 
also exhibit increased proliferation rates and nutrient requirements (Yeatman, 2004).
v-SRC differs from c-SRC in that it contains several activating point mutations and 
lacks vital C-terminal regulatory sequences. The C-terminal region of c-SRC and other 
SFKs is targeted by CSK (C-terminal SRC kinase) (Okada et al., 1991) and its homolog 
CHK (CSK homologous kinase) (Klages et al., 1994), which negatively regulate c-SRC
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Figure 8: Cellular consequences of c-SRC activation. c-SRC regulates cell-cell adhe­
sions (adherens junctions) and cell-matrix adhesions (focal adhesions) and c-SRC activa­
tion leads to decreased adhesion, increased motility and invasiveness. Active c-SRC 
disrupts adherens junctions by promoting E-Cadherin internalisation. Active SRC-FAK 
complexes regulate focal adhesion turnover through R-Ras, which inhibits integrin func­
tion. The focal adhesion components Paxillin and Cas and the cytoskeletal regulator 
RhoA are also targeted by SRC-FAK complexes. SRC-FAK association leads to JNK 
activation and transcription of matrix-metalloprotease genes, mmp2 and mmp9. c-SRC 
activation also promotes angiogenesis and proliferation by increasing levels o f STAT3. 
Figure adapted from (Yeatman, 2004).
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by phosphorylating a conserved tyrosine residue (Tyr527 in avian c-SRC). This 
inactivates c-SRC by causing an intramolecular interaction between the phosphorylated 
tyrosine and its SH2 domain, reducing the ability of substrates to access the kinase 
domain and also blocking access to the SH2 and SH3 protein-protein interaction 
domains (Pawson, 1997). Unexpectedly, the crystal structure of inactive c-SRC revealed 
another interesting feature; in the inactive conformation, the SH3 domain contacts a 
region within the SH2-kinase domain linker region. This interaction is thought to force 
a crucial residue (Glu310) away from the active site, thus inhibiting activity. Functional 
data showing that the binding surface of the SH3 domain is essential for kinase 
inhibition supports this idea (Pawson, 1997). A similar intramolecular interaction was 
observed when the crystal structure of Hck, a closely related SFK was determined 
(Pawson, 1997) suggesting that switching between the open active conformation and the 
closed conformation is important for regulation of other SFK members. The v-SRC C- 
terminal truncation produces an activated SRC molecule resistant to inhibition by CSK 
and CHK. The transforming capabilities of v-SRC highlight the importance o f Tyr527 
phosphorylation in preventing inappropriate c-SRC activation.
In addition c-SRC is negatively regulated by ubiquitylation followed by proteasome- 
mediated degradation, for example, expression of the ubiquitin ligase CBL-3 inhibits v- 
SRC transformation (Kim et al., 2004a). CBL-3 binds specifically to fully active c-SRC 
(Tyr419 phosphorylated, see below) and promotes its ubiquitination and 
downregulation (Kim et al., 2004a).
c-SRC can be activated by removal of the Tyr527 phosphorylation by phosphatases 
such as PTP1 and SHP2, which allow c-SRC to adopt an open, active conformation 
(Jung and Kim, 2002; Zheng et al., 1992). Full activation of c-SRC also requires an 
auto-phosphorylation o f a tyrosine (Tyr419) within the kinase domain. Binding o f other 
proteins to c-SRC can also regulate its activity, for example, focal-adhesion kinase 
(FAK) and CRK-associated substrate (CAS) can bind to the SH2 and SH3 domains of 
c-SRC and this can prevent the inactive conformation from forming (Burnham et al., 
2000; Schaller et al., 1994; Thomas et al., 1998). c-SRC can also be activated in 
response to extracellular cues via interaction with activated receptor tyrosine kinases 
such as the EGF receptor (Tice et al., 1999) and the FGF receptor (Landgren et al., 
1995). Co-transfection of c-SRC and EGFR into fibroblasts results in a synergistic
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potentiation of transformation, c-SRC associates directly with EGFR and 
phosphorylates tyrosine residues (Tyr-854 and Tyr-1101), an event necessary for the 
mitogenic response (Tice et al., 1999).
c-SRC activity is also regulated by its sub-cellular localization; activated c-SRC is 
translocated to the plasma membrane to which it binds via its myristoylated SH4 
domain, allowing full activation through auto-phosphorylation of Tyr419 (Kmiecik and 
Shalloway, 1987; Yeatman, 2004). The membrane localization allows c-SRC to gain 
access to target proteins including RTKs and components of focal adhesions.
1.8.3 Downstream effectors of c-SRC
Many of the downstream targets of c-SRC (see figure 8) were identified using phospho- 
tyrosine antibodies and these include transcription factors, adaptor proteins and focal 
adhesion components (Yeatman, 2004). The numerous c-SRC targets identified indicate 
that there are probably also many indirect targets contributing to the activated c-SRC 
transformation phenotype. Gene expression profiling of SRC-transformed rat fibroblasts 
uncovered a SRC ‘transformation footprint’. Interestingly, the homologs of many of the 
genes identified were also mis-expressed in colon tumour samples where c-SRC is 
known to be activated (Malek et al., 2002).
1.8.3.1 c-SRC regulates STAT3 to promote proliferation and angiogenesis
The STAT family of proteins are believed to be important targets of c-SRC. In v-SRC 
transformed cells, levels o f STAT3 are increased and dominant negative STAT3 
expression can inhibit transformation (Bromberg et al., 1998). The role of STAT3 in v- 
SRC transformation is probably to increase proliferation via transcription o f cell cycle 
regulators such as cyclinE and c-Myc. However, STAT3 upregulation may also 
contribute to angiogenesis as it regulates the expression of vascular endothelial growth 
factor (VEGF) (Frame, 2004).
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1.8.3.2 Regulation of focal adhesions by c-SRC
Focal adhesions are large complexes of over 50 proteins, including c-SRC, FAK, CAS, 
paxillin, tensin and a-catenin, which bind to integrins. Integrins are the proteins that 
link the actin cytoskeleton to the extracellular matrix (ECM). Focal adhesions are 
dynamic structures with a rapid turnover in migrating cells. Migrating cells extend 
protrusions and form new adhesions near the leading edge, followed by disruption of 
old adhesions at the rear. It is thought that c-SRC facilitates the disruption of focal 
adhesions partly through phosphorylating two cytoplasmic tyrosines o f pi A integrin 
subunits. Mutation of one of these residues (Tyr-783) inhibits the ability of v-SRC to 
transform mouse fibroblasts and focal adhesions are maintained in the presence o f v- 
SRC (Sakai et al., 2001). v-SRC induced phosphorylation of another integrin subunit, 
P3, has also been reported to contribute to decreased adhesion (Datta et al., 2002). This 
suggests that phosphorylation of integrins by v-SRC reduces interaction between the 
actin cytoskeleton and the ECM, thus reducing adhesion. v-SRC is also thought to 
regulate integrins indirectly through tyrosine phosphorylation of an intermediate 
protein, R-Ras, a RAS family small GTPase. v-SRC has been shown to phosphorylate 
R-Ras at Tyr-66 leading to inhibition of integrin activity and reduced adhesion (Zou et 
al., 2002). v-SRC can also regulate focal adhesions by inhibiting RHOA, a small 
GTPase absolutely required for their assembly. v-SRC phosphorylates and activates 
p i90 RHOGAP leading to inhibition of RHOA activity and to focal adhesion disruption 
(Chang et al., 1995; Fincham et al., 1999).
In addition to their role as adhesion molecules integrins can also affect cellular 
processes by recruiting and activating signalling molecules, including the tyrosine 
kinase FAK. FAK is recruited to integrin P-subunits via its C-terminal region and 
becomes activated by an unknown mechanism, leading to phosphorylation of Tyr-397. 
This provides a binding site for the SH2 domain of SFKs leading to the formation of 
active c-SRC-FAK complexes and subsequent phosphorylation of numerous target 
proteins with roles in cell motility, invasion and adhesion (Mitra and Schlaepfer, 2006).
Targets of c-SRC-FAK complexes include the focal adhesion adaptor proteins Paxillin 
and CAS, which recruit other molecules to focal adhesions upon activation. Active c-
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SRC-FAK complexes are believed to be important for rapid turnover of focal adhesions 
and hence affect cell motility.
Active c-SRC-FAK complexes also can lead to increased invasiveness by localising to 
invadopodia, which are integrin enriched cytoplasmic extensions formed by invasive 
cells. Expression of FRNK, a FAK inhibitor, is sufficient to inhibit v-SRC mediated 
invasion through matrigel, suggesting that c-SRC-FAK complexes can promote 
invasion (Hauck et al., 2002). This idea is supported by data showing that expression of 
v-SRC in FAK-/- fibroblasts does not lead to invasive phenotypes (Hsia et al., 2003). 
Additionally, activation of FAK leads to stimulation of the JNK signalling pathway and 
concurrent expression of matrix-metalloproteases MMP2 and MMP9, which promote 
ECM breakdown and facilitate invasion (Hauck et al., 2002; Hsia et al., 2003) (see 
figure 8).
1.8.3.3 Regulation of cell-cell adhesions by c-SRC
Activated SRC not only regulates adhesion to the ECM via interactions with focal 
adhesion components but also regulates cell-cell adhesions via regulation o f adherens 
junctions. Cell-cell adhesion is achieved through homotypic E-cadherin interactions 
between neighbouring cells. Adherens junction components also include |3-catenin and 
a-catenin, which provide a link to the actin cytoskeleton, and the adherens junction 
regulator p i20 catenin. c-SRC inhibits adherens junctions by reducing E-cadherin 
localization and function and by promoting its internalization by the endocytic pathway 
(Palacios et al., 2005) (see figure 8). Translocation of E-cadherin to the membrane is 
blocked by v-SRC expression when cells are supplied with calcium and attempt to form 
cell-cell contacts. Therefore activated SRC can affect the sub-cellular localization o f E- 
Cadherin (Frame, 2004). pl20-catenin is thought to both stabilise and disrupt adherens 
junctions depending on the context. It has been proposed that pl20-catenin binds to E- 
Cadherin and this facilitates its phosphorylation by v-SRC, in turn leading to reduced 
Cadherin function (Frame, 2004). With respect to E-cadherin internalization, it was 
shown that activated c-SRC leads to tyrosine phosphorylation, ubiquitination and 
internalization of E-Cadherin in a process requiring the E3 ubiquitin ligase, Hakai 
(Fujita et al., 2002). The loss of E-Cadherin from the surface of cells results in loss of
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cell-cell contacts and epithelial to mesenchymal transition (EMT) (Frame, 2004). 
Cancer cells that have undergone EMT show a switch in adhesion from cell-cell 
contacts to cell-matrix contacts and are considered to be more prone to metastasis. 
Therefore the suppression of E-Cadherin function by activated c-SRC may partly 
account for the correlation between tumours with activated c-SRC and metastasis such 
as in the case of advanced colon cancers.
In summary, activated c-SRC regulates both cell-cell contact (adherens junction) and 
cell-ECM contact (focal adhesion) components to achieve its dramatic effects on cell 
adhesion, motility and invasiveness. Loss of adherens junctions promotes EMT, leading 
to loss of cell-cell adhesion and increased motility. The actions of activated c-SRC at 
focal adhesions increase motility and promote invasiveness. It is probably for these 
reasons that activated c-SRC is so often associated with metastasis. The kinase FAK 
plays a pivotal role in several of the processes occurring downstream of activated c- 
SRC, particularly in promoting invasion. Activated c-SRC can also increase 
proliferation rates and induce angiogenesis.
1.8.4 c-SRC and cancer
Activated c-SRC is known to increase fibroblast proliferation rates but whether this 
effect has any consequences during tumourigenesis is not clear. For example, c-SRC 
activity in colon cancer cells does not correlate with proliferation rates or with tumour 
growth rates in vivo (Yeatman, 2004). However, it is well documented that 
gastrointestinal-tract tumours show increasing levels of c-SRC activity as the disease 
progresses with the highest levels of activity observed in metastatic growths (Talamonti 
et al., 1993). The link between activated c-SRC and metastasis is supported by data 
showing that expression of CSK, the c-SRC inhibitor, suppresses metastasis in murine 
models (Nakagawa et al., 2000). Several other cancer types have been reported to show 
increased c-SRC activity, such as pancreatic, oesophageal, breast and lung cancers (Irby 
and Yeatman, 2000). Interestingly, some colon cancers simultaneously have high levels 
of c-SRC and low levels of CSK, a combination causing further increases in c-SRC 
activity (Cam et al., 2001). Surprisingly, despite the increases in c-SRC activity 
observed in various tumours, there has been only one report of naturally occurring c-
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SRC mutations in human cancer; it was shown that a small proportion o f colon cancers 
have an activating mutation at residue 530 (Irby and Yeatman, 2000). However, the fact 
that c-SRC can be activated by other means than mutation, such as by the EGF receptor, 
provides an explanation for the apparent lack o f c-SRC mutations described. Work is 
currently underway to develop inhibitors of c-SRC activation as new drugs for cancer 
treatment and several compounds are now entering clinical trials (Yeatman, 2004). 
Depletion of c-SRC only has mild cellular consequences meaning that c-SRC inhibitors 
may be relatively non-toxic compounds.
1.8.5 Functions of other SFKs
Of the nine SFK members identified, c-SRC, Yes and Fyn are considered to be 
ubiquitously expressed and show a broad expression pattern throughout mouse 
development. These three SFKs are also the only members identified as viral 
transforming oncogenes. The study of mutants lacking various combinations of these 
SFKs revealed that they have partially overlapping functions during development. LOF 
of any one of these genes gives rise to either restricted phenotypes in the case of c-SRC 
(mutant mice are viable but die after a few weeks due to bone remodelling defects) 
(Soriano et al., 1991) or no phenotype in the case of Fyn or Yes (Stein et al., 1994). 
However, c-SRC / Fyn double mutants or c-SRC / Yes double mutants commonly die 
before birth and the number o f offspring is considerably lower than expected. This 
suggests that these SFKs function redundantly and can compensate for LOF of another 
(Stein et al., 1994). A proportion of Fyn /  Yes double mutants do survive to adulthood 
but these mice commonly develop renal diseases. This is unexpected as Fyn is not 
thought to be expressed in mouse kidneys. However, Fyn and Yes are both expressed in 
T-cells suggesting that the renal disease may be a consequence of an autoimmune 
disorder (Stein et al., 1994). Therefore it is possible that Fyn and Yes play redundant 
roles in T-cells.
Aside from their roles in controlling proliferation and adhesion, the main other 
described function for SFKs is regulation of immune cell function. The role of SFKs in 
the immune system is well documented but will be discussed only briefly here as this 
function is largely irrelevant when studying Drosophila SFKs as insects do not possess
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and adaptive immune system. Several SFK members have important roles in the 
immune system and those members that are not ubiquitously expressed show specific 
expression in hematopoetic lineages. For example, myeloid lineages express Hck, Fgr 
and Lyn; B cells express Fyn, Lyn and Blk; T cells primarily express Fyn and Lck 
(Palacios and Weiss, 2004).
Lck and Fyn are crucial for T-cell function and are involved in the transmission of 
signals from proximal T-cell antigen receptors (TCRs). Lck and Fyn are recruited to 
TCRs and phosphorylate intracellular tyrosine residues to which members o f the Syk 
family kinases bind. Syk family kinases, particularly ZAP-70, are phosphorylated and 
activated by Lck and Fyn and mediate the propagation of signalling (Palacios and 
Weiss, 2004). TCR signalling, and thus Lck and Fyn activity, is required at multiple 
stages during T-cell development and also in mature T-cells for proliferation following 
antigen recognition and survival signalling (Palacios and Weiss, 2004). With the 
exception of T-cell survival, which requires both Lck and Fyn, the major contributor to 
TCR signalling is Lck. In an analogous manner, SFKs are also required for signal 
transduction from B-cell antigen receptors. CSK is required to inhibit SFKs in T-cells 
and B-cells and loss of CSK prevents T-cell and B-cell maturation (Thomas and 
Brugge, 1997).
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1.9 CSK and CHK - endogenous SFK inhibitors
1.9.1 An introduction to CSK and CHK
Carboxy-terminal SRC kinase (CSK) and Csk-homologous kinase (CHK) are 
endogenous inhibitors of SFKs, which phosphorylate SFKs at a conserved tyrosine 
residue in the C-terminal regulatory tail. Evidence supporting a biologically functional 
role for CSK as a c-SRC inhibitor comes from studies of knockout mice. CSK  knockout 
mice die at an early embryonic stage, in contrast, CSK  / c-SRC double mutants die 
shortly before birth and show less severe neural tube defects (Thomas et al., 1995). 
Additionally, cells derived from CSK mutant embryos show high c-SRC and Fyn 
activity and reduced c-SRC C-terminal phosphorylation (Imamoto and Soriano, 1993). 
In contrast to SFKs, CSK is a highly specific tyrosine kinase. This is thought to be 
because long range three dimensional interactions occurring specifically between CSK 
and c-SRC are required for phosphorylation (Cole et al., 2003).
CSK and CHK are related to SFKs (CSK and c-SRC showing 40% overall sequence 
identity) and have similar domain architecture, including a tyrosine kinase domain and 
SH2 and SH3 domains. CSK and CHK differ from SFKs in that they lack the N- 
terminal myristoylation domain involved in membrane anchoring and also lack the C- 
terminal regulatory tail (Cole et al., 2003). It appears that the SH2 and SH3 domains of 
CSK are important for the catalytic activity of the kinase domain rather than negatively 
regulating it, as is the case for c-SRC. When the SH2 and SH3 domains are deleted 
from purified CSK enzyme, a 100-fold reduction in catalytic activity is observed 
suggesting that these domains are involved in an intramolecular interaction (Sondhi and 
Cole, 1999). It was further shown that only the SH3 domain is important for catalytic 
activity as it, but not the SH2 domain, could partially rescue the activity o f the isolated 
kinase domain (Sondhi and Cole, 1999). However, the SH3 domain only rescued the 
catalytic activity of the isolated kinase domain to 5% of that of full length CSK 
indicating that other interactions are involved. The crystal structure of full length CSK, 
determined in 2002, has indicated that the intramolecular interaction that is required for 
catalytic activity is between the SH2-SH3 linker region and the catalytic domain 
(Ogawa et al., 2002). This is a distinct mode of regulation to that used by c-SRC and 
Hck.
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1.9.2 Regulation of CSK
Whereas the localization of c-SRC is largely membranal, CSK is found throughout the 
cytoplasm. However, expression of activated c-SRC causes a re-localization o f CSK to 
regions of high c-SRC activity, in particular, actin rich structures called podosomes 
(Howell and Cooper, 1994). Kinase-dead CSK protein also co-localized with activated 
c-SRC at podosomes but CSK mutants lacking either the SH2 domain or SH3 domain 
did not. This suggests that the SH2 and SH3 domains of CSK are important in 
controlling its sub-cellular localization to efficiently inhibit c-SRC (Howell and Cooper, 
1994).
It is now thought that the localization of CSK is controlled by its interaction with a 
transmembrane phosphoprotein called Cbp (CSK-binding protein). Cbp was identified 
as a tyrosine phosphorylated protein that co-precipitates with CSK following 
immunoprecipitation of CSK from neonatal rat brain lysates (Kawabuchi et al., 2000). 
Cbp is ubiquitously expressed but enriched in a detergent insoluble membrane fraction 
also enriched for CSK and the SFK Fyn. Immunoprecipitation of proteins in this 
fraction revealed that Cbp specifically binds to CSK but not c-SRC or Fyn and that 
binding requires the SH2 domain of CSK (Kawabuchi et al., 2000). This agrees with 
previous studies showing that the SH2 domain of CSK is important for its relocalization 
to areas of high c-SRC activity. SFK inhibitors partially prevented phosphorylation of 
Cbp, suggesting that SFKs contribute to Cbp phosphorylation and association with 
CSK. An important Cbp phosphorylation site was identified as Tyr-314. Mutation of 
this residue prevented association with CSK and its subsequent relocalization as 
visualised by immunofluorescence (Kawabuchi et al., 2000). Cbp not only regulates the 
membrane recruitment of CSK but also seems to positively regulate its activity. 
Addition of phosphorylated Cbp was shown to increase the ability o f CSK to 
phosphorylate c-SRC in kinase assays (Takeuchi et al., 2000). Therefore the 
identification of Cbp provides a new mechanism by which SFKs are regulated that 
involves negative feedback; high SFK activity leads to Cbp phosphorylation and 
recruitment of the SFK inhibitor CSK to the membrane.
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1.9.3 CSK co-operates with other proteins to inhibit SFKs
Inhibition o f active SFKs by CSK may also require the action of various phosphatases 
as fully active, autophosphorylated (Tyr-419 in c-SRC) c-SRC and Yes proteins are 
resistant to inhibition. However, dephosphorylation of Tyr-419 by protein tyrosine 
phosphatase IB (PTP1B) allows for inhibition of c-SRC by CSK (Sun et al., 1998), 
suggesting that CSK and PTP1B co-operate in SFK inhibiton. Shp2 is another 
phosphatase regulating CSK function as it has been shown to control the 
phosphorylation status o f Cbp. Shp2 dephosphorylates Cbp leading to reduced 
recruitment of CSK to SFKs. Shp2-deficient cells show increased phosphorylation of 
SFK C-terminal regions, implying that Shp2 is a positive regulator o f SFK signalling 
(Zhang et al., 2004). Therefore, the inhibition of SFKs by CSK is a complex process 
involving the contribution of other proteins, including Cbp and PTP1B, and the 
antagonistic effects of Shp2.
1.9.4 In vivo studies of CSK
In vivo studies of CSK function support its role as an SFK inhibitor and reveal 
important roles for CSK in epithelial development. Conditional inactivation o f CSK in 
mouse squamous epithelia using a keratin-5 promoter and the Cre-lox system results in 
skin defects leading to hyperplasia and inflammation (Yagi et al., 2007). Analysis of 
CSK deficient epidermis showed that epidermal basal cells overproliferate and show a 
delay in differentiation. Additionally, P-catenin staining of basal epidermal cells is 
abnormal and is observed in a diffuse cytoplasmic pattern instead o f at cell-cell 
contacts. Therefore loss of CSK affects epidermal cell-cell adhesion (Yagi et al., 2007). 
Keratinocytes cultured from mutant mice show high levels of tyrosine phosphorylation 
of c-SRC targets involved in focal adhesion regulation such as FAK and Paxillin. This 
implies a switch in the adhesion properties of CSK mutant cells from cell-cell adhesion 
to cell-substrate adhesion, a hallmark of EMT. Mutant keratinocytes showed high levels 
of the c-SRC targets MMP2 and MMP9, which have roles in both EMT and 
inflammation, and high levels of TNF-a, a trigger for inflammatory responses. 
Treatment of areas of the mutant skin displaying dermatitis with the anti-inflammatory 
agent FK506 reduced the thickness of the epidermis and decreased basal proliferation
65
(Yagi et al., 2007). This suggests that CSK inactivation leads to an inflammatory 
response, which causes hyperplasia in the conditional knockout mice.
1.9.5 CSK and tumourigenesis
Whereas there are many examples in the literature of increased SFK activity in cancers, 
there are relatively few examples of the association of loss of CSK and tumourigenesis. 
This may reflect the fact that, despite its restricted expression pattern under normal 
conditions (see below), CHK may be able to compensate for loss o f CSK in tumour 
suppression. However, reduced CSK levels have been reported in early colorectal 
cancer (CRC) during the pre-malignant, hyperproliferative phase. Further, knockdown 
of CSK in colon cancer cell lines results in increased proliferation via the MAPK 
signalling pathway (Kunte et al., 2005), suggesting that loss of CSK may contribute to 
the aberrant proliferation during early stages of CRC. CSK also inhibits the ability of 
SFKs to influence integrin mediated signalling during advanced stages o f CRC. 
Expression of wild-type CSK in human colon cancer cell lines reversed some of the 
defects associated with SFK overactivation including decreased cell-cell adhesion, 
increased focal contacts and increased motility and invasiveness (Rengifo-Cam et al., 
2004). This result does not imply that loss of CSK is responsible for the metastatic 
phenotypes but suggests that agents with the ability to recapitulate the function of CSK 
may be useful in preventing CRC metastasis.
1.9.6 An introduction to CHK (CSK homologous kinase)
CHK is homologous to CSK (mouse CSK and CHK share 53% identity), has a similar 
domain architecture and is also able to inhibit SFKs by phosphorylation o f the C- 
terminal region (Klages et al., 1994). However, CSK is ubiquitously expressed whereas 
CHK expression is restricted to neurons and haematopoietic cells. Another difference 
between CSK and CHK seems to be the mode of SFK inhibition employed. Both 
proteins inactivate SFKs by phosphorylation of C-terminal tyrosine residues but CHK 
also inhibits SFKs by a novel non-catalytic mechanism involving binding and the 
formation of stable complexes. For example, CHK can bind to and inhibit the function 
of Hck even when the C-terminal tyrosine is mutated (Chong et al., 2004) suggesting
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that phosphorylation of Hck by CHK is not required for inhibition. A further report by 
the same group showed that CHK binds to and inhibits multiple active conformations o f 
the SFK Hck. For example, CHK is able to bind and inhibit the activity o f Hck 
molecules lacking the SH2 and SH3 domains. This mechanism is specific to CHK as 
CSK is not able to inhibit these forms of Hck. Interestingly CHK does not form stable 
complexes with SFK proteins (Lyn was tested) in the inactive, ‘closed’ conformation 
(Chong et al., 2006). This mode of regulation may act to control events downstream of 
SFKs involving SFK mediated tyrosine phosphorylation but also those involving 
binding o f targets to SFKs. Downregulation of CHK has been reported in human brain 
tumours (neuroblastoma and glioblastoma) and in transformed neuroblastoma and 
astrocytoma derived cell lines (Kim et al., 2004b). The specific loss o f CHK in these 
cancers probably reflects its restricted neuronal expression.
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1.10 Drosophila SFKs and Csk
1.10.1 Identification of dCsk as a negative regulator of growth
While SFK inhibition by phosphorylation of the C-terminal region is carried out by 
CSK and CHK in mammals, Drosophila has a single CSK/CHK ortholog. dCsk was 
first identified in a genetic screen for modifiers of a small, rough eye phenotype 
resulting from over-expression of the wts/LATS tumour suppressor. dCsk mutations 
dominantly suppress the small eye phenotype implying that dCsk, like wts, is a tumour 
suppressor gene and functions in the same cellular processes (Stewart et al., 2003). 
dCsk shows high homology to hCsk within the kinase and SH2 domains (62% and 73% 
amino acid identity respectively) although the SH3 domain is not conserved.
Analysis o f dCsk mutant phenotypes revealed that dCsk is indeed a negative regulator of 
tissue growth, dCsk mutants typically die as giant pupae and imaginal discs from 
homozygotes are larger than controls (Read et al., 2004; Stewart et al., 2003). This 
increase in tissue size was attributed to a proliferation defect as cells posterior to the MF 
fail to exit the cell cycle in a timely fashion in mutant discs, much like the phenotype 
seen in hpo or w/s clones (Read et al., 2004; Stewart et al., 2003).
Wts contains a C-terminal tyrosine (Y1098), which is within a motif similar to the m otif 
surrounding the CSK tyrosine phosphorylation target site of SFKs (Stewart et al., 2003). 
In kinase assays GST-dCsk phosphorylated its known target dSrc42A using GST- 
Src42K267R as a substrate (this dSrc42A mutant is incapable o f autophosphorylation). 
GST-dCsk also phosphorylated GST-Wts but not GST-WtsY1098F, indicating that Wts is 
a target of dCsk and specifically phosphorylates a C-terminal tyrosine residue (Stewart 
et al., 2003). Over-expression of wts rescues the lethality of dCsk mutants but over­
expression of dCsk does not rescue the lethality o f a weak wts mutant indicating that 
dCsk functions upstream of Wts in the control of tissue size (Stewart et al., 2003). 
However, this rescue is incomplete potentially due to the fact that dCsk regulates other 
targets besides Wts including dSrc42A and dSrc64B, the two Drosophila c-SRC 
orthologs.
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1.10.2 Pathways functioning downstream of dCsk
Using genetic approaches the signalling pathways functioning downstream of dCsk 
were examined. Reducing the gene dosage of dSrc64B by 50 % partially rescued the 
pupal stage lethality of dCsk mutant animals (26% of adults eclosed) supporting a role 
for dCsk upstream of Drosophila SFKs. Interestingly, heterozygosity for dSrc42A 
suppressed dCsk lethality to a lesser extent (4% of adults eclosed), which could reflect 
different requirements for dCsk inhibition between dSrc42A and dSrc64B (Read et al., 
2004). Tec29A/Btk (Btk) is another Src family kinase and functions downstream of 
dSrc42A and dSrc64B in Drosophila and downstream of c-SRC in mammals (Guarnieri 
et al., 1998; Roulier et al., 1998; Saouaf et al., 1994; Tateno et al., 2000). btk mutations 
dominantly suppress the lethality of dCsk mutant flies (70% of adults eclosed), this 
suppression is stronger than that by dSrc42A or dSrc64B mutations possibly due to 
redundancy between the Drosophila Src genes and because Btk functions downstream 
of both SFKs (Read et al., 2004).
The JNK signalling pathway mediates events downstream of c-SRC in mammals (Dolfi 
et al., 1998; Hauck et al., 2002; Hsia et al., 2003) and accordingly, heterozygosity for 
basket (bsk), a member of the Drosophila JNK signalling pathway, suppresses dCsk 
lethality (60% of adults eclosed). This implicates the JNK pathway in mediating 
signalling downstream of dCsk in Drosophila (Read et al., 2004). Activated c-SRC up- 
regulates STAT3 and this is known to be important for its transforming capabilities 
(Bromberg et al., 1998). STAT also seems to function downstream of dCsk; dCsk 
mutations enhance the eye phenotype elicited by over-expression o f the Jak/STAT 
ligand Unpaired (Upd), and levels of ST AT protein are increased in dCsk mutant cells. 
This indicates that dCsk negatively regulates Jak/STAT signalling (Read et al., 2004). 
Taken together this data confirms that dCsk regulates Drosophila SFKs, which target a 
similar set of signalling pathways to human c-SRC.
1.10.3 The relationship between dCsk and Drosophila SFKs
Further proof that dCsk is a regulator of Drosophila SFKs (dSrc42A and dSrc64B) was 
provided by in vivo analysis of SFK over-expression, which gives rise to similar
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phenotypes to dCsk LOF. Mild over-expression o f either SFK, achieved using weakly 
expressing transgenes, results in delayed cell cycle exit posterior to the MF and 
moderate overgrowth of adult eyes (Pedraza et al., 2004). This is highly similar to the 
phenotype of hypomorphic dCsk alleles. Strong over-expression of either SFK, 
achieved using strongly expressing transgenes, results in eye ablation by apoptosis 
(Pedraza et al., 2004). dCsk LOF can also lead to apoptosis. Complete removal of dCsk 
in the eye using a recently generated null allele (<dCskPI56stop) leads to eye ablation 
(Vidal et al., 2007) and dCsk mutant cells at boundaries are susceptible to apoptosis 
(Vidal et al., 2006) (see below). These results suggest that the dCsk phenotype is indeed 
due to increased SFK signalling and that the intensity o f SFK signalling governs the 
phenotype observed. Furthermore, the SFK over-expression phenotype is highly 
sensitive to dCsk levels. Removing one copy of dCsk enhances the weak SFK  
expression phenotype leading to partial ablation of the eye. Moreover, dCsk expression 
is sufficient to rescue the eye ablation phenotype resulting from strong SFK  expression 
(Pedraza et al., 2004). This data provides in vivo evidence that dCsk is a critical 
regulator of Drosophila SFKs.
Combining the weakly expressing SFK transgenes (which cause overgrowth) with 
expression of the cell cycle inhibitor p21 , results in almost ablated eyes without altering 
the levels of apoptosis. This suggests that the pathways promoting proliferation and 
apoptosis downstream of SFKs are separable and the balance between them determines 
the phenotype observed (Pedraza et al., 2004).
It has been shown that dCsk phosphorylates Drosophila SFKs using in vitro kinase 
assays. dCsk phosphorylates dSrc42A and dSrc64B at Tyr511 and Tyr547 respectively 
and when these residues are mutated dCsk no longer phosphorylates either fusion 
protein. The biological significance of these sites was confirmed in vivo by expressing 
constitutively active SFKs lacking the tyrosine targeted by dCsk. Whereas dCsk 
expression rescues the eye ablation resulting from strong expression o f wild-type SFKs, 
it fails to rescue the eye ablation resulting from expression of constitutively active SFKs 
(Pedraza et al., 2004). This provides further evidence that dCsk regulates SFKs and 
shows that this is achieved through an inhibitory C-terminal phosphorylation.
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As strong expression of SFKs leads to apoptosis, it is expected that loss o f dCsk also 
results in apoptosis. However, it has been suggested that dCsk actually protects cells 
from apoptosis, for example dCsk knockdown on the eye using RNAi largely blocks the 
wave of apoptosis occurring at 29h APF in the developing pupal retina (Vidal et al.,
2006). Conversely, it is reported that complete removal o f dCsk using a null allele does 
result in apoptosis, leading to eye ablation. These differences in phenotype can be 
explained if  there is a threshold level of SFK activation above which apoptosis is 
triggered. For example, mild SFK activation induced by dCsk RNAi may protect cells 
from apoptosis whereas strong SFK activation resulting from complete loss o f dCsk 
induces apoptosis.
1.10.4 Phenotypes of dCsk boundary cells
Although broad loss of dCsk has not been reported to induce cell death in wing 
imaginal discs, loss of dCsk in discrete patches results in apoptosis of mutant cells at the 
interface between mutant and wild-type cells (Vidal et al., 2006). For example, if the 
EGUF/hid (ey-Gal4/UAS-FLP/GMR-hid) technique (Stowers and Schwarz, 1999) is 
used to generate eyes composed only of dCsk mutant cells, the resulting eye is 
overgrown and mispatterned due to excess proliferation, inhibition of apoptosis and 
reduced cell adhesion. However, if dCsk clones are generated using conventional 
FLP/FRT methods, they are eliminated within developing tissues such as the eye and 
wing and replaced by wild-type cells. Additionally, if dCsk is depleted by RNAi in the 
Patched (Ptc) domain, which forms a stripe down the anterior-posterior boundary of the 
wing disc, mutant cells juxtaposing wild-type cells move to a basal position within the 
epithelium, migrate away from the Ptc domain and apoptose (Vidal et al., 2006). The 
different outcomes of loss o f dCsk in whole tissues versus discrete patches is proposed 
to be due to specific interactions between mutant and wild-type cells at boundaries.
The exclusion and migration of dCsk mutant cells at boundaries is highly reminiscent of 
epithelial to mesenchymal transition (EMT) and metastasis of tumour cells, two 
processes that are thought to involve c-SRC activation. Furthermore, the phenotype of 
dCsk boundary cells requires the cell adhesion mediators dE-Cadherin and pi 20- 
catenin, the cytoskeletal regulator Rhol, the JNK pathway and MMP2, a matrix
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metalloprotease (Vidal et al., 2006). These have all been implicated in SFK signalling in 
mammals, particularly in c-SRC mediated control of cell adhesion and migration. Data 
from mammalian cell culture indicates that phosphorylation o f Cadherins by c-SRC can 
promote weakened adhesion between cells, a crucial step in progression towards 
metastasis (Takeda et al., 1995). pl20-catenin has also been named as a c-SRC 
substrate. It directly interacts with Cadherin molecules and is thought to promote 
adhesion by preventing their endocytosis. pl20-catenin also directly interacts with and 
inhibits RhoGTPase to increase cell motility (Fox and Peifer, 2007). Therefore it 
appears that SFKs target a similar repertoire of cell adhesion and motility regulators in 
Drosophila and mammals. Interestingly, reducing Rhol and dpl20-catenin function can 
rescue loss of dCsk in discrete areas but does not suppress broad loss o f dCsk 
suggesting that these factors are specifically required in the response at boundaries 
(Vidal et al., 2006). Rhol over-expression in discrete patches can phenocopy loss of 
dCsk highlighting its importance in removal of dCsk boundary cells (Vidal et al., 2006).
Small GTPases of the Rho family can promote JNK pathway activity and activation of 
the JNK pathway promotes apoptosis in Drosophila wing discs (Adachi-Yamada et al.,
1999). The death of dCsk boundary cells is JNK pathway dependent and is highly 
sensitive to alterations in JNK pathway activity. For example, heterozygosity for the 
JNK phosphatase puckered (puc) dramatically enhances the levels of apoptosis at dCsk 
boundaries (Vidal et al., 2006). Interestingly the migratory behaviour o f these cells is 
also sensitive to JNK pathway alterations. This may not be surprising, as the JNK 
pathway has been implicated in the cell movements required for dorsal closure in 
Drosophila (Tateno et al., 2000). Additionally JNK signalling is required for expression 
of MMP2 in mammalian cells expressing v-SRC (Hauck et al., 2002). In fact, increased 
expression of matrix metalloproteases such as MMP2 is highly characteristic of 
metastatic tumour cells and allows for degradation of the extracellular matrix, a step 
necessary for metastasis. Accordingly, the migration of dCsk mutant cells away from 
the ptc domain is suppressed by MMP2 mutation (Vidal et al., 2006). Therefore the 
apoptosis and migration of dCsk mutant boundary cells requires JNK signalling.
Taken together the Drosophila and human data point towards an attractive model 
whereby activated SFKs affect multiple adherens junction components ultimately 
leading to decreased adhesion and increased motility and apoptosis mediated by
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downstream events. The fact that this effect seems to be specific to boundary cells 
implies that cells at the periphery of tumours, which contact wild-type cells may be 
more prone to metastasis (Vidal et al., 2006). However, one major difference between 
dCsk boundary cells and metastatic cells or those undergoing EMTs is that most if  not 
all excluded dCsk cells undergo apoptosis. This suggests that a second mutation that 
prevents apoptosis would be minimally required for dCsk LOF cells to become
• Y 1 2metastatic. Co-operation between the adhesion regulator Scribble and Ras has been 
shown to induce metastatic-like behaviour in Drosophila (Pagliarini and Xu, 2003). It 
has recently been shown that loss of dCsk can indeed lead to metastasis in Drosophila 
when combined with RasV12 expression. Generating such clones in the eye imaginal disc 
leads to the formation of secondary tumours throughout the larval body (Vidal et al.,
2007).
Besides a clear role for Drosophila SFKs in regulating tissue growth and epithelial 
integrity, several other developmental processes requires SFKs including formation of 
nurse cell ring canals, packaging during oogenesis, dorsal closure and regulation of 
receptor tyrosine kinase signalling. The roles of Drosophila SFKs in ring canal 
formation and dorsal closure will be discussed below as it is relevant to this work.
1.10.5 Drosophila SFK function in nurse cell ring canal formation
At the start o f Drosophila oogenesis, a cystoblast divides four times, to give rise to a 
sixteen-cell germline cyst. However, these divisions are incomplete and the intercellular 
bridges that connect the cells are stabilized by actin and form ring canals. One o f the 
germline cyst cells becomes the oocyte and is supplied with maternally derived products 
via the ring canals, which increase in size during oogenesis to reach a final size of about 
10pm (Cooley, 1998). Prior to the addition of actin filaments, ring canals are 
identifiable by phospho-tyrosine labelling. In dSrc64B or Tec29/btk (btk) mutants ring 
canals form but are unusually small and show a reduction in phospho-tyrosine staining 
(Guarnieri et al., 1998; Roulier et al., 1998). These reports also noted that dSrc64B is 
required for the localization o f Btk to the ring canals. One proposed model suggests that 
Btk is recruited to the ring canals by interacting with PIP3 where it is activated by 
dSrc64B phosphorylation (Lu et al., 2004). The role for dSrc64B in Btk localization is
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explained by the fact that Btk activity is necessary for its own localization (Lu et al.,
2004). It has been shown that a dSrc64B-dependent pathway leads to phosphorylation 
of the actin bundling protein Kelch at Y627, providing a mechanism for how dSrc64B 
and Btk regulate ring canal growth (Kelso et al., 2002). Interestingly regulation by dCsk 
does not seem to be important for dSrc64B in ring canal formation; loss o f dCsk does 
not affect ring canal size and dCsk mutants do not rescue the ring canal defects 
associated with hypomorphic dSrc64B alleles (O'Reilly et al., 2006).
1.10.6 Drosophila SFKs are involved in dorsal closure
Dorsal closure during embryogenesis and the thoracic epidermal closure during 
metamorphosis require dynamic cell shape changes. Members of the JNK signalling 
cascade are heavily implicated in these processes and pathway mutants show embryonic 
dorsal open and adult thoracic cleft phenotypes. Weak dSrc42A mutants that survive to 
adulthood show thoracic cleft phenotypes, which are enhanced by reducing Bsk activity 
(Tateno et al., 2000). Strong dSrc42A mutants are embryonic lethal and do not show 
embryonic dorsal open phenotypes but do have deformed mouthparts, a phenotype 
shared with btk mutants. However either dSrc42A /  btk or dSrc42A /  dSrc64B double 
mutants exhibit a dorsal closure phenotype indicating that, at least for this process, 
dSrc42A and dSrc64B function redundantly and that Btk is also involved in dorsal 
closure (Tateno et al., 2000). Importantly, the dorsal open phenotype of dSrc42A /  btk 
mutants is rescued by activated dJun expression, implying that dSrc42A and Btk 
function upstream of the JNK pathway during development (Tateno et al., 2000). The 
expression of the JNK phosphatase puc, is regulated by the JNK pathway to provide a 
negative feedback loop and can therefore be used as a readout of pathway activity, puc 
is expressed in the midline of the notum in wild-type third-instar wing discs but not 
dSrc42A mutant discs and expression of activated dSrc42A can induce ectopic puc 
expression (Tateno et al., 2000). Therefore, Drosophila SFKs function upstream of the 
JNK pathway during dorsal closure.
dSrc42A has been reported to mediate regulation of adherens junction components 
necessary for dorsal closure. Mutations in shotgun (shg), the Drosophila homolog of E- 
Cadherin, or armadillo (arm), which links E-Cadherin to the cytoskeleton via a-catenin,
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can give rise to dorsal closure phenotypes when combined with dSrc42A mutants 
(Takahashi et al., 2005). dSrc42A forms a ternary complex with E-cadherin and 
Armadillo at the membrane and a 14 amino acid dSrc42A peptide containing the 
autophosphorylation site binds Armadillo. Additionally, dSrc42A; dSrc64B/+ embryos, 
which exhibit dorsal open phenotypes have reduced E-Cadherin and F-actin 
accumulation at the leading edge suggesting that SFKs are required to stabilize adherens 
junctions during dorsal closure (Takahashi et al., 2005).
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1.11 An introduction to ASPP family proteins
1.11.1 The p53 tumour suppressor
Members of the ASPP (Apoptosis Stimulating Protein of p53) family of proteins have 
been described as important regulators of p53, which specifically mediate the apoptotic 
function of p53.
Mutations in the p53 tumour suppressor gene are frequent in a wide variety o f human 
cancers underlying the importance of p53 in regulating cellular homeostasis. For 
example p53 is mutated in 50% of all human tumours and it is inactivated by other 
means, such as increased expression of inhibitors, in most other cases (Vogelstein et al., 
2000). p53 essentially acts as a damage sensor and is capable of inducing cell cycle 
arrest and/or apoptosis in response to cellular stresses such as DNA damage caused by 
ionizing radiation, reactive oxygen species, and inappropriate growth signalling as a 
result o f oncogene activity (Vogelstein et al., 2000). In the absence o f functional p53, 
abnormal cells are able to continue dividing unchecked and to evade cell death. For this 
reason p53 is regulated by a complex network of proteins and by an array of 
mechanisms including phosphorylation, ubiquitylation and nuclear translocation.
p53 is a transcription factor and exerts most of its effects via transcriptional control of 
target genes. Many known apoptosis regulators are targets of p53, including death 
receptors such as CD95 and DR5 and other molecules such as BAX, PUMA and NOXA 
(Trigiante and Lu, 2006). The pro-apoptotic function of p53 is thought to be particularly 
important for its tumour suppressor function and involves both the receptor and 
mitochondrial mediated apoptotic pathways (Haupt et al., 2003). Post-transcriptional 
regulation by p53 has also been described whereby p53 is able to activate BAX to 
induce mitochondrial membrane permeabalization and apoptosis. p53 is able to induce 
BAX-dependent apoptosis even when nuclear import is blocked, suggesting that p53 co­
operates with BAX to induce apoptosis (Chipuk et al., 2004). p53 is thought to induce 
cell cycle arrest via another target, the cyclinE/cdk2 inhibitor p21, which blocks entry 
into S-phase. It has been proposed that different post-transcriptional modifications on
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p53 and binding o f different co-factors can determine whether p53 induces apoptosis or 
cell cycle arrest (Trigiante and Lu, 2006).
1.11.2 Introduction to ASPP family
The ASPP family of proteins are regulators o f p53, which specifically mediate the 
apoptotic response and their identification gave insights into how p53 makes the 
decision between inducing apoptosis and cell cycle arrest. ASPP proteins are 
characterized by a conserved C-terminal portion containing ankyrin repeats, an SH3 
domain and a proline rich region. The ASPP proteins were first identified following a 
yeast two-hybrid screen for mouse p53 interacting proteins that identified a p53-binding 
molecule, which was named p53BP2 (Iwabuchi et al., 1994). In other reports p53BP2 
was identified as an interactor of several other proteins in yeast two-hybrid experiments 
including BCL-2 (Naumovski and Cleary, 1996), protein phosphatase 1 (PP1) (Helps et 
al., 1995) and YES-associated protein (YAP) (Espanel and Sudol, 2001). Interestingly, 
like for p53, all of these interactions occur via the conserved ankyrin repeat and SH3 
domains o f p53BP2. Although these studies highlight the importance of the p53BP2 
ankyrin and SH3 domains, the biological significance the interactions described, with 
the exception of p53, is not known.
p53BP2 has since been shown to represent a truncated splice variant of full length 
ASPP2, a protein of 1128 amino acids (Samuels-Lev et al., 2001). Searches for ASPP2 
homologous proteins revealed that there are 2 other ASPP family members, ASPP 1 and 
iASPP, proteins of 1091 and 828 amino acids respectively, which both contain the 
characteristic C-terminal proline rich region and SH3 and ankyrin domains (Trigiante 
and Lu, 2006). Therefore the ASPP protein family consists of three members on 
different chromosomes; ASPP1 and ASPP2 are more similar to each other than either 
are to iASPP because the N-terminal portion o f iASPP is not homologous to the other 
family members.
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1.11.3 ASPP1 and ASPP2
Endogenous, full length ASPP1 and ASPP2 were shown to bind to endogenous p53 and 
this interaction is increased upon UV treatment indicating that ASPP proteins may 
regulate p53 in response to DNA damage (Samuels-Lev et al., 2001). Co-expression of 
ASPPJ or ASPP2 with p53 results in a marked increase in the number of apoptotic cells 
within a population compared to p53 expression alone. Furthermore, co-expression of 
ASPP1 or ASPP2 with p53 did not affect the number of cells in G1 as analysed by 
FACS suggesting that the ASPP proteins specifically stimulate the apoptotic but not cell 
cycle checkpoint function of p53 (Samuels-Lev et al., 2001). In support o f this notion a 
chromatin immunoprecipitation (CHIP) experiment using a p53 antibody showed that 
expression of ASPP2 is able to enhance the binding of p53 to the box promoter by 3 
fold but has no effect on the binding of p53 to the p21 promoter. Using cell-based 
luciferase reporters it was shown that ASPP1 and ASPP2 are able to stimulate p53- 
mediated expression of pro-apoptotic genes box and PIG-3 but have little effect on other 
reporters such asp21 , mdm2 and cyclinG (Samuels-Lev et al., 2001).
A truncated form of ASPPl and p53BP2, the truncated form of ASPP2, which both lack 
the N-terminal sequences, were not as efficient at stimulating the apoptotic function of 
p53 as the full-length proteins. This suggests that although the ASPP C-terminus binds 
to p53, there are N-terminal sequences important for ASPP function. Interestingly, 
ASPPl or ASPP2 did not stimulate bax expression and apoptosis when co-expressed 
with mutant forms of p53 derived from tumours, offering an explanation for the 
inability of these forms of p53 to induce apoptosis. Furthermore ASPP expression was 
shown to be downregulated in several wild-type p53-expressing breast tumours; this 
result provides an insight into how some tumours may tolerate wild-type p53 (Samuels- 
Lev et al., 2001).
Mdm2 and Mdmx are important endogenous p53 inhibitors, which bind to the N- 
terminal region of p53 and prevent p53 transcriptional activation. Mdm2 possesses E3 
ligase activity and also regulates p53 via proteasome-mediated degradation (Coutts and 
La Thangue, 2005). It has been demonstrated that Mdm2 and Mdmx can prevent 
ASPPl and ASPP2 from enhancing the transactivation functions of p53. Importantly 
this is not achieved simply through p53 degradation, as Mdmx and Mdm2 (A222-437),
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which do not target p53 for degradation, are still able to abrogate apoptosis induced by 
p53 and ASPP expression (Bergamaschi et al., 2005).
Another report from the same group showed that ASPP proteins regulate all p53 family 
members including p63 and p73 and in this manner can induce apoptosis independently 
of p53. ASPPl and ASPP2 are able to bind to p63 and p73 in vivo and in vitro and can 
enhance p63 and p73 expression of apoptotic target genes such as box and PIG-3 but 
not the cell cycle regulating target p21 (Bergamaschi et al., 2004). Expression of either 
ASPPl or ASPP2 in p53-deficient Soas-2 cells induces a modest apoptotic response. 
This is prevented by p63 or p73 RNAi but not p53 RNAi (control), suggesting that the 
apoptotic response induced by ASPP expression in the absence of p53 is mediated via 
p63 and p73 (Bergamaschi et al., 2004).
ASPP proteins may also contribute to the p53-dependent cell death that results from 
aberrant E2F activation since ASPPl and ASPP2 were reported to be transcriptional 
targets o f E2F. Therefore ASPP proteins may constitute a novel mechanism linking the 
cell cycle to apoptosis, which protects against over-proliferating cells (Fogal et al.,
2005).
1.11.4 iASPP
iASPP shares significant C-terminal homology to ASPPl and ASPP2 and is also able to 
bind to and regulate p53. However iASPP has an opposing role to that of ASPPl and 
ASPP2 in that it acts to inhibit the p53 apoptotic response rather than enhance it 
(Bergamaschi et al., 2003). iASPP was first identified as a protein o f 351 amino acids, 
which binds to the RelA/p65 subunit of NF-kB and inhibits its transcriptional activity 
(Yang et al., 1999). This protein was named RAI (RelA associated inhibitor) due its 
described function. In conflict with subsequent data on iASPP/RAI this group found no 
interaction with p53 by yeast two-hybrid and showed that iASPP/RAI expression does 
not affect levels of p53 induced PIG-3 reporter expression (Yang et al., 1999).
Knockdown of iASPP/RAI in human cell lines induces apoptosis and knockdown of 
C.elegans iASPP (Ce-iASPP) by RNA interference induces germ cell apoptosis
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(Bergamaschi et al., 2003). This increase in germ cell apoptosis was prevented when 
worms were mutant for Ce-p53 suggesting that iASPP functions to inhibit p53 in vivo 
(Bergamaschi et al., 2003). The 4 critical ASPP residues required for binding to p53 are 
conserved in iASPP, indicating that iASPP may function by competing with ASPPl and 
ASPP2 for binding to p53. Indeed expression of iASPP or Ce-iASPP is able to abrogate 
the box reporter induction observed when p53 and ASPPl or ASPP2 are expressed 
(Bergamaschi et al., 2003). iASPP is also able to co-operate with oncogenes such as Ras 
to transform cells in vitro; this oncogenic role likely reflects the ability o f iASPP to 
inhibit p53-mediated apoptosis (Bergamaschi et al., 2003).
Further searches identified a longer form of iASPP. Full-length iASPP is protein o f 828 
amino acids and has exactly the same C-terminal sequences as the shorter RAI form 
previously studied but has extra N-terminal sequence. The N-terminal region o f iASPP 
is thought to be important for its sub-cellular localization as full-length iASPP is largely 
cytoplasmic and iASPP/RAI is nuclear (Slee et al., 2004).
In vivo evidence for a link between ASPP and p53 was provided by studies on ASPP2 
null mice. ASPP2 null mice are recovered a lower than expected frequency following 
crosses between heterozygotes and those that do survive birth die within 30 days 
displaying heart defects and hydrocephalus. The lethality of ASPP2 null mice is further 
increased by heterozygosity or homozygosity for p53 indicating that p53 and ASPP2 
function in a common process in vivo (Vives et al., 2006). Furthermore, ASPP2 
heterozygous mice are prone to the development of spontaneous tumours compared to 
wild-type mice; 40% of ASPP2 knockout mice developed B-cell lymphomas compared 
to 22% of wild-type mice and 15% of ASPP2 mutant mice developed sarcomas (Vives 
et al., 2006). Mice doubly heterozygous for p53 and ASPP2 developed lymphomas 
more quickly than single heterozygotes. This data provides evidence that ASPP2 
functions as a tumour suppressor in vivo.
1.11.5 ASPP proteins and cancer
Several lines of evidence indicate a role for ASPP family proteins in tumourigenesis. 
Firstly, all of the residues in p53 required for ASPP binding (His178, Arg181, Met243 and
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Arg247) are commonly mutated in human cancers (Gorina and Pavletich, 1996).
• i  o  i  t
Importantly, mutation of Arg , detected in breast and cervical tumour cells, renders 
p53 defective in apoptosis induction but still capable o f arresting the cell cycle (Ludwig 
et al., 1996). This supports the in vitro data showing that ASPP specifically regulates 
p53-mediated apoptosis and suggests that this function of ASPP is physiologically 
significant. Secondly, reduced ASPPl and ASPP2 expression is observed in roughly 
60% of breast tumours that express wild-type p53. In some tumour samples with no 
change in ASPPl or ASPP2 levels, an increase in iASPP levels was detected 
(Bergamaschi et al., 2003; Samuels-Lev et al., 2001). Reduced ASPPl expression is 
also detected in leukaemia cell lines (Liu et al., 2004) and is a feature of acute 
lymphoblastic leukaemia (ALL) (Agirre et al., 2006). ASPPl promoter methylation was 
detected in 25% of ALL patients with reduced ASPPl mRNA levels and correlates with 
a poor prognosis (Agirre et al., 2006). Thirdly, ASPP2 heterozygous mice are 
susceptible to tumour development and the tumours often retain the remaining ASPP2 
allele suggesting that ASPP2 is a haploinsufficient tumour suppressor.
ASPP proteins function as p53 regulators and hence are obvious targets for the 
development of therapeutic agents for cancer treatment, however there are no such 
molecules currently in use presumably owing to the relatively recent discovery o f this 
family of proteins. One promising agent is a short peptide derived from ASPP2, called 
CBP3, which is able to restore DNA binding and killing capabilities to a p53 mutant 
defective in apoptosis induction (Friedler et al., 2002).
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1.12 The Ras signalling pathway in Drosophila
1.12.1 Overview of the Ras pathway
The EGFR/Ras/MAPK signalling pathway (the Ras pathway) carries out several 
important functions in the developing Drosophila eye. The Ras pathway promotes cell 
proliferation and cell survival and is re-iteratively utilised to control the differentiation 
of ommatidial cell types posterior to the MF (Dickson, 1998). Much of what we know 
about the Ras pathway comes from studies into its function in photoreceptor 
differentiation in Drosophila.
In a greatly simplified view of the pathway, RTK activation leads to tyrosine 
phosphorylation of cytoplasmic residues that act as docking sites for Drk (downstream 
of receptor kinases). Drk functions as an adapter protein to link RTKs (EGFR and Sev) 
to Sos, the guanine nucleotide exchange factor (GEF) for Rasl (Olivier et al., 1993; 
Simon et al., 1993). Rasl is a small GTPase and the ratio between active (GTP bound) 
and inactive (GDP bound) Ras is controlled by the activities of Sos and the GTPase 
activity of Ras itself, which is stimulated by various GTPase activating proteins 
(GAPs). Active Rasl initiates a kinase cascade that transmits the signal to the nucleus 
via dRafl (RAF), dSorl (MEK) and Rolled (MAPK). Active MAPK enters the nucleus 
and phophorylates target transcription factors, including Pnt, Yan and Jun, to regulate 
transcription of pathway targets (Raabe, 2000).
1.12.2 EGFR and Sev are required to specify ommatidial cell fates
In the Drosophila eye, photoreceptors and other ommatidial cells are sequentially 
recruited in the order R8, R2/R5, R3/R4, R1/R6, R7 (Raabe, 2000), cone cells, and 
lastly the pigment cells (Freeman, 1996). Using cell lineage studies it was shown that 
the different photoreceptor cells are not clonally related, suggesting a model whereby 
photoreceptors are recruited from a population of naive cells (Lawrence and Green, 
1979). Photoreceptors that have differentiated secrete the EGFR ligand, Spitz, which 
acts over a short range to recruit subsequent photoreceptors by activating the Ras 
pathway in presumptive cells. The final photoreceptor to differentiate, the R7 cell,
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requires additional input from another RTK, Sevenless (Sev) that also functions 
upstream of the Ras pathway (Dickson, 1998). Sev is activated in the R7 precursor 
following interaction with Bride of Sevenless, which is a transmembrane ligand 
expressed in the R8 cell (Reinke and Zipursky, 1988).
Inducing knockdown of EGFR function at specific time points by using a hs-Gal4 
driver to express UAS-EGFR-DN (dominant negative EGFR), prevents formation of 
ommatidial cell types that are differentiating at the time of heat shock. For example if 
EGFR-DN is expressed in late third instar larvae then ommatidia with missing cone 
cells are observed. These ommatidia however contain the full complement of 
photoreceptors as these cell types differentiate before the cone cells (Freeman, 1996). 
By knocking down EGFR function at different time points it was shown that EGFR is 
required for the differentiation of all ommatidial cell types. Signalling via EGFR is also 
sufficient to induce differentiation as ectopic expression of Spitz can lead to the 
recruitment of extra photoreceptors or cone cells (Freeman, 1996). Although EGFR is 
required for the formation o f all photoreceptors and Sev is required specifically in the 
R7 photoreceptor, these two RTKs are interchangeable. For example, EGFR expression 
can rescue R7 formation in a Sev mutant background and conversely Sev ectopic 
expression can lead to recruitment of extra cone cells (Freeman, 1996).
Over-expression of activated Sev in sev-expressing cells (R1/R6, R3/R4, R7, cone cells) 
leads to rough eye phenotype as supernumerary R7 cells are specified (Basler et al., 
1991). This phenotype is highly sensitive to modulations in Ras signalling and was used 
a sensitized background to identify components acting downstream of Sev. This and 
other similar screens led to the identification of several proteins functioning 
downstream of Sev including Rasl and Raf (Raabe, 2000). Ras and Raf over-expression 
phenotypes were then used in subsequent genetic modifier screens leading to the 
identification of further Ras pathway components (Dickson et al., 1996; Karim et al., 
1996). These screens corroborated data on the Ras pathway from mammalian studies 
and helped to define a conserved pathway transducing signals from RTKs to the 
nucleus.
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1.12.3 Pointed and Yan - transcription factors functioning downstream of MAPK
How does activation of Ras signalling induce photoreceptor differentiation ? The first 
clue to answering this question came with the identification of the ETS domain 
containing transcriptional repressor, Yan. yan LOF results in the production of excess 
photoreceptors. Yan is expressed exclusively in undifferentiated cells in the eye 
imaginal disc (Lai and Rubin, 1992) suggesting that it functions as an inhibitor of 
photoreceptor differentiation. It was subsequently shown that Yan is a phosphorylation 
target of MAPK, a downstream component of the Ras pathway. Activation of the Ras 
signalling pathway in presumptive photoreceptor cells leads to Yan phosphorylation and 
exclusion from the nucleus, thus permitting differentiation (Rebay and Rubin, 1995). 
Mutating the putative MAPK phosphorylation sites in Yan results in a constitutively 
active protein and its expression completely blocks differentiation. Furthermore, it was 
shown that Yan functions as a general inhibitor of differentiation as activated Yan 
blocks mesoderm development in embryos (Rebay and Rubin, 1995). Therefore, Ras 
signalling promotes differentiation, at least in part, by inhibiting the function o f Yan, a 
general inhibitor o f differentiation.
Another ETS domain transcription factor playing important roles in photoreceptor 
determination downstream of Ras is Pointed (Pnt). The pnt gene encodes two isoforms 
PntPl and PntP2, which function as transcriptional activators. MAPK has been shown 
to phosphorylate Thrl51 of PntP2, which increases its activity as a transcritiptional 
activator. PntPl activity is thought to be constitutive (Brunner et al., 1994; O'Neill et 
al., 1994). Unlike Yan, PntP2 plays a positive role in photoreceptor differentiation and 
loss of PntP2 blocks differentiation of all photoreceptors. In one model it is suggested 
that Pnt and Yan constitute a cellular ‘switch’ involved in the control of differentiation. 
The default state is inhibition of differentiation by Yan; when Ras signalling is induced 
in presumptive photoreceptors Yan becomes inactivated and PntP2 becomes activated 
leading to transcription of target genes (Raabe, 2000).
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1.12.4 Tramtrack functions downstream of MAPK and represses neuronal fates
Inhibition of Yan is a prerequisite for differentiation, however, another barrier to 
differentiation must be overcome by Ras signalling. The transcriptional repressor 
Tramtrack (Ttk) functions as an inhibitor of neuronal differentiation and is regulated by 
the Ras pathway. The ttk locus encodes two different proteins, Ttk69 and Ttk88. 
Expression of Ttk88 in photoreceptor precursors prevents neuronal differentiation and 
loss of Ttk88 leads to ectopic R7 production. Phyllopod (Phyl) is an early target o f the 
Ras pathway and acts along with Seven in Absentia (Sina) to degrade Ttk88. This was 
shown genetically and using Ttk88 specific antibodies. The ttk88 over-expression eye 
phenotype is rescued by over-expression of phyl and vice versa, but not in a sina mutant 
background (Tang et al., 1997). Furthermore, phyl over-expression leads to loss of 
Ttk88 protein staining in third instar eye discs but not in a sina mutant background 
(Tang et al., 1997). Taken together these results support a model whereby Phyl 
functions to downregulate Ttk88 by a Sina dependent mechanism. This model is 
supported by in vitro binding assays showing that Phyl, Sina and Ttk88 physically 
interact (Tang et al., 1997). Sina also physically interacts with U bcDl, a ubiquitin 
conjugating enzyme providing a mechanism linking the complex to the proteasome 
degradation pathway. Therefore, the Ras pathway promotes differentiation by inducing 
Phyl expression, which acts along with Sina to degrade Ttk88. However, this is not the 
complete picture since, although Ttk88 degradation is required for all photoreceptors to 
differentiate, Phyl is only expressed in R1/R6 and R7 photoreceptors and Sina is only 
required for R7 development (Dickson, 1998). This suggests that other factors must 
exist that function to inhibit Ttk88 in the remaining photoreceptors.
Ttk69 also functions as an inhibitor of neuronal differentiation and is targeted for 
degradation by Phyl and Sina (Li et al., 1997) suggesting that the Ttk proteins are 
functionally similar. However Ttk69 plays additional roles in eye development, for 
instance, ttk69 has also been shown to promote cone cell differentiation (Wen et al.,
2000). Furthermore, Ttk69 is proposed to have both negative and positive effects on 
photoreceptor development. In the larval eye disc Ttk69 functions as a repressor of 
differentiation, and must be degraded by Phyl and Sina. However, in the pupal retina 
Ttk69 functions to maintain photoreceptors in a differentiated state. Ttk69 (but not 
Ttk88) is detected in all photoreceptor cells in the pupal retina and ttk69 mutant clones
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in the adult eye lack photoreceptors (Lai and Li, 1999). This suggests that Ttk69 plays 
both positive and negative roles in photoreceptor development.
1.12.5 Control of proliferation by Pnt and Ttk
Ttk69 has also been shown to have roles in the control of cell division in response to 
Ras signalling. In the third instar eye disc, uncommitted cells posterior to the MF enter 
S-phase and arrest in G2. Only those cells that receive the Spitz signal from 
neighbouring precluster cells enter mitosis (Baker and Yu, 2001). This final, 
synchronous round of division is known as the second mitotic wave (SMW) and 
provides a sufficient population of cells to complete eye development. The Spitz signal 
from the precluster also provides a survival signal to the neighbouring uncommitted 
cells. This helps to adjust the number of uncommitted cells to the number of ommatidia 
as cells that don’t receive the signal are susceptible to apoptosis (Baker and Yu, 2001). 
The transcription factors PntP2 and Ttk69 regulate entry into mitosis in the SMW by 
oppositely affecting the transcription of cdc25/string, a crucial regulator o f mitosis. 
Over-expression of ttk69 of loss of PntP2 (in clones) blocks the SMW; cells posterior to 
the furrow incorporate BrdU suggesting that they enter S-phase but fail to stain for 
phospho-histone 3 (PH3) indicating that mitosis is blocked (Baonza et al., 2002). It was 
further shown that PntP2 and Ttk69 compete for binding to the cdc25/string promoter 
and that if both ttk69 and cdc25/string are overexpressed the SMW is rescued (Baonza 
et al., 2002). It is proposed that control of cdc25/str\ng levels by Ras signalling via 
PntP2 and Ttk69 is not restricted to the SMW but is important for cell cycle control in 
other contexts.
1.12.6 Ras signalling promotes cell survival
The Ras signalling pathway is known to promote cell survival in Drosophila by 
specifically inhibiting the activity of the pro-apoptotic protein, Hid (Bergmann et al., 
1998; Kurada and White, 1998). Hid is believed to be a phosphorylation target of 
MAPK/ERK and contains several MAPK consensus phosphorylation sites (Bergmann 
et al., 1998). Hid induces apoptosis by promoting the polyubiquitination and 
degradation of DIAP1, consequently relieving inhibition of Caspases (Yoo et al., 2002).
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Therefore Ras signalling promotes cell survival in Drosophila by indirectly increasing 
DIAP1 protein levels via Hid inhibition. In addition, the Ras pathway likely has other 
effects on cell survival, mediated via its inputs to other signalling pathways.
This introduction to the Ras pathway in Drosophila has focused mainly on eye imaginal 
disc development but the pathway regulates proliferation, survival and differentiation in 
a wide variety of contexts during development.
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CHAPTER 2 Materials and methods
2.1 Genetics and immuno-histochemistry
2.1.1 General immunofluorescence protocol
3rd instar ‘wandering’ larvae of the relevant genotype were collected from vials and 
placed in a drop of lxPBS (see solutions) on a silicon dissection pad. Eye-antennal or 
wing imaginal discs were dissected from larvae using micro-dissection tweezers. The 
eye-antennal discs were dissected and left attached to the mouthparts. Wing imaginal 
discs were dissected so that they remained attached to the trachea and anterior 
epidermis. This allowed the tissue to be seen while washing, thus avoiding losing 
material. Following dissection tissues were fixed with fresh periodate-lysine- 
paraformaldehyde (PLP) (see solutions) in glass depression wells for 20 minutes in the 
dark at room temperature. Tissues were then transferred to 1.5 ml eppendorf tubes and 
washed three times for 10 minutes at room temperature in PBT (PBS + 0.1% triton). 
Tissues were then permeabilized and pre-blocked by incubating for 1 hour at room 
temperature in PBT (PBS + 0.3% triton) containing 5% Normal Goat Serum (NGS) 
(MP Biomedicals). Following one wash in PBT (PBS + 0.1% triton), samples were 
incubated with primary antibody overnight at 4°C. All washes and antibody incubations 
were done with agitation on a rotating wheel.
The next day tissues were washed five times in PBT (PBS + 0.1% triton) and incubated 
with secondary antibodies for 2 hours at room temperature in PBT containing 5% NGS. 
Tissues were then washed a further five times in PBT and once in PBS for 10 minutes at 
room temperature. The PBS was then replaced with CitiFluor mounting medium (50% 
Glycerol, 50 % PBS) and tissues were transferred by pipette to a 1mm glass slide. 
Samples were then transferred using micro-dissection tweezers to a 15pi drop of 
Vectashield mounting medium (Vector Laboratories) on another 1mm glass slide. Eye- 
antennal discs and wing discs were then dissected away from the other remaining tissue 
and a coverslip was placed onto the slide. Imaging was done on an upright Zeiss
LSM510 Laser Scanning Microscope using 25x or 40x objectives and LSM510 
software. Images were treated with Adobe Photoshop CS2.
2.1.2 Pupal retina immunofluorescence protocol
Pupal retina-brain complexes were dissected and immuno-labelled using a modified 
version of the Rubin Lab protocol (http://www.bio.com/protocolstools/protocol.jhtml7id 
= p i9). Animals at the white pre-pupal stage were collected from crosses and 
transferred to new vials. The pupae were incubated at 25°C for 40-42 hours. Pupae were 
then transferred onto a silicon dissection pad where they were stuck to a piece of double 
sided sticky-tape such that the anterior end was secured and the posterior end accessible 
for dissection. Roughly one-third of the hard exterior cuticle was removed from the 
posterior end using micro-dissection tweezers. The pupae were then removed from the 
pupal case by pulling them out from the posterior end with micro-dissection tweezers. 
Dissected pupae were transferred immediately to a drop of PBS on the pad. A small 
dorsal to ventral incision was made in the soft cuticle at the anterior end using a fine 
razor blade. The retina-brain complexes were pushed out through this incision by 
pressing down on the middle of the pupae with micro-dissection tweezers to ‘squeeze’ 
out the contents. Soft tissue was washed away from the retina-brain complexes using a 
20[a1 pipette, and complexes were transferred by 20 pi pipette to ice cold PBS in a glass 
depression well until the remaining pupae were dissected.
Pupal retina-brain complexes were immuno-labelled in much the same way as eye- 
antennal or wing imaginal discs (see General antibody staining protocol) except washes 
and antibody incubations were done in glass depression wells and liquid was removed 
from samples using a syringe. Following antibody staining pupal retina-brain 
complexes were transferred to 15pl Vectashield drops on 1mm glass slides and the 
retinas were dissected away from the brain.
2.1.3 Scanning electron microscopy (SEM)
Adult female flies of the relevant genotype were collected and transferred to fresh vials 
for 6 hours. They were then submerged in 10% ethanol for 30 minutes followed by
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further 30 minute incubations in ethanol solutions of increasing concentration (30%, 
50%, 70%, 90% and 100%). Samples were prepared and imaged by Anne Weston of the 
Cancer Research UK EM facility using a Jeol JSM 6700F Scanning electron 
microscope.
2.1.4 Mutagenesis by imprecise P-element excision
Shown below are cross schemes used to generate dASPP mutants by imprecise excision 
of second chromosome P-element insertions; GE13722 was excised to generate the
dASPP1, dASPP1 and dASPPpreclse lines (cross scheme A) and P(XP)CG4302domo was
F2 Single w ; GE13722*/ CyO X  w ; S p / C y O  £  £
Cross scheme B:
Po <? <? w;  P(XP)CG4302d03020 (mw) /  CyO X  w ; Sp /  C yO ; 62-3, Sb /  TM6B £
I
Fi <? w ; P(XP)CG4302d03020 (mw) /  C yO ; A2-3, Sb /  + X w ; S p /  CyO $  £
F2 Single w ; P(XP)CG4302dm l° * /  CyO X w ; dASPP1 /  CyO $  $
In cross scheme A, the P-element line (GE13722) is crossed to the transposase source 
(A2-3). Hybrid males (mosaic orange and white eyes) are selected from the FI and 
crossed en masse to second chromosome balancer virgins (Sp /  CyO). In the F2 
generation, white-eyed excision males (GE13722*) are selected and crossed 
individually to Sp /  CyO virgins. Males are ‘lifted’ from this cross after 4 days and
excised to generate the dASPP8 and dASPPctrl lines (cross scheme B).
Cross scheme A:
Po cf w / GE13722(mw) /  CyO X w ; S p /  C yO ; A2-3, Sb /  TM6B £  £
I
Fi t f d 71 w ; GE13722(mw) / C y O ; A2-3, S b / +  X w ; S p / CyO £  £
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screened for deletions by PCR. Once mutant chromosomes had been identified the 
relevant crosses to Sp /  CyO were kept and progeny were mated inter se to obtain 
balanced mutant stocks. Cross scheme B is similar to cross scheme A except the F2 
generation, white-eyed males (P(XP)CG4302d03020 *) were crossed to dASPP**/  Cyo and 
new deletions were recovered by screening for the dASPP phenotype.
2.1.5 Creating recombinant chromosomes
Shown below is a cross scheme that was used to generate recombinant chromosomes. 
The example shown is the generation of a recombinant second chromosome that has 
both an FRT site (FRT,42D) near the base of the 2R chromosome arm and the dASPP8 
mutation, which is at a more distal location on 2R. This chromosome was used to 
generate dASPP8 LOF clones. A similar cross scheme was used to generate all 
recombinant chromosomes used in this work.
Po dASPP8 /C yO  X FRT.42D / FRT,42D £ £
F, cPJ1 w ; Sp / CyO X dASPP8 / FRT.42D £ £
I
F2 & & FRT,42D(?), dASPP8(?) /  CyO X w / S p/C yO  £  £
In the first cross FRT42D and dASPP8 are bought together. Virgin females are selected 
in the FI that have both FRT42D and dASPP8 in trans on the second chromosome and 
are identified by the absence of the dominantly marked CyO chromosome. These 
females are crossed en masse to Sp/CyO males and the meiotic recombination event 
occurs in the female germline. The F2 generation contains putative recombinant flies. 
F2 males are crossed to second chromosome balancer virgins, then ‘lifted’ after 4 days 
and screened for presence of both FRT42D and dASPP8 by PCR. Crosses from 
recombinant males were kept and progeny were mated inter se to obtain recombinant 
stocks.
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2.1.6 Density-controlled wing measurements
Crosses to obtain the relevant genotypes were initiated. Once the females were laying 
eggs (1-2 days), the flies were transferred to a container, which was inverted over an 
agar and apple juice substrate. Eggs were collected for 4-6 hours before the flies were 
removed. The embryos were kept at 25°C for 24 hours and then first instar larvae were 
collected. 30-50 (depending on the experiment) larvae were transferred to each yeasted 
vial and cultured at 25°C until eclosion. For some genotypes it was necessary to collect 
enough larvae for up to 8 vials (400 larvae) due the low expected frequency of that 
genotype in the FI. When the flies eclosed from the density-controlled crosses, the 
relevant genotype was collected and either put into 100% ethanol (for wing 
measurements) or anaesthetised (for weighing). Males were used for wing area and 
body weight measurements.
When it came to mounting the wings, flies were put into a glass depression well in 
ethanol and ‘right hand’ wings were removed with micro-dissection tweezers. Wings 
were dried on a piece of tissue then placed into a drop of Euparal (Sigma-Aldrich) on a 
slide. A coverslip was placed over the wings and the slides were dried overnight on a 
65°C hotplate. Wings were digitally photographed using a LeicaDC200 camera on an 
MFIII dissection microscope. Wings were then measured using the Polygonal Lasso 
tool on Adobe Photoshop. Generally, the area of 20 male wings from different flies was 
measured for each genotype and the average wing size, standard deviation and Student’s 
T-test p values were calculated using Excel.
2.1.7 Alignment of dASPP and Boa with homologs from other species
The alignment of dASPP-PA and Boa-PA with human, A.gambiae and C.elegans 
homologous proteins were done using SMART (http://smart.embl-heidelberg.deA) and 
blastp 2 sequences (http://www.ncbi.nhn.nih.gov/blast/bl2seq/wblast2.cgn
2.2 Molecular biology and Biochemistry
2.2.1 DNA extraction protocol
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Genomic DNA was prepared from adult flies either by using the DNeasy kit (Qiagen) 
and following manufacturers directions or by using a ‘rapid’ DNA extraction protocol. 
The latter involves homogenizing flies in 49 p.1 o f SB buffer (see solutions) in 1.5ml 
eppendorf tubes using the handles of plastic inoculation loops. Samples were then 
transferred to a 200pl PCR tube and 1 pil of lOpM Proteinase K (Invitrogen) was added. 
Samples were then run on the following PCR program:
1) 30 minutes at 37°C
2) 2 minutes at 95°C (to denature the proteinase K enzyme.)
2.2.2 PCR -  Polymerase chain reaction
PCR products were amplified using Taq PCR Master-mix kit (Qiagen) and a PTC-200 
peltier thermal cycler (MJ Research). For cloning PWO master-mix (Roche) was used 
due to its high fidelity. A typical PCR reaction of 50pl was composed o f the following 
ingredients:
25|fi Master-mix 
lp l 5’-primer (20pM) 
lp l 3’-primer (20pM) 
lp l Template DNA (10-50ng)
22pl distilled H2 O
A typical PCR reaction was run on the following PCR program:
1) 95 °C for 5 minutes.
2) 95°C for 40 seconds.
3) 60°C for 30 seconds.
4) 72°C for 1 minute per kb of product.
5) Go to step (2) - 32 cycles.
6) 72°C for 10 minutes.
7) 4°C forever.
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PCR products were run on 1% Agarose Gels (TAE + 1% Agarose (Invitrogen) + 1 pil of 
Ethidium Bromide (Roche)) and gels were photographed using an IMAGO compact 
imaging system (B and L systems).
2.2.3 DNA sequencing
DNA was sequenced by the Sequencing Service at Cancer Research UK using a 3730 
DNA Analyzer (Applied Biosystems). Extension products were amplified and purified 
using the DyeEx Spin kit (Qiagen). Purified extension products were handed to the 
Sequencing Service for sequencing.
2.2.4 RNA extraction and RT-PCR
dASPP, boa, tankyrase and actin transcript analysis was done on total adult fly RNA 
isolated using the RNeasy mini kit (Qiagen) and following manufacturers instructions. 
RNA samples were quantified using a Nanodrop (Nanodrop). For each sample 0.5p,g of 
RNA was reverse transcribed using the First Strand cDNA Synthesis System (Roche), 
lp l of the cDNA template was used for RT-PCR using primers specific to the relevant 
transcripts. PCRs were run for 28 cycles and bands were resolved on 1% agarose gels.
2.2.5 Drosophila cell-culture
Drosophila Kcl67 cells were cultured at 25°C in Schneiders medium (Gibco) + 10% 
FCS (foetal calf serum) (Gibco). Cells were split (1/6) every 3 days in fresh medium.
2.2.6 Cloning of dASPP, dCsk and Boa
dASPP-RA, dCsk-RB and Boa-RA were cloned using the Gateway system (Invitrogen). 
dASPP-RA cDNA was amplified using an EST (RE 13301) as a template and the 
primers dASPP-5’ RA and dASPP-3’ no stop (see primers table). dCsk-RB cDNA was 
amplified using an EST (LP09923) as a template and the primers dCsk-5’ RB and dCsk- 
3’ RB (see primers table). Boa-RA was amplified using an EST (GH01133) as a
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template and the primers Boa-5’ and Boa-3’ (see primers table). PCR products were 
then purified using a QIAquick PCR Purification kit (Qiagen) and ligated into the 
pENTR-topo vector (Invitrogen). The resulting plasmids were transformed into One- 
shot Top 10 cells (Invitrogen) according to the manufacturers instructions, and plated 
onto Kanamycin (lOOng/pl) selection plates, which were placed at 37°C overnight. 
Colonies were picked the following day and cultured in 5ml of L-broth (see solutions) 
overnight at 37°C with agitation. Mini-preps were done using the QIAquick Spin Mini- 
prep kit (Qiagen) and plasmid DNA was sequenced (see DNA sequencing) using 
primers supplied with the Gateway system (Invitrogen).
dASPP-RA, dCsk-RB or Boa-RA were then transferred from pENTR-TOPO to multiple 
Gateway expression vectors by the LR reaction. These included pActin 3xHA and 
pActin 6xMyc for the expression of tagged proteins in Kcl67 cells, and pUASP for 
UAS-dASPP and UAS-boa transgenic generation. Following the LR reaction the 
resulting plasmids were transfected into One-shot ToplO cells (Invitrogen), which were 
plated on Ampicillin (lOOng/pl) plates and placed at 37°C overnight. Colonies were 
picked and cultured for 8 hours at 37°C in 2ml L-broth. This 2ml culture was poured 
into 50ml of L-broth and placed at 37°C overnight with agitation. The following day 
midi-preps were performed using the High-speed Plasmid Midi and Maxi kit (Qiagen). 
The resulting plasmid DNA was quantified using the Nanodrop (Nanodrop), sequenced 
and stored at minus 20°C. All Gateway vectors were obtained from the Gateway 
Drosophila Vector Collection (Murphy lab, Carnegie Institution)
2.2.7 Immunoprecipitations (IPs) and Western blotting
The relevant plasmids were transfected into Drosophila Kcl67 cells in 6 well plates 
using Effectene reagent (Qiagen) according to the manufacturers instructions, and cells 
were cultured at 25°C for three days. Cells were collected and lysed in 200pl of IP 
buffer (see solutions) for 20 minutes on ice. Samples were cleared by centrifugation at 
14,0000 rpm at 4°C for 10 minutes. The supernatant was removed and proteins were 
quantified on an Eppendorf Biophotometer using Bradford reagent (Biorad). 150pg of 
protein was used for kinase assays and 500pg of protein was used for co- 
immunoprecipitations. 1/10th of the total input was loaded on the gel to check
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expression levels of tagged proteins (labelled input in figure 23 A and C). All the 
following steps were carried out at 4°C in the cold room.
Samples were pre-cleared by incubating protein samples in 250pl o f IP buffer with 60pl 
of protein A/G sepharose beads for 1 hour with agitation on a spinning wheel. The 
beads were then spun down by centrifugation for 1 minute at 2000rpm. The supernatant 
was transferred to a clean 1.5ml eppendorf and lp l of the relevant IP antibody was 
added (HA for dASPP or Boa IP, Myc for dASPP or dCsk IP and GFP for control IPs). 
Samples were then incubated for 1 hour with agitation to allow the antibody to bind to 
the relevant tagged protein. 80pl of a 50:50 resuspension o f protein A/G sepharose 
beads were added and samples were incubated for 1 hour with agitation to allow the 
antibody to bind to the beads. The beads were then spun down and the supernatant was 
removed with a syringe and discarded. The beads were washed 3 times in 1ml of IP 
buffer for 2 minutes. Following each wash the beads were spun down and the 
supernatant removed. After the last wash beads were spun down and 15pl o f SDS- 
PAGE sample buffer (Invitrogen) was added.
Samples were boiled at 70°C for 10 minutes and then resolved on SDS-PAGE gels 
(NuPAGE 4-12% Bis-Tris gels from Invitrogen) and proteins were transferred to PVDF 
membranes. Proteins were visualised by immunoblotting with the relevant antibodies 
and chemiluminescence was observed using the ECL-plus Western blotting detection 
system (Amersham Biosciences).
2.2.8 Kinase assay and quantification of dCsk activity
Cells were transfected with either dCsk-Myc alone (125ng DNA) or co-transfected with 
dCsk-Myc (125ng plasmid DNA) and dASPP-HA (125ng, 250ng or 375ng plasmid 
DNA) using Effectene reagent (Qiagen). dCsk-Myc was immunoprecipitated from cell 
lysates as described above. Following the 3 washes with IP buffer (see above) the beads 
were washed 3 times with 1ml of kinase assay buffer (see solutions). After the final 
wash, lOpl of kinase assay buffer, lOpCi of 32p-ATP and lOpg of substrate (GST-
K.276RSrc42A , see below) were added to the beads. The samples were incubated for 20 
minutes at 37°C to allow the immunoprecipitated dCsk to phosphorylate the substrate.
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Then 15pl of sample buffer was added and samples were boiled at 70°C for 10 minutes 
to denature proteins. Samples were resolved by SDS-PAGE and gels were stained with 
coomassie blue to visualise GST-Src42AK276R levels and then exposed for 20 minutes in 
the phosphorimager (Molecular Dynamics STORM 860) to quantify the radioactive 
signal, and thus dCsk kinase activity. The phosphorylation signal value was normalized 
to the efficiency of dCsk-Myc immunoprecipitation (l/5 th of IP was kept after final IP 
buffer wash, see above, labelled TP myc’ on figure 23 C), which was quantified using 
fluorescent secondary antibodies (see antibodies) and the Odyssey Infrared Imaging 
System (Li-COR Biosciences).
2.2.9 Generation of GST fusion proteins
A glutathione-S-transferase (GST)-dCsk fusion protein was produced. dCsk-RB was 
amplified using an EST template (LP09923) and the primers GST dCsk-5’ and GST- 
dCsk-3’ (see primers table). dCsk-RB was cloned into the Bglll and Xhol sites of the 
pGEX4Tl vector (Pharmacia). The plasmid was transfected into BL21 pLysS (protease 
deficient) cells (Stratagene). 500ml bacterial cultures were grown until they reached the 
appropriate density (OD600=0.65). The culture flask was chilled on ice for 5 minutes, 
then 500p,l of 1M IPTG was added to induce expression of GST-dCsk. Cultures were 
grown at 37°C for a further 3 hours to allow production of GST-dCsk. Cells were spun 
down at 4000rpm for 20 minutes and frozen on liquid nitrogen and thawed on ice. Cells 
were re-suspended in 10ml of lysis buffer (see solutions) and sonicated 3 times for 40 
seconds on ice to break cell membranes. Cells were then spun down at 10,000rpm in a 
fixed-angle rotor. The supernatant was transferred to a clean 15ml conical flask and 
500p,l o f Glutathione-sepharose beads (Pharmacia) were added. The sample was 
incubated for 30 minutes at 4°C with agitation to allow GST-dCsk to bind to the beads. 
The beads were then spun down for 1 minute at 4000rpm at 4°C and then washed 4 
times for 5 minutes in lysis buffer. To recover GST-dCsk from the beads they were re­
suspended in 500pl of thrombin re-suspension buffer (see solutions) containing 5mM 
reduced glutathione (which competes with the beads for GST-dCsk binding) and 
incubated for 5 minutes with agitation at 4°C. The beads were spun down and the 
supernatant was kept, this elution step was repeated once more and the eluates pooled. 
Samples were then dialysed overnight at 4°C in 4 litres of PBS. Samples were then
97
concentrated (Millipore, Centricon), quantified and aliquotted, frozen in liquid nitrogen 
and placed in a - 80°C freezer for storage.
This method was also used to produce GST-Src42AK276R (the kinase assay substrate). 
dSrc42A was amplified from an EST (LD35329) using primers GST Src42A-5’ and 
GST Src42A-3’ (see primers table). dSrc42A was ligated into the EcoRl and Xhol sites 
of pGEX4Tl (Pharmacia). dSrc42A mutagenesis to generate a non- 
autophosphorylatable dSrc42A (Src42AK276R, mutation of the ATP binding site) was 
done using unique restriction sites (Mfel and Stul) and PCR fragments amplified from 
pGEX4Tl-Src42A using the primers Src m utl-5’, Src m utl-3’, Src mut2-5’ and Src 
mut2-3’ (see primers table). The subsequent steps to produce GST-Src42AK276R fusion 
protein were the same as used to generate GST-dCsk (see above). GST-Src42AK276R 
was generated for the kinase assays (see above) so that the observed signal is the result 
of dCsk activity and not autophosphorylation.
2.2.10 GST pulldown
For the GST pull-down (see figure 23 B) Drosophila Kcl67 cells were transfected with 
dASPP-HA. Cells were lysed in lysis buffer for 20 minutes and samples were cleared 
by centrifugation at 14,0000 rpm at 4°C for 10 minutes. Protein concentration was 
quantified using Bradford reagent (Biorad). 1/10* of the total protein after lysis was 
kept for the input (labelled input in figure 23 B). 500pg of total protein was incubated 
with either lOpg GST or 1 Opig GST-dCsk overnight at 4°C with agitation. Then 40pl of 
Glutathione-sepharose beads (Pharmacia) were added to the samples and incubated for 
4 hours at 4°C with agitation to allow GST to bind. The beads were spun down for 2 
minutes at 2000rpm, the supernatant was removed and discarded and the beads were 
washed 3 times in lysis buffer for 5 minutes at 4°C. Following the last wash, the beads 
were spun down and 15pl of sample buffer (Invitrogen) was added. Samples were 
boiled at 70°C for 10 minutes and spun down for 1 minute at 2000rpm. The supernatant 
was removed and samples were resolved by SDS-PAGE and proteins were transferred 
to PVDF membranes. Immuno-labelling blots with anti-HA revealed whether dASPP 
was present in either the GST or GST-dCsk pull-downs.
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2.3 Solutions
lOx Flv PBS -  Phosphate buffered saline (11).
76.1g NaCl
18.8g Na2 HP0 4  (sodium phosphate dibasic)
4. lg  NaH2 P0 4  (sodium phosphate monobasic)
Add ddH20 up to 11 and autoclave.
TAE
40mM Tris Acetate 
ImM EDTA
PLP (2%  paraformaldehyde) fixative (lOmB.
5ml ddH20
3.75ml 0.2M NaHP04 pH7.2 
1.25ml 0.2M Na2H P04 
0.18g lysine
- Remove 2.5ml. To the remaining 7.5ml add:
1.25ml ddH20
1.25ml 16% paraformaldehyde 
25mg NaIC>4 (sodium periodate)
P B S/ PBT
SB Buffer (for genomic flv preps).
lOmM Tris-Hcl pH 8.2 
ImM EDTA 
25mM NaCl
IP Buffer.
50mM Tris pH8 
150mM 5M NaCl 
1 % NP40 
ImM EGTA 
50mM NaF 
lOmM Vanadate
1% Phosphatase Inhibitor Cocktail II (Sigma)
1 pill / 10ml of Protease Inhibitor Cocktail (Roche)
Kinase Assay buffer
20mM Hepes 
20mM MgCb 
4mM NaF
1 pill / 10ml of Phosphatase Inhibitor Cocktail II (Sigma) 
2mM DTT
Lvsis buffer.
50mM Tris pH7.2 
50mM NaCl 
5mM MgCE 
ImM DTT
Thrombin 
resuspension buffer.
50mM Tris pH8 
150mM Nacl 
2mM MgCb 
ImM DTT
L-Broth (1 litre)
1 Og tryptone 
5g yeast extract 
5g NaCl 
lm l lM N aO H
L-agar
L-broth + 1 % Agar 
add lOOmg/ml of 
appropriate antibiotic.
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2.4 Table of genotypes shown in figures
Figure number Genotype
9 C vv ; GMRsav,wts /  +
9 C’ w ; GE13722 /  + ; GMRsav.wts /  +
9 C” w ; D f (2R)Exel6072 /  + ; GMRsav.wts /  +
11 B - B ’ yw, eyFLP ; FRT42D, dASPP* /  FRT42D, ubi-GFP
11 C See figure for genotypes.
11 C - C ’ yw, eyFLP ; FRT42D, dASPP8 / FRT42D, ubi-GFP
11 D See figure for genotypes.
12 B w and w ; dASPPd /  CyO
12 C w and w ; dASPP8 /  dASPP8
12 D w ; dASPP8 /  dASPP8
13 A - A ” vv ; dASPPctrl /  dASPPc,rl
13 B - B ” w ; dASPP8 /  dASPP8
14 A vv ; dASPPclrl
14 B w ; dASPP8
14 C w ; dASPPclrl and dASPP8
14 D Rescue - w ; dASPP8 /  dASPP8 ; da-Gal4 /  UAS-dASPP
15 A See figure for genotypes.
15 B w / FRT42D, ASPPd/ FRT42D, ASPPd
15 B’ w ; FRT42D, ASPPd / FRT42D, ASPPd; FRT82B, wtsXI /  +
15 C yw, eyFLP ; FRT42D, dASPPd/ FRT42D, ubi-GFP
15 C’ yw, eyFLP ; FRT42D, dASPPd / FRT42D, l(2)cl-Rll
15 C” yw, eyFLP ; FRT42D, dASPPd/ FRT42D, l(2)cl-Rl 1 ; FRT82B, wt/ ’ /  +
16 A - A ” yw, hsFLP ; FRT42D, hpo42'47 / FRT42D ubi-GFP ; DIAP-LacZ/ +
1 6 B - B ” yw, hsFLP ; FRT42D, dASPPd/ FRT42D ubi-GFP ; DIAP-LacZ/  +
1 6 C - C ” yw, hsFLP ; FRT42D, hpo42'47 / FRT42D ubi-GFP ; CycE-LacZ/ +
16 D -  D” yw, hsFLP ; FRT42D, dASPP*/ FRT42D ubi-GFP ; CycE-LacZ/ +
17 A - A ” vv / FRT82B, dCskljd8 /  +
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Figure number Genotype
1 7 B - B ” w ; dASPP8 /  dASPP8
17 C -  C” w ; dASPP8 / dASPP8 ; FRT82B, dCskIjds /  +
17 D -  D” w ; dASPP8, btk*02006 /  dASPP8 ; FRT82B, dCsk,jd8 /  +
17 E -  E* w ; FRT82B, dCsklJd8 /  FRT82B, dCskIjd8
18 A - A ” w ; dASPPd /  dASPPd ; FRT82B, dCskljd8 /  +
1 8 B - B ” w ; dASPP8 /  dASPP8 ; FRT82B, wt/ '  /  +
19 A - A ’” w ; dASPP8 /+ ;  pucE69 /  +
19 B -  B’” w ; FRT82B, dCsk,jd8 / pucE69
19 C -  C’” w ; dASPP8 /  + ; FRT82B, dCskijdS / pucE69
19 D -  D’” w ; dASPP8 /  dASPP8 ; pucE69 /  +
20 A - A ” w ; ptcGal4 /  UAS-GFP
20 B - B ” vv, dCskIR ; ptcGal4 /  UAS-GFP
20 C -  C” w, dCskIR ; ptcGal4, dASPP8 /  UAS-GFP, dASPP8
20 D - D ” vv, dCskIR ; ptcGal4, dASPP8 /  UAS-GFP, dASPP8 ; UASdASPP /  +
20 E -  E” w, dCskIR ; ptcGaU, dASPP8 /  UAS-GFP, dASPP8 ; UASdASPP /  +
21 A w, dCskIR ; ptcGal4 /  UAS-GFP
21 B w, dCskIR ; ptcGal4, dASPP8 /  UAS-GFP, dASPP8
22 A - A ” w, dCskIR ; ptcGaU, dASPP8 /  UAS-GFP, dASPP8
22 B - B ” w, dCskIR ; ptcGal4, dASPP8 /  UAS-GFP, dASPP8 ; UAS-DIAP1 /  +
24 A - A ” yw , eyFLP ; FRT82B, dCskIjd8 / FRT82B, ubi-GFP
25 A - A ’ w ; dASPPc,rl /  dASPPc,rl
25 B - B ’ w ; dASPP8 /  dASPP8
2 5 C - C ’ w ; dASPP8, btk*02006 /  dASPP8
25 D - D ’ w ; dSrc64BKO /  dSrc64BKO
25 E - E ’ w ; dASPP8 /  dASPP8 ; dSrc64BKO /  dSrc64BKO
28 B - B ’ yw, eyFLP ; FRT82B, boa6/ FRT82B, ubi-GFP
28 C See figure for genotypes.
29 A - A ” yw ; boactrl /  boac!rl
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Figure number Genotype
2 9 B - D y w  ; boa6/ boa6
30 A yw ; boactrl /  boactrl
30 B yw ; boa6/ boa6
30 C yw ; boac,H /  boactrl and yw ; boa6 /  boa6
30 D yw ; boactrl /  boactrl and yw ; boa6 /  boa6
31 A- A” yw , eyFLP ; FRT82B, boa6 / FRT82B, ubi-GFP
32 A - A ” yw ; boa6/ boa6
32 B -  B” y w  ; FRT82B, dCskIJd8, boa6 /  boa6
<i< w
33 B - B ” yw , hsFLP /  UAS-EGFRact; act>CD2>Gal4, UAS-GFP (FLPout) /  +
34 A - A ” yw , hsFLP ; act>CD2>Gal4, UAS-GFP (FLPout) /  +  ; UAS-pntPl /  +
34 B -  B” yw , hsFLP ; act>CD2>Gal4, UAS-GFP (FLPout) /  + ; UAS-pntP2 /  +
34 C -  C” yw , hsFLP; act>CD2>Gal4, UAS-GFP (FLPout) /  +  / UAS-ttk69 /  +
34 D - D ” yw , hsFLP ; act>CD2>Gal4, UAS-GFP (FLPout) /  +  / UAS-ttk88 /  +
35 A - A ” yw , eyFLP ; FRT82B, ttkJeN / FRT82B, ubi-GFP
35 B - B ” yw , eyFLP ; FRT82B, ttk1 / FRT82B, ubi-GFP
35 C -  C” yw , eyFLP ; FRT42D, yanexI / FRT42D, ubi-GFP
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2.5 Table of antibodies used
Primary Antibody Species Concentration Source
P-Galactosidase Mouse 1 1000 Promega
Discs-Large (Dig) Mouse 1 500 DSHB
Cleaved Caspase 3 Rabbit 1 500 Cell signalling
DIAP1 Mouse 1 500 Bruce Hay
dASPP38 (a.a 1006-1020) Rat 1 1000 Eurogentec, Belgium
dASPP39 (a.a 733-746) Rat 1 1000 Eurogentec, Belgium
Boa803 (a.a 218-232) Guinea Pig 1 300 Eurogentec, Belgium
c-Myc (9E10): sc-40 Mouse 1 5000 (blot) Santa Cruz
c-Myc (A-14): sc-789 Rabbit 1 5000 (blot) Santa Cruz
HA (3F10) Rat 1 5000 (blot) Roche
GFP Mouse Only used for IPs Cancer Research UK
Secondary antibody Species Concentration Source
anti-mRRX Mouse 1 500 Jackson
anti-rbRRX Rabbit 1 500 Jackson
anti-ratRRX Rat 1 500 Jackson
anti-gpRRX Guinea pig 1 500 Jackson
anti-ratAlexa633 Rat 1 500 Molecular probes
anti-mouseFITC Mouse 1 500 Jackson
IRdye700DX-labelled Rat 1:6000 Rockland
IRdye800-labelled Rabbit 1:6000 Rockland
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2.6 Table of primers used
Prim er Name Prim er sequence Application
dASPP-3’a GAACGTGCGACAGAGAGGGCAG detects dASPPd
dASPP-5’a CGATCGCCAACGCCGCAACAAG detects dASPPd
2.2-5’ CCTTTTGTATTTGGAGGCGGAGGC detects dASPP8
dASPP-3’b T AG ATCGTTTCG TTTGGG CCTCTCTG detects dASPP8 and dASPPctrl
dASPP-5’b GGTCATCAGGTGACCATGGTAACAG detects dASPPctrl
2.2-3’ CGGAATGTTCTCCTTTGCGAAAGGC used to define dASPP8
2.3-3’ CAACGCTTCGCTTAACGCGAAGG used to define dASPP8
2.3-5’ CGAAAGTCTGTAGTTTTCGCCTGGAC used to define dASPP8
ATG-3’ CCAGTGGATTTTTATGTTCGTGCTGCG used to define dASPP8
ATG-5’ GTTTGTCTGTTTGCTGATTCTGACTTCTC used to define dASPP8
Boa-5’a GGTTTTACACAAATTTGTGCTTCAGTGTGCAC detects boa2
Boa-5’b AGGAGAAGCAGAAGCAGAAGAGGAG detects boa6
Boa-3’a GTTGTGGCTGCTATGCTGATCGTAGTC detects boa2 and boa6
RT-3’b CTGCTGATGATGGGTGTTGGCCT dASPP RT-PCR
RT-RA-5’b GAGCCGACGAACACTTTGGATGAAAT dASPP RT-PCR (RA)
RT-RB-5’b ATCCTCCGCGTCGTCCTCAACAT dASPP RT-PCR (RB)
BoaRT-5’a ACCTGGCCCCCAATGAGAATCCA boa RT-PCR
BoaRT-5’b TGTCAGTGTTGTGCAGAGCCTGGT boa RT-PCR
TankRT-5’a CTCATCCTTTCGATATTCGCCGGTCAAT tankyrase RT-PCR
TankRT-3’a AGCTCTTCGAGGCCTGCAAAACG tankyrase RT-PCR
actRT-5’ CACCCTGAAGTACCCCATTGAGCAC actin RT-PCR
actRT-3’ CAGACGCAGGATGGCATGGGGAAGG act in RT-PCR
dASPP-5’ RA CACCATGAAGGAGCCGACGAACACTTTGG Cloning dASPP-RA
dASPP-3 ’nostop ATCGCTGAAGTGCGGCGAATGCGGC Cloning dASPP-RA
dCsk-5’ RB CACCATGAACAGCCACGCGACTGCC Cloning dCsk-RB
dCsk-3’ RB CGCCGTGGCATTGTTCAGTAGC Cloning dCsk-RB
Boa-5’ CACCATGGAGCTGAAAGTTTGGGTCGAGGG Cloning Boa-RA
Boa-3’ TTAAACCCACACACCATGAGGAT Cloning Boa-RA
GST Src42A-5’ GGAATTCGGTAACTGCCTCACCACACAGAAGG Cloning Src42A
GST Src42A-3’ CCGCTCGAGTCAGTTACAGGCTTCTCGATCTGGA Cloning Src42A
Src mutl-5’ CAATTGGACGAAGGCGGCTTCTTCA Src42AK276R generation
Src mutl-3’ TTTCAGAGTTCTAATTGCCACAGGT Src42AK276R generation
Src mut2-5’ ACCTGTGGCAATTAGAACTCTGAAA Src42AK276R generation
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Prim er Name Prim er sequence Application
Src mut2-3’ AGGCCTGCGCCTCTTTGTAGTCGCT Src42AK276R generation
GST dCsk-5’ GAAGATCTAACAGCCACGCGACTGCCACGCAG GST-dCsk generation
GST dCsk-3’ CCGCTCGAGTCACGCCGTGGCATTGTTCAGT GST-dCsk generation
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CHAPTER 3 Drosophila ASPP
3.1 A screen for novel components of the Drosophila Hippo signalling 
pathway
3.1.1 The basis of the screen
The Hippo signalling pathway was identified using genetic screens in Drosophila and 
has been the focus of intensive research over the past 5 years. The Hippo pathway has 
potent growth regulatory functions and negatively regulates the size o f organs by 
carrying out dual roles of promoting apoptosis and exit from the cell cycle (Harvey and 
Tapon, 2007). At least 11 components of the pathway have now been identified (see 
figure 7). When this project began in 2003, the only known members of the pathway 
were Hippo (Hpo), Salvador (Sav) and Warts (Wts). For this reason I carried out a 
candidate-based screen with the aim of identifying novel components of the Hippo 
pathway.
The Drosophila eye is well suited to studying the control of tissue size. Firstly, it is a 
non-essential organ so phenotypes can be examined in adult flies. Secondly, even minor 
changes in cell numbers disrupt the lattice to produce visible phenotypes. Over­
expression of sav and wts using the eye-specific GMR (Glass Multimer Reporter) driver 
(GMRsav,wts) results in a small, rough eye phenotype as a result of increased cell death 
(see figure 9 C). GMRsav,wts was used a sensitised background for screening for novel 
components of the Hippo pathway. Candidate alleles (see below) were crossed into this 
background and tested for their ability to modify the eye phenotype.
Candidates were selected based on their interaction with Hpo, Sav or Wts in a published 
yeast 2-hybrid screen. A genome-wide yeast 2-hybrid screen performed by Curagen Inc. 
provides an online protein-protein interaction map for all Drosophila proteins (Giot et 
al., 2003). Using Hpo, Sav or Wts as a starting point, interaction ‘webs’ were 
constructed that included primary and secondary interactions (an example is shown in 
figure 9 A). A ‘score’ (0-1) is given for each interaction, which represents the
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CGI 5803
CG17002
CG18375
CGI8506 
CG32677 
CG5859
  VCG6416
CG 5053 r — — CG7417 
CGI 099 
CG11326
CG4209
CG1587
CG17045
CG4847
CG5675
CG9949 
CG14408
CG4840
B no. of genes genes with EP suppressors enhancers
Sav interactors 29 22 6 1
Hpo interactors 32 27 9 2
Wts interactors 23 17 5 0
total 84 66 20 3
GMRsav,wts /  + GMRsav.wts /  GE13722
C”
*
GMRsav,wts /  Df
Figure 9: A genetic screen for novel components of the Hippo signalling pathway. (A)
Candidate genes were selected based on their interaction with either Hpo, Sav or Wts in 
a published 2-hybrid screen performed by Curagen. Shown are the primary and secondary 
interactors of Wts, similar interaction ‘webs’ were constructed for Hpo and Sav (not 
shown). P-element insertions in the candidate genes were obtained, and tested for their 
ability to modify a Hpo pathway overexpression phenotype (see C). (B) Summary of the 
results of the screen. (C) The small, rough eye phenotype resulting from overexpression 
of sav and wts (GMRsav,wts). (C’) An example of a strong suppressor of the GMRsav.wts 
phenotype. GE13722, which is a P-element insertion in CG I8375 gene (see A) domi­
nantly suppresses the GMRsav,wts phenotype. (C” ) Df(2R)Exel6072, a deficiency for 
CGI8375 also dominantly suppresses the phenotype.
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probability that any interaction is biologically significant. The score is calculated based 
on several criteria including the number of overlapping cDNAs recovered in the screen 
and the strength of the interaction. With the aim of filtering out some false positives I 
only included interactions with a score of 0.3 or above when generating the list of 
candidates.
The second resource used in this screen was a large transposon insertion collection 
generated by Genexel Inc. This allowed me to obtain P-element insertions in the loci of 
about 80% of the candidate genes (see figure 9 B). As P-elements can disrupt gene 
expression, the Genexel lines are putative LOF alleles for the screen candidates. These 
lines were crossed to GMRsav, wts and the extent of suppression or enhancement of the 
eye phenotype was scored using an arbitrary scale ranging from -2 to +2 (0 
corresponding to no modification of the phenotype and +2 corresponding to strong 
enhancement).
3.1.2 Results of screen and confirmation of hits
As GMRsav, wts gives a phenotype resulting from activation of the Hippo pathway, it is 
expected that suppressors will be positively involved in the pathway and enhancers will 
antagonize the pathway. Of the 66 candidates screened, 20 suppressors and 3 enhancers 
of the phenotype were identified (see figure 9 B). I selected 2 of these genes, C G I8375 
and CG5053 for further analysis. These genes were selected because the C G I8375 
insertion was the strongest suppressor of GMRsav,wts (see below). The CG5053 
insertion also suppressed GMRsav.wts (data not shown) and this gene links C G I8375 to 
wts in the yeast 2-hybrid interaction ‘web’ (see figure 9 A). The CG I8375 and CG5053 
insertions both suppressed GMRsav.wts suggesting that these genes function as negative 
regulators of tissue size and may do so by regulating the Hippo pathway.
The strongest suppressor of the GMRsav.wts phenotype was GE13722 (see figure 9 C 
and C’), a P-element insertion upstream of the CG18375-RA transcription start site. This 
insertion dominantly suppressed GMRsav.wts and partially rescued both the eye size 
and morphology. The genetic interaction was confirmed using another C G I8375 allele; 
Df(2R)Exel6072 is a deficiency stock that removes CG I8375 and also suppresses the
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GMRsav.wts phenotype (see figure 9 C” ). However, Df(2R)Exel6072 suppressed 
GMRsav.wts to a lesser degree than GE13722. This was a surprising result as GE13722 
is likely a hypomorphic C G I8375 allele and Df(2R)Exel6072 is a null allele for the 
gene. Unfortunately, no deficiency was available for CG5053 so this interaction could 
not be confirmed.
The Genexel insertions are EP elements, which are P-elements containing a basal 
promoter and 14 UAS sequences (Rorth, 1996). By supplying Gal4 one can use EP 
elements to drive tissue-specific expression of endogenous genes near the insertion site. 
en-Gal4 places Gal4 under the control of the engrailed promoter and expression in 
wings is restricted to the posterior compartment. Crossing en-Gal4 to GE13722 leads to 
CG I8375 over-expression, and results in an 11% reduction in the size of the posterior 
wing compartment (data not shown). This result provides further evidence that 
CGI8375 is a negative regulator of tissue size.
3.2 Characterization of CG18375/dASPP 
3.2.1 CGI8375 homologs
CGI8375 shows significant homology to the mammalian ASPP family genes, which 
include ASPP1, ASPP2 and iASPP. For this reason CG I8375 was named dASPP 
(Drosophila ASPP) and will be referred to as dASPP in the following text. Proteins of 
the ASPP family have been characterised and are implicated in regulation of the tumour 
suppressor p53 (Trigiante and Lu, 2006). Mammalian ASPP proteins possess a C- 
terminal region containing an SH3 domain, an ankyrin domain and a proline rich region 
(see figure 10). The SH3 and ankyrin domains are present in dASPP and show a high 
degree of conservation with the equivalent ASPP1 and ASPP2 domains (see figure 10). 
The proline rich region is not conserved. dASPP also shows homology to the C.elegans 
ASPP homolog, ape-1, and an unnamed A gambiae gene (see figure 10).
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Figure 10: Domain structure of dASPP and alignment with homologs from other 
species. Alignment of dASPP-PA (NP_788423.1) with A.gambiae (XP 555930.1), 
C.elegans (NP 505955.1) and human (CAC83011 for hASPPI and CAC83012 for 
hASPP2) homologs. dASPP has a conserved C-terminal region containing an SH3 
domain and an ankyrin domain. Percentage amino acid identity within the conserved 
domains is indicated. The alignments and figure were done by Julien Colombani.
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3.2.2 dASPP mutagenesis, excision of GE13722
As GE13722 is inserted upstream of dASPP within the promoter region, it is likely to 
constitute a weak hypomorphic dASPP allele. Indeed, GE13722 homozygous flies are 
viable and fertile with no obvious phenotype. Therefore, to analyse the function of 
dASPP, I generated stronger LOF alleles by imprecise excision of GE13722.
First, the GE13722 insertion site was confirmed. This was achieved by amplifying a 
PCR product from GE13722 genomic DNA using a P-element specific primer and a 
genomic primer near the reported insertion site. A band of the expected size was 
detected (data not shown) and sequenced. This confirmed that the reported insertion site 
was correct, and GE13722 is inserted 27bp upstream of the transcription start site o f the 
dASPP RA transcript (see figure 11 A).
Once the insertion site was confirmed, I initiated the cross scheme to excise the P- 
element and generate mutants (see materials and methods for cross scheme). Putative 
mutant males were crossed individually to second chromosome balancer virgin females 
(Sp/CyO) to retain mutant chromosomes. Once the cross had ‘taken’ the males were 
removed and screened by PCR using primers dASPP-5’a and dASPP-3’a (see primers 
table), which flank the P-element insertion site (see figure 12 A). I screened for a 
downward band-shift of the PCR product, which indicates that a genomic deletion has 
occurred during P-element excision.
In the vast majority of cases the expected 2kb band size was seen, this can be the result 
of four possible events. The first possibility is a precise excision event where the P- 
element is completely removed without deleting surrounding genomic DNA. The 
second possibility is an imprecise excision event where the deletion of sequence 
between the primers is too small to detect by PCR. The third is an imprecise event 
where a small piece of P-element sequence remains at the insertion site but this is not 
detectable by PCR. The fourth possibility is an imprecise excision event creating a large 
deletion. If a large deletion removes one or both of the primer binding sites then no 
product will be generated from the mutant chromosome. However, a product of the 
expected size will be amplified from the homologous balancer chromosome. Therefore 
large deletions are not identified using this method of screening.
I l l
A
P{EP}GE13722
' T
H  h
dASPP*
P{XP}CG4302d03020
-ry- -H----1
CG18375 CG15561 CG4302
dASPP8
dASPPctrl
1kb
GFP B’
m . J !
i f
dASPP* clones
dASPP
dASPP8 c lon es
( f
Figure 11: dL4£PP mutagenesis by imprecise P-element excision. (A) A map of the dASPP 
locus showing the two predicted transcripts (RA and RB), the insertion sites of the P-elements 
used (P(EP)GE13722 and P(XP)CG4302do302°) and the deletions generated (dASPP3, dASPP 
and dASPP*1). P(EP)13722 was excised to generate dASPP , which is a 533bp deletion. 
P(XP)CG4302d03020 was excised to generate dASPP and dASPP*1. dASPP is a 29kb deletion 
that removes CGI5561 and all of the dASPP coding sequence. dASPP*1 is a 1.1 kb deletion and 
removes most of CGI5561. (B-E) Confirmation of the dASPP alleles. (B) An eye-antennal 
imaginal disc bearing dASPP clones, marked by absence of GFP. (B’) Note the strong reduction 
of dASPP antibody staining (red) in dASPP clones. (C) RT-PCR on samples prepared from 
either control (P(EP)GE13722 precise excision) or dASPP  adult flies. In dASPP  samples the 
RA transcript is not detected but the RB transcript is still expressed, actin (act) transcript levels 
provide a positive control. (D) An eye-antennal imaginal disc bearing dASPP clones, marked by 
absence of GFP. (D’) Note the strong reduction of dASPP antibody staining (red) in dASPP 
clones. (E) RT-PCR on samples prepared from either dASPP*1 or dASPP adult flies. In dASPP 
samples neither the RA nor RB transcript is detected.
112
P{EP}GE13722
, - 2 _
* «•
5'a 3'a
H
dASPP*
*>«•
22 2 3
ATG
-4^- -7 -^ -M  H
P{XP}CG4302dO3O2°
Y■■■ ‘i f  3 ’
ATG
dASPP CG15561 CG4302 
«• 3 'b
dASPP8 Ik b
B
5’a + 3’a 
wt dASPPd
1kb — 1kb
dASPP8
2.2-5' 2.3-5
Figure 12: Molecular characterization of the dASPP  alleles. (A) An illustration o f the 
dASPP locus showing the location of the P-elements excised, the primers used (small 
arrows) and the breakpoints of the dASPP alleles generated. (B) A PCR on genomic DNA 
from either wildtype (wt) or dASPPd flies using primers 5’a and 3 ’a. This primer pair 
amplifies a product of ~2kb from wt DNA. This product is reduced in size when ampli­
fied from dASPPd DNA due to the 533bp deletion. (C) Determining the limits o f the 
dASPP8 deletion. The ATG PCR product fails to be amplified from dASPP8 genomic 
DNA but the 2.2 PCR product is amplified suggesting that the 5’ deletion breakpoint is 
between the 2.2 and ATG primer pairs. (D) Confirmation of the dASPP8 allele. Using the 
5’primer of the 2.2 primer pair and 3’b (see A) it is possible to amplify a band from 
dASPP8 but not wt (not shown) DNA. No product is amplified when the 3 ’b primer is 
used in combination with the 5’-primer of the 2.3 primer pair.
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For some of the putative mutant chromosomes screened an upward band-shift was 
observed, this occurs when the P-element excises imprecisely and part o f its sequence 
remains at the insertion site. In a small percentage of cases (-1% ), a downward band 
shift was observed. This indicates that an imprecise excision event has occurred that 
results in deletion of genomic DNA between the screening primers. These males are 
likely to be dASPP mutants and the corresponding cross to the second chromosome 
balancer virgins was kept. Progeny of the cross were mated inter se to obtain mutant 
stocks.
3.2.3 Description of the alleles generated by excision of GE13722
Overall, I screened 200 putative mutant males by PCR following excision o f GE13722 
and identified 2 novel dASPP alleles, dASPPd and dASPP6 (see figure 11 A and data not 
shown). These alleles are deletions of 533bp and 1070bp respectively and remove most 
of the 5’UTR of the dASPP RA transcript. Both of these deletions result in a downward 
band shift when using the screening primers (see figure 12 B and data not shown). A 
faint band of the expected size is seen (see figure 12 B) resulting from amplification of 
the product from the balancer chromosome. The shifted bands were cut out of the gels 
and sequenced to determine the exact breakpoints. A precise excision (dASPPprecise) was 
also recovered to use as a control in genetic experiments. This was identified by 
sequencing PCR products amplified using the dASPP-5’a and dASPP-3’a primers (see 
primers table) from homozygous flies obtained from 10 different putative mutant lines 
and selecting a precise excision line. As expected the precise excision line has no visible 
phenotype.
Both dASPP* and dASPP1 are homozygous viable alleles and the homozygous flies 
showed visible phenotypes including rough eyes and enlarged wings (see below for 
phenotypic characterisation). This was the first clear indication that dASPP is a 
regulator of tissue size and the phenotype observed (overgrowth) agrees with the 
genetic screening data suggesting that dASPP is a negative regulator of tissue size.
As dASPP** and dASPPe only affect the sequence of the RA transcript, it was possible 
that they are not null alleles as the RB transcript is intact. Indeed, the RB transcript can
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still be detected by RT-PCR on dASPP4 flies, whereas the RA transcript was absent (see 
figure 11 C). To address this question the dASPP alleles were crossed to a dASPP 
deficiency (Df(2R)Exel6072), which is a null for dASPP. However the phenotype of 
dASPP4 /  Df(2R)Exel6072 (data not shown) is comparable the phenotype of 
dASPP4/dASPP4 indicating that dASPPd behaves at least like a strong hypomorphic 
allele or a null. Similar results were obtained for dASPP6. However, in order to fully 
appreciate the dASPP mutant phenotype it was important to generate a null allele and 
ascertain whether removing both dASPP transcripts elicits a stronger phenotype. For 
this reason I undertook another round of P-element excisions.
Initially, GE13722 was excised again with the aim of generating a larger deletion that 
removes all the dASPP coding sequence. However, the distance from the GEJ3722 
insertion site to the start of the dASPP coding sequence common to both transcripts is 
roughly 30kb. As deletions this large are not common and cannot be screened for easily 
by PCR, a different strategy was used when screening for mutant chromosomes.
As the dASPP4 allele generated is viable over a dASPP deficiency (Df(2R)Exel6072), it 
was possible to screen for a dASPP null allele by crossing all putative mutant males to 
dASPP4/CyO virgins and looking for the distinctive dASPP phenotype in the FI 
generation. This method of screening is much faster as it does not rely on PCR and I 
was able to screen 1000 putative mutant chromosomes relatively quickly.
At least 10 new dASPP alleles were identified, including 3 new lethal dASPP alleles. 
The lethal alleles were balanced over CyO-GFP so that the stage of lethality could be 
assessed. The lethal dASPP alleles generated were all lethal at the first instar larval 
stage and homozygous mutant embryos (non GFP) were collected for PCR analysis. 
Disappointingly, the lethal dASPP alleles were all very large deletions removing dASPP 
and several neighbouring genes. For example, a PCR product from the tudor locus was 
not amplified from homozygous mutant embryos from the lethal dASPP excision stocks 
(data not shown). As tudor is the fifth gene downstream of dASPP, these alleles delete 
several genes and are not useful. Additionally, the new viable dASPP alleles were 
genotyped by PCR but none of the deletions generated were large enough to reach the 
dASPP coding sequence common to both transcripts. Therefore, I was not able to 
generate a useful dASPP null allele by excising GE13722 as the deletions generated
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were either not large enough to fully delete dASPP or too large to be useful. Due to this 
difficulty I decided to excise a different P-element, which is inserted closer to the 
dASPP coding sequence common to both transcripts.
3.2.4 dASPP mutagenesis, excision of P(XP)CG4302d0S020
The nearest available insertion to the dASPP coding sequence is P(XP)CG4302d03020. 
This P-element is inserted downstream of dASPP and downstream of the neighbouring 
gene, CGI5561 (see figure 11 A). Having confirmed the insertion site of this 
transposon, I began the cross scheme to generate excisions (see materials and methods 
for cross scheme). Roughly 1000 putative mutants were screened for phenotypes when 
crossed to dASPI^/CyO  and stocks were established for any deletions recovered. 
Several of the mutant stocks generated by excision of P(XP)CG4302d03020 were 
homozygous viable with phenotypes similar to dASPPd. PCR analysis revealed that one 
of these homozygous viable alleles, dASPP8, might remove all of the dASPP coding 
sequence (see figure 12 A). A PCR product near the start codon (amplified using ATG 
primers, see primers table and figure 12 A) of the RA transcript fails to amplify from 
dASPP8 genomic template (see figure 12 C) suggesting that the 5’-breakpoint extends 
beyond this point. A PCR product roughly 7kb to the 5’-side of the ATG product 
(amplified using 2.2 primers, see primers table and figure 12 A) does amplify from 
dASPP8 genomic DNA (see figure 12 C). This suggests that the dASPP8 5’-breakpoint 
is between the ATG and 2.2 primer pairs. By using a primer to the 3’-side of the 
P(XP)CG4302d03020 insertion site (dASPP-3’b primer, see primers table and figure 12
A) in combination with the 5’-primer of the 2.2 primer pair (see primers table and figure 
12 A) I was able to amplify a band of roughly 1.5kb from dASPP8 but not wild-type 
genomic template (see figure 12 D). This band was purified and sequenced to determine 
the exact breakpoints of the dASPP8 deletion.
dASPP8 is a 29.5kb deletion to the 5’-side o f P(XP)CG4302d03020 that removes
o
CG15561 and all of the dASPP protein coding sequence. Therefore dASPP is a null 
dASPP allele and as it is homozygous viable I concluded that dASPP is not an essential 
gene. dASPP8 is a double mutant for dASPP and C G I5561, therefore a single C G I5561 
mutant was recovered to use as a control in genetic experiments. dASPP°trl is a 1.1 kb
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deletion to the 5’-side of P(XP)CG4302d03020 that removes most of the C G I5561 coding 
sequence (see figure 11 A). dASPPclrl is a homozygous viable and fertile line with no 
obvious phenotype suggesting that the dASPP8 phenotype is due to deletion of dASPP 
rather than C G I5561.
3.2.5 Confirmation of dASPP mutants
The 2 most useful dASPP mutations, dASPPd (the RA specific allele) and dASPP8 (the 
null allele) were recombined onto the FRT42D chromosome, which carries an FRT site 
near the base of the 2R chromosome arm. dASPP** and dASPP8 clones were generated in 
eye-antennal imaginal discs and the level o f dASPP protein within the clones was 
examined using a dASPP antibody (dASPP38, see materials and methods). The 
dASPP38 antibody was generated by Eurogentec and raised in rats against a peptide 
corresponding to amino acids 1006-1020 of dASPP. In dASPPd clones (see figure 11 B- 
B’) and dASPP8 clones (see figure 11 D-D’) a strong reduction in dASPP protein was 
observed. This result confirms that my alleles are dASPP mutants and also confirms that 
the dASPP38 antibody specifically recognises dASPP. Perhaps surprisingly, the loss of 
dASPP protein in dASPPd and dASPP8 clones is comparable. The fact that removal of 
the RA transcript is sufficient to largely abolish dASPP protein expression suggests that 
the predicted RB transcript may be either not expressed or expressed at very low levels.
The dASPP alleles were also confirmed by RT-PCR following generation of cDNA 
templates from whole fly RNA preps. This confirmed that dASPP** is indeed an RA 
specific mutant as the RA transcript is not detected in dASPPd samples (see figure 11 
C). The RB transcript is detected in dASPP1irecise and dASPPd samples suggesting that 
this transcript is actually expressed (see figure 11 C). One possibility is that the RB 
transcript is expressed either at very low levels and this accounts for the strong 
reduction of dASPP protein observed in dASPPd clones. Alternatively, the RB transcript 
may not be expressed in the eye. Intriguingly, the level of RB transcript appears to be 
higher in dASPP** than dASPPprecise samples, although the significance o f this is not 
known. As expected, neither the RA nor the RB transcript is detected in dASPP8 
samples (see figure 11 E). Therefore the RT-PCR results confirm that dASPP** is an RA 
specific mutant and that dASPP8 removes both transcripts.
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3.2.6 dASPP  loss of function results in a large, rough eye phenotype
dASPPd and dASPP3 are both viable mutations and homozygous flies show visible 
phenotypes including large, rough eyes, large wings and excess thoracic macrochetes. 
Scanning electron micrographs (SEMs) of dASPP mutant eyes show that dASPP LOF 
results in a large, rough eye phenotype (see figure 13 A, B and C). Interestingly, the 
dASPP^Qye phenotype appears to be slightly stronger than the dASPP8 eye phenotype. I 
quantified the average number o f ommatidia in dASPPctrl and dASPP8 eyes and show 
that dASPP mutant eyes contain more ommatidia than control eyes (see figure 13 A and 
B). In the developing eye, a differentiation front called the morphogenetic furrow (MF) 
sweeps across the eye-disc during the third larval instar (Held, 2002). The passage of 
the MF sets the number of ommatidia, such that increased proliferation before this stage 
results in an increase in final ommatidia number. dASPP8 eyes contain significantly 
more ommatidia (796 ± 24 per eye, n=7, p<0.003) than dASPPctrl eyes (747 ± 25 per 
eye, n=7) suggesting that proliferation is accelerated in dASPP mutant eyes and that this 
contributes to the observed increase in eye size. Higher magnification images reveal that 
dASPP mutant eyes show disorganization of the ommatidial lattice and an abnormal 
arrangement of bristle cells (see figure 13 A ’, B’ and C’).
The phenotype of dASPP mutant eyes was also examined at the pupal stage using a 
Discs-large antibody to mark cell membranes in pupal retinas at 40-44h APF (see figure 
13 A ” and B” ). In wild-type (or dASPPctrl) retinas, the ommatidiae, which are the units 
of the compound eye, consist o f 8 photoreceptor cells (not visible at this apical plane of 
focus), 4 cone cells and 2 primary pigment cells (Held, 2002). These hexagonal units 
are separated from each other by 6 secondary pigment cells occupying the sides of the 
hexagon, 3 tertiary pigment cells occupying three o f the vertices, and 3 bristle cells
o
occupy the other three vertices. dASPP retinas are mis-patterned and clustering of 
bristle cells is commonly observed (arrow in figure 13 B” ). Frequently, bristles are 
missing from positions near the cluster. This suggests that the clustering phenotype may 
be the result of cells failing to maintain appropriate cell-cell contacts and moving out of 
their niche rather than overproduction of bristle cells. Additionally, in wild-type (or 
dASPPctrl) retinas, each bristle cell always contacts three secondary inter-ommatidial 
cells (inset in figure 13 A ” ). In dASPP8 mutant retinas bristle cells may contact 4 or 
more secondary inter-ommatidial cells (inset in figure 13 B” ). This disrupts the regular
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Figure 13: dASPP  loss of function results in a large, rough eye phenotype. (A) Scan­
ning electron micrograph (SEM) o f a dASPP0*1 adult eye (180x). The average number of 
ommatidia per eye is indicated. (B) SEM of a dASPP8 / dASPP8 adult eye (180x), note the 
large size compared to the dASPPc,rl eye and the rough appearance. The average number 
of ommatidia per dASPP8 eye is indicated and is significantly higher (p<0.01) than the 
number of ommatidia per dASPP0*1 eye. (A’) High magnification (lOOOx) SEM of a 
dASPP0*1 eye to show the regular arrangement o f bristles. (B’) High magnification 
(lOOOx) SEM of a dASPP8 eye. Irregularities in the arrangement of bristles are observed 
and bristles commonly cluster together (arrows). (C and C’) The dASPPd eye phenotype 
is very similar to the dASPP8 eye phenotype. (A” ) dASPP0*1 pupal retina at 40h after 
puparium formation (APF) stained with a Discs-large (Dig) antibody to outline cells. The 
inter-ommatidial cells form a regular hexagonal lattice and bristle cells always contact 
three secondary inter-ommatidial cells (inset). (B” ) dASPP8 pupal retina at 40h APF 
stained with anti-Dlg. The regularity of the lattice is disrupted and bristle cells may 
contact four inter-ommatidial cells (inset). Another phenotype of dASPP8 mutant retinas 
is bristle clustering (arrow).
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hexagonal lattice seen in wild-type retinas and ommatidiae in dASPP8 retinas often have 
five vertices as opposed to six.
The phenotype observed in dASPP8 retinas is probably the consequence of several 
phenomena. There is a minor increase in the number o f inter-ommatidial cells 
(approximately one extra cell per ommatidium). This may be the result o f either delayed 
cell cycle exit or reduced apoptosis of inter-ommatidial cells during the early pupal 
stages. The effect of dASPP LOF on cell cycle exit and inter-ommatidial cell apoptosis 
was not directly tested as such a minor defect is unlikely to be detectable using BrdU 
incorporation or TUNEL staining. The increase in inter-ommatidial cell number cannot 
account for the patterning defects observed. The retinal mis-patterning in dASPP eyes 
is probably also the result of an adhesion defect as clustering of bristles and abnormal 
arrangements of cells are observed. As described later dASPP is regulator of 
Drosophila SFKs, which are heavily implicated in cell-cell adhesion processes.
3.2.7 dASPP functions as a tumour suppressor gene
dASPPd and dASPP8 homozygous mutants also have large wings as a result o f increased 
proliferation. This phenotype was quantified by carrying out density-controlled crosses 
at 25°C to obtain the required genotypes, followed by measurement of wing area (see 
materials and methods for details). It is important that crosses are density controlled 
when quantifying organ or animal size as final size is affected by the availability of 
nutrients during the larval growth phase. In density-controlled experiments carried out 
by myself, I found that FRT,dASPPd wings (n=20) are on average 11.7% larger than 
control (dASPPprease) wings (n=20) (see figure 15 A). In a separate experiment I found 
that dASPP8 wings (n=20) are on average 7.8% larger than control (dASPPctrl) wings 
(n=20). Interestingly, in these experiments the dASPPd allele has a stronger phenotype 
than the dASPP8 null allele. This difference in strength o f phenotype between the alleles 
is also observed in the eye; dASPPd seems to result in a stronger rough eye phenotype 
(see figure 13 B and C).
The large wing phenotype of dASPP mutants was confirmed in density-controlled 
experiments carried out by Julien Colombani (see figure 14). In this experiment it was
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Figure 14: dASPP is a negative regulator of tissue size. Density controlled crosses 
were performed at 25°C to obtain the genotypes indicated and adult wing area was deter­
mined. (A-C) dASPP mutant wings (B) are larger than dASPP0"1 wings (A). (D) Quantifi­
cation of body weight, wing area and wing hair density of dASPPctrl and dASPP8 flies. 
dASPP8 flies are heavier than controls and have larger wings (** indicates that p<0.01, 
using a student’s t-test), the hair density is similar to controls suggesting that dASPP8 
wings contain more cells rather than larger cells. dASPP8 overgrowth phenotypes are 
rescued by ubiquitous dASPP expression. The data and figure were generated by Julien 
Colombani.
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found that dASPP8 wings (n=20) are on average 11.8% larger than dASPPctrl wings
o
(n=20) (see figure 14 A-D). This increase in dASPP wing area is more significant than 
the increase observed in the previous experiment (7.8%) but different medium was 
used, which may affect the phenotype. Regardless, each experiment showed
o
independently that dASPP mutant wings are larger than control wings. Little 
developmental apoptosis occurs in the developing wing disc, therefore an increase in 
wing size can be attributed to either increased proliferation or increased cellular growth. 
Each cell in the wing secretes a hair, or trichome, and the density o f wing hairs can be 
used as a measure of cell size. Importantly, the density of wing hairs in dASPP8 (n=12) 
and dASPPclrl (n=12) wings is comparable (see figure 14 D) suggesting that the size of 
cells is not affected by loss of dASPP. Therefore, proliferation is increased in dASPP 
mutants, and adult wings contain more cells o f normal size. This is in agreement with 
the result o f the ommatidial counts, which indicated that increased proliferation occurs 
in dASPP mutant eyes.
Julien Colombani also quantified the adult body weight and in density-controlled 
crosses dASPP8 flies (n=100) are 6.1% heavier than dASPPctrl flies (n=130) (see figure 
14 D). This is in agreement with the eye and wing phenotype characterization 
suggesting that dASPP functions as a negative regulator of tissue and animal size. Both 
the wing size and body weight are rescued by ubiquitous expression of dASPP under the 
control of the daughterless {da) promoter using the Gal4-UAS system (see figure 14 D). 
Ubiquitous expression of dASPP in a dASPP mutant background results in similar wing 
size and body weight to control flies. dASPP expression also rescues the rough eye 
phenotype of dASPP8 mutants (Julien Colombani, personal communication). This 
confirms that the observed phenotypes are indeed due to loss o f dASPP.
dASPP mutants have excess thoracic macrochetes, although this phenotype has not been 
quantified it is observed in dASPPd and dASPP8 homozygous mutants. Wild-type and 
dASPPctrl have 4 large macrochete bristles towards the posterior end o f the thorax. 
dASPP mutants typically have one or two extra macrochetes. Caspases also have non- 
apoptotic functions, which include controlling the number o f macrochetes. In dark 
mutants ectopic macrochetes are observed (Kanuka et al., 2005). Therefore it is possible 
that dASPP leads to a minor increase in Caspase activity (possibly indirectly via DIAP1
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regulation), which is not significant enough to cause cell death but instead affects the 
number of macrochetes on the scutellum.
3.3 The relationship between dASPP and the Hippo pathway
3.3.1 Genetic interactions between dASPP and Hippo pathway components
As dASPP was identified in a screen for novel components of the Hippo signalling 
pathway, I used the mutant alleles generated to test for genetic interactions with the 
Hippo pathway. The phenotype of dASPP mutants indicate that dASPP, like members 
of the Hippo pathway, is a negative regulator of tissue size. However, the overgrowth 
phenotype of dASPP mutants is much less severe than the phenotype of hpo, sav or wts 
mutants. This suggests that if  dASPP is a novel component of the Hippo pathway it only 
plays a minor role in the control o f tissue growth by Hippo signalling.
The large wing phenotype of dASPP mutants was used to test for genetic interactions 
with components of the Hippo pathway. LOF of Hippo pathway components in the 
wing has been shown to cause overgrowth (Harvey and Tapon, 2007). Therefore if 
dASPP is involved in Hippo signalling then hpo or wts mutants should enhance the 
large wing phenotype o f dASPP mutants. In this experiment the FRT42D,ASPPd 
recombinant chromosome was used and adult FRT42D,ASPPd wings were 16.3% larger 
than white (w) wings, 18% larger than FRT42D wings and 11.7% larger than 
dASPPprecise wings (see figure 15 A). FRT42D,ASPPd is a recombinant chromosome and 
the control with the most similar genetic background is FRT42D as over half o f the 
FRT42D,ASPPd chromosome is derived from the FRT42D  chromosome. However, 
white (w) and dASPPprec,se were also included as additional controls. All three control 
genotypes had a comparable wing area although dASPPprec,se wings were slightly larger 
than FRT42D  or white wings. For the purpose of this experiment it does not matter 
which control is used so the white wing area was taken as the value to which the wing 
area of other genotypes was normalised (see figure 15 A).
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Figure 15: Genetic interactions between dASPP  and Hippo pathway members. (A)
The large wing phenotype of dASPPd mutants was used to screen for genetic interactions 
with the Hippo pathway. The genotypes tested are indicated in the legend. Crosses were 
carried out in a density controlled manner at 25°C and twenty male wings were measured 
for each genotype. (B-B’) An example of the increase in wing area observed when the 
gene dosage of wts is reduced in a dASPPd mutant background. (C-C” ) wts mutations also 
enhance the rough eye phenotype of dASPP mutants. SEMs of adult eyes (180x). (C) 
Generating dASPF** clones in the eye using eyFLP does not significantly alter adult eye 
morphology and only small patches o f mutant tissue are observed. (D) However, generat­
ing dASPPJ clones in the eye over a cell lethal (c.l) FRT chromosome disrupts eye mor­
phology and large clones are recovered. (C” ) This phenotype is clearly enhanced by 
removing one copy of wts.
FRT,dASPF* /  FRT,dASPP*; wts*1 /  +
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FRT42D,ASPPd wings are 16.3% larger than white wings; halving the gene dosage of 
wts in this background using an amorph allele (wts*l) increases the large wing 
phenotype to 22.7% larger than white wings. Surprisingly, when a weaker wts allele 
(wtsM541) is used the increase in wing area is even greater and wings are 26.1% larger 
than white wings (see figure 15 A, B and B’). This was unexpected as wts*1 has a 
considerably stronger overgrowth phenotype the wtsM541, so should theoretically be the 
stronger enhancer of the FRT42D,ASPPd wing phenotype. One possibility is that 
excessive proliferation in wings of this genotype is countered by increased apoptosis. 
This was not tested thoroughly, although in later experiments I show that introducing a 
copy of wts*1 into an FRT42D,ASPPd background does not result in considerable 
apoptosis in the 3rd instar wing disc (see figure 18 B-B’). Halving the gene dosage of 
hpo in an FRT42D,ASPPd background using a null allele (Jhpo42'47) does not affect the 
large wing phenotype (see figure 15 A).
Therefore, it appears that dASPP genetically interacts with wts but not hpo. However, it 
was important to also measure the wings size o f wts heterozygotes to address whether 
loss of one copy of wts alone is sufficient to cause overgrowth. I found that this was the 
case, wts*1 heterozygotes or wtsM54‘ heterozygotes have large wings that are 11.5% and 
11.6% larger than white wings respectively (see figure 15 A). This result suggests that 
the enhancement of the dASPP large wing phenotype when wts is compromised may be 
due to additive rather than synergistic effects. In the case of wtsM541, the additional 
increase in wing area seen when this mutation is introduced into a dASPP mutant 
background can be accounted for by the increase in wing area of wtsM541 heterozygotes. 
One possibility is that dASPP and wts regulate wing size by independent mechanisms 
and when both are compromised the resulting phenotype is the sum of each phenotype. 
Alternatively, this experiment may not reveal the full extent of the interaction. For 
example, if excessive proliferation leads to increased apoptosis in dASPP-wts 
compromised discs then the final wing size will be affected. Therefore it is difficult to 
conclude whether dASPP genetically interacts with wts from the results o f this 
experiment. The fact that dASPP showed no interaction with hpo in this experiment 
suggests that dASPP is not a general regulator of Hippo pathway signalling but may be 
regulating Wts functions that are independent of Hpo.
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Although the interaction between dASPP and wts in the wing appears to be due to 
additive effects, a more convincing genetic interaction is observed in the eye (see figure 
15 C-C” ). Generating dASPPd clones specifically in the eye using eyFLP does not 
significantly alter adult eye morphology and only small patches o f clonal tissue are 
observed (see figure 15 C). However, generating dASPP** clones over a cell lethal FRT 
chromosome to give the clones a growth advantage disrupts eye morphology and large
Y  i
clones are recovered in adults (see figure 15 C’). If a copy of wts1 is introduced into 
this genetic background the eye phenotype is noticeably enhanced (see figure 15 C” ). 
The size of the eye is increased and the roughness is enhanced. This is a convincing 
genetic interaction, as heterozygosity for wts*1 does not produce any visible eye 
phenotype (data not shown). Therefore, in this case, it cannot be argued that the genetic 
interaction is due to additive effects and I conclude that dASPP and wts do genetically 
interact.
3.3.2 dASPP loss of function does not affect Hippo pathway targets
I continued to explore the relationship between dASPP and the Hippo pathway by 
examining the expression of Hippo pathway transcriptional targets in dASPP mutant 
clones. DIAP1 (.Drosophila Inhibitor o f  Apoptosis 1) and cyclinE are both 
transcriptional targets of Yki (Huang et al., 2005). In hpo, wts, sav, or MATS mutant 
clones, Yki is in the nucleus and drives transcription o f target genes including DIAP1 
and cyclinE. This can be visualised using transcriptional reporters. DIAP-LacZ is an 
enhancer trap resulting from insertion of a P-element containing the LacZ  gene into the 
first intron of the endogenous DIAP1 gene. CyclinE-LacZ is a synthetic construct 
comprised of 16.4kb of the cyclinE promoter placed upstream of the LacZ  gene (Jones 
et al., 2000). I confirmed that hpo LOF results in transcriptional upregulation o f DIAP1 
and cyclinE by examining expression of their reporters in hpo42'47 clones in the eye. 
DIAP-LacZ (see figure 16 A-A” ) and cyclinE-LacZ (see figure 16 C-C” ) are, as 
expected, upregulated in hpo42'47 clones as visualised by (3-Gal staining. These 
genotypes also provided a positive control for the experiment. Conversely, in dASPPd 
clones I did not observe any upregulation of either DIAP-LacZ (see figure 16 B-B” ) or 
cyclinE-LacZ (see figure 16 D-D” ). One obvious explanation is that dASPP simply is 
not a component of the Hippo pathway. An alternative explanation is that dASPP is a
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Figure 16: Hippo pathway readouts are not affected by loss of dASPP. DIAP1 is 
transcriptionally regulated by the Hippo pathway and DIAP-LacZ can be used as a read-out 
of pathway activity. (A-A”) Expression of the DIAP-LacZ reporter is increased in hpo42 47 
clones as indicated by Beta-Gal staining (red). (B-B”) Expression of the DIAP-LacZ reporter 
is unchanged in dASPI** clones. cyclinE is also a transcriptional target of the Hippo pathway. 
(C-C”) Expression of a cyclinE-LacZ reporter is increased in hpo42'47 clones as indicated by 
Beta-Gal staining (red). (D-D”) cyclinE-LacZ is not obviously elevated in dASPI** clones. 
The fact that Hippo pathway readouts are unaffected in dASPP clones suggests that dASPP is 
not a major contributor to the pathway. In A-D mutant clones are marked by absence of GFP. 
Arrows in A and C indicate examples of hpo42 47 clones with elevated DIAP-LacZ and 
CyclinE-LacZ respectively.
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component o f the Hippo pathway but its LOF phenotype is not strong enough to induce 
detectable changes in the expression o f targets. To address these possibilities a more 
sensitive readout of pathway activity would be required.
It was surprising to find that the dASPP mutants I generated did not show a convincing 
genetic interaction with the Hippo pathway, because the original P-element stock 
(GE13722), which is presumably a very weak dASPP allele, strongly suppresses the 
GMRsav.wts phenotype. This suggests that GE13722 represented a ‘false positive’ in 
my screen and that the suppression of GMRsav.wts observed is not due to loss o f 
dASPP function but instead due to secondary mutation(s) on the GE13722 
chromosome. This view is supported by the fact that the precise excision line 
(dASPPprease), which is essentially wild-type for dASPP, also strongly suppresses 
GMRsav.wts. Additionally, the dASPP null allele (dASPP8), which was generated from 
a different genetic background, does not appreciably suppress GMRsav.wts (data not 
shown).
In summary, it was not possible to firmly conclude whether dASPP plays a role in the 
Hippo pathway. The fact that heterozygosity for wts enhances the eye phenotype of 
dASPP mutants is the strongest argument that dASPP plays a role in the Hippo 
pathway. However, in the wing, interactions between dASPP and wts are merely 
additive rather than synergistic and dASPP shows no interaction with hpo. Additionally, 
known targets of the Hippo pathway are not affected by loss o f dASPP. Therefore, if 
dASPP does play a role in the Hippo pathway it is certainly a minor role.
3.4 dASPP genetically interacts with dCsk
3.4.1 The basis for testing interactions between dASPP and dCsk
The lack of convincing evidence suggesting that dASPP functions in the Hippo pathway 
led me to investigate whether the dASPP growth regulatory functions are mediated 
through another tumour suppressor pathway. For several reasons a strong candidate 
pathway was the dCsk/SFK pathway, which has also been shown to negatively regulate 
the size of tissues (Read et al., 2004). Firstly, dASPP phenotypes are highly similar to
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dCsk phenotypes. The strength o f the dASPP overgrowth phenotype is more similar to 
the dCsk phenotype than hpo or wts phenotypes; dCsk mutants die as giant pupae 
whereas hpo and wts mutants are lethal at an early larval stage. Also the retinal mis- 
patteming phenotype observed in dASPP mutants is highly reminiscent o f the mis- 
patterning phenotype reported for dCsk mutant retinas (Vidal et al., 2006). Secondly, 
although dCsk mutant tissues or animals have overgrowth phenotypes, discrete patches 
of dCsk mutant cells do not overgrow; instead cells delaminate from the epithelial layer 
and undergo apoptosis (Vidal et al., 2006). The result o f this is that dCsk mutant clones 
are eventually eliminated from tissue during the course of development. Similarly, 
dASPP mutant flies are overgrown, however, when dASPP clones are generated they do 
not have any apparent growth advantage over control clones (data not shown). This 
suggests that loss of dCsk or dASPP in discrete patches results in a similar phenomenon. 
However, dASPP clones are not completely eliminated during development in the same 
way as dCsk clones are. This may be due to the fact that dCsk has a stronger phenotype 
than dASPP. Thirdly, dCsk has been reported to phosphorylate Wts and dCsk 
genetically interacts with wts (Stewart et al., 2003). As I have shown, dASPP also 
genetically interacts with wts in certain contexts; it is possible that dASPP indirectly 
regulates Wts through dCsk. For these reasons I decided to address whether dASPP and 
dCsk genetically interact and uncovered a strong relationship between these genes, the 
rest of the characterization of dASPP focused on exploring this relationship.
3.4.2 dASPP-dCsk deficient wing discs show ectopic apoptosis
Reducing dCsk function in a dASPP mutant background by introducing a strong dCsk 
allele (dCskljd8) results in a striking notched wing phenotype (see figure 17 C” ). This
o
wing notching of dASPP mutants lacking one copy of dCsk is due to ectopic apoptosis. 
I observed large patches of cell death in the wing pouch of 3rd instar wing discs as 
visualised using an antibody directed against cleaved (activated) Caspase 3 (see figure 
17 C and C’). This wing notching phenotype is only observed when dASPP and dCsk 
mutations are combined. Very little apoptosis occurs in wing discs o f dCsk 
heterozygotes (see figure 17 A and A ’) or dASPP8 homozygotes (see figure 17 B and 
B’) and adult wings of these genotypes are never notched (see figure 17 A ”  and B” ). 
Furthermore, this phenotype is only observed when both copies of dASPP are lost;
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Figure 17: dASPP genetically interacts with dCsk. (A-E) Cleaved Caspase 3 (C3) (red) 
immunostainings of third instar wing discs of the indicated genotypes to label apoptotic 
cells. (A’-E’) Overlays of C3 immunostainings and phase contrast images. (A” -D” ) Adult 
wings of the corresponding genotypes. (C-C” ) Halving the dCsk gene dosage in a dASPP 
mutant background leads to ectopic apoptosis in the wing disc and notching of adult 
wings. (D-D” ) Introducing a btk mutation into this genetic background rescues the apop­
tosis and notching phenotypes. (E-E’) Large patches of apoptosis are also observed in 
dCsk homozygous mutant discs, no adult wing is shown as this allele is pupal lethal. Very 
little apoptosis is observed in control discs, dCsk heterozygotes (A-A” ) or dASPP homo­
zygotes (B-B” ) and adult wings are not notched.
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ectopic apoptosis and wing notching does not occur in flies heterozygous for both 
dASPP and dCsk (data not shown). This suggests that dASPP and dCsk strongly 
genetically interact and may function in the same or in parallel signalling pathways.
It is thought that the dCsk phenotype is primarily caused by increased activation of 
Drosophila SFKs (Read et al., 2004; Vidal et al., 2006). Accordingly, it can be largely 
rescued by reducing the function of Btk (Bruton’s tyrosine kinase), which has been 
shown to function downstream of SFKs in Drosophila and mammals (Guarnieri et al., 
1998; Roulier et al., 1998; Saouaf et al., 1994; Tateno et al., 2000). In particular, 
heterozygosity for btk can rescue the pupal stage lethality of the dCsk,jd8 homozygous 
mutants (Read et al., 2004). For this reason I decided to test whether heterozygosity for 
btk could rescue the apoptosis phenotype observed in dASPP-dCsk compromised wings. 
Interestingly, I found that removing a copy of btk largely suppresses the ectopic 
apoptosis and wing notching in dASPP-dCsk compromised wings (see figure 17 D-D” ). 
This suggests that the observed apoptosis and wing notching phenotypes are the 
consequence of increased signalling through SFKs and Btk.
Previously, loss of dCsk in discrete patches has been reported to result in apoptosis of 
cells at the mutant / wild-type boundary (Vidal et al., 2006). However, it has not been 
previously shown that broad loss of dCsk results in apoptosis as my results suggest. In 
fact, it has been proposed that loss o f dCsk signalling actually protects cells from 
developmental apoptosis, at least in the developing pupal retina. In agreement with the 
idea that broad loss of dCsk results in apoptosis in the wing disc I found that dCskIjd8 
homozygous wings show considerable apoptosis (see figure 17 E and E ’). As in dASPP- 
dCsk compromised wing discs the patch of apoptosis is largely confined to the wing 
pouch. This suggests that broad loss of dCsk does result in apoptosis in the wing and 
that the phenotype I observe in dASPP-dCsk compromised wing discs is indeed due to 
loss of dCsk function. There is no adult wing shown for dCskIjd8 homozygotes as this 
allele is lethal at the pupal stage. Taken together, these results suggest that dASPP and 
dCsk may function in the same signalling pathway. As dASPP phenotypes are weaker 
than dCsk phenotypes it is probable that dASPP is required for maximal dCsk 
signalling.
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To check that the genetic interaction observed between dASPP and dCsk is not due to 
unspecific effects, for example secondary background mutations present on either 
chromosome, I tested whether the interaction was still observed when other dASPP and 
dCsk alleles are combined. Firstly, I asked whether dASPPd also genetically interacts 
with dCskljd8. Introducing one copy of dCskIjd8 into a dASPPdmutant background results 
in apoptosis in the 3rd instar wing disc and notching of adult wings (see figure 18 A- 
A ” ). This interaction is highly similar to the interaction between dASPP8 and dCsk,jd8 
suggesting that the notching phenotype is caused by loss o f dASPP and not by 
background mutations on dASPP mutant chromosomes. Furthermore, the interaction is 
not due to background mutations on the dCskIjd8 chromosome as wing notching is 
observed when dASPPd is combined with other dCsk alleles. Introducing a copy of 
either dCsk8017909 (a P-element insertion in the dCsk locus) or dCskQI56stop (an EMS 
allele reported to be a dCsk null) into a dASPPd mutant background results in notching 
of adult wings (data not shown). These results suggest that dASPP specifically interacts 
with dCsk in the wing disc.
As dCsk has been reported to function upstream of Wts (Stewart et al., 2003) I tested 
whether the phenotype of dASPP-dCsk deficient wing discs was due to loss of
V' I
signalling through Wts. However, removing a copy of wts (using the amorphic wts' 
allele) in a dASPP1* mutant background does not lead to ectopic apoptosis or wing 
notching (see figure 18 B-B” ). This suggests that the apoptotic phenotype of dASPP- 
dCsk deficient wings is not due to loss of signalling through Wts and may in fact be due 
to mis-regulation of Drosophila SFKs. The btk rescue experiment supports this 
hypothesis.
3.4.3 Apoptosis of dASPP-dCsk deficient cells is mediated via the JNK pathway
The JNK pathway has been shown to mediate apoptosis of dCsk mutant cells. Firstly, 
the apoptosis of dCsk boundary cells (see below) requires components of the JNK 
pathway (Vidal et al., 2006). Secondly, the lethality of dCskJJd8 can be rescued by 
removing a copy of bsk, the Drosophila JNK ortholog (Stewart et al., 2003). Taken 
together these results suggest that dCsk functions upstream of SFKs and the JNK 
pathway in Drosophila to protect cells from apoptosis. Indeed, it has been shown that c-
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Figure 18: Multiple dASPP  alleles genetically interact with dCsk. (A-A”) Removing 
one copy of dCsk in a dASPPd mutant background leads to ectopic wing disc apoptosis, 
as visualised using a cleaved Caspase 3 antibody (C3) (red), and notching of adult wings. 
This is highly similar to the phenotype observed when dCsk is compromised in a dASPP8 
mutant background (see Figure 14). (B-B” ) This phenotype is not seen when a copy of 
wts is removed in a dASPP mutant background.
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SRC functions upstream of the JNK pathway in mammalian cells (Dolfi et al., 1998; 
Hauck et al., 2002; Hsia et al., 2003). Therefore, I tested whether the apoptosis observed 
in dASPP-dCsk deficient wings is JNK pathway dependent.
Puckered (Puc) is the phosphatase responsible for shutting down Basket / JNK. puc  is 
also transcriptionally activated by the pathway, providing a negative feedback loop 
(Martin-Bianco et al., 1998). JNK pathway activity can thus be monitored using puc- 
LacZ (pucZ) reporter, which is a transposon insertion placing the LacZ  gene under the 
control o f the endogenous puc  promoter (Martin-Bianco et al., 1998). Additionally, as 
pucZ  is a mutant allele for puc  and allowed me to test for genetic interactions with the 
JNK pathway.
In pucZ  heterozygotes (data not shown) or pucZ, dASPP8 double heterozygotes (see 
figure 19 A-A’” ) pucZ  reporter expression is visualised in a few cells at the dorsal tip 
of the wing disc (arrows in figure 19 A), and adult wings are normal. As expected based 
on published results, dCsk/jd8 shows a strong genetic interaction with pucZ. I found that 
dCskljd8, pucZ  double heterozygotes have a wing notching phenotype (see figure 19 
B” ’) and 3rd instar wing discs show ectopic apoptosis within the wing pouch (see figure 
19 B’). This is presumably a result o f excessive JNK pathway activation since strong p- 
Galactosidase expression is detected in the wing pouch (see figure 19 B).
The ectopic apoptosis of dCskljd8, pucZ  double heterozygotes is enhanced when animals 
are also heterozygous for dASPP8 (see figure 19 C-C’” ), leading to a severely reduced 
adult wing size (see figure 19 C” ’). Extensive expression of the pucZ  reporter is 
observed (see figure 19 C’). Adult flies of this genotype also have leg deformities (data 
not shown), which is a phenotype ascribed to JNK pathway activation (Kirchner et al., 
2007). Additionally, removing both copies of dASPP in a dCsk1Jd8, pucZ  double 
heterozygous background results in lethality before the 3rd instar larval stage (data not 
shown).
Furthermore, I showed that dASPP genetically interacts with puc even when dCsk is not 
compromised. Introducing a copy of pucZ  into a dASPP8 homozygous mutant 
background results in moderate patches of apoptosis in 3rd instar wing discs (see figure 
19 D-D” ’), which are labelled by pucZ  reporter expression (arrow in figure 19 D). Such
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Figure 19: Apoptosis of dASPP/dCsk deficient cells is mediated by the JN K  pathway.
(A-D) Beta-Galactosidase staining (green) to visualise pucZ  reporter expression in wing 
discs of the indicated genotypes. (A’-D’) Cleaved Caspase 3 staining (C3) (red) to label 
apoptotic cells. (A”-D”) Overlay of B-Galactosidase staining, Caspase 3 staining and a 
phase contrast image of the disc. (A’” -B”’) Adult wings of the corresponding genotypes.
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patches of apoptosis are not observed in dASPP8 homozygous discs (compare figure 19 
D to figure 17 B) or in pucZ  heterozygotes (data not shown). This moderate level of cell 
death is not sufficient to induce notching of adult wings (see figure 19 D ’” ). Taken 
together, this data suggests that dCsk and, to a lesser extent, dASPP prevent 
inappropriate JNK pathway activation and thus protect wing pouch epithelial cells from 
apoptosis. The fact that dASPP and puc genetically interact, although not as strongly as 
dCsk and puc , strengthens the argument that dASPP may be required for maximal dCsk 
signalling.
3.4.4 dASPP loss of function enhances the phenotypes of dCsk boundary cells
dCsk mutant cells bordering wild-type cells have previously been shown to delaminate 
from wing disc epithelia, migrate away from their original position and undergo 
apoptosis (Vidal et al., 2006). Therefore, I examined whether loss of dASPP enhances 
these specific phenotypes of dCsk mutant boundary cells.
The patched (ptc) gene encodes the Hedgehog receptor and is expressed in a stripe 
along the anteroposterior boundary of wing imaginal discs. This can be visualised using 
a ptc-Gal4 driver combined with a UAS-GFP transgene (see figure 20 A-A” ). As in 
wild-type wing discs (data not shown), little apoptosis is detected in discs o f this 
genotype using an antibody directed against cleaved Caspase 3 (see figure 20 A ’). 
Driving expression of a dCsk RNAi transgene along with GFP leads to delamination, 
movement and apoptosis of a few cells along the mutant/wild-type boundary (see figure 
20 B-B” ). Cell movement and apoptosis predominately occur at the posterior-most 
boundary of the ptc expression pattern (indicated by the arrow in figure 20 B). 
Removing dASPP leads to a dramatic enhancement of the dCsk RNAi phenotype. The 
number o f boundary cells undergoing apoptosis and moving away from the ptc  domain 
is greatly increased (see figure 20 C-C” ). This result confirms that dASPP and dCsk 
genetically interact and suggests that dASPP and dCsk collaborate to maintain epithelial 
integrity.
As an additional control I examined the effect of removal o f dASPP in 
ptcGal4> UASGFP wing discs. This was done to be sure that dASPP is interacting
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Figure 20: dASPP  mutants enhance the phenoty pe of dCsk deficient boundary cells.
All images focus on a region within the wing pouch of the 3rd instar wing disc. (A-A” ) 
Patched (Ptc) is expressed along the anterior-posterior boundary of the wing disc as visu­
alised by ptc-Gal4 driving GFP expression. Cleaved Caspase 3 antibody (C3) (red) is 
used as a marker of cell death, little apoptosis occurs in control discs (A’). (B-B” ) Reduc­
ing dCsk function in the ptc domain by RNAi leads to apoptosis and migration (arrow in 
B) of some cells at the mutant-wildtype boundary. (C-C” ) These phenotypes are strongly 
enhanced by loss of dASPP, many more boundary cells undergo apoptosis and spread 
away from the ptc domain. (D-D”) Re-expressing dASPP in this genetic background 
largely rescues the apoptosis along the boundary. (E-E” ) shows an image of the same disc 
shown in D-D” in an apical plane to visualise dASPP overexpression using a dASPP 
antibody (blue).
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specifically with dCsk. Wing discs of this genotype however show similar levels of 
apoptosis to ptcGal4> UASGFP wing discs (data not shown), suggesting that dASPP is 
specifically interacting with dCsk.
The enhanced phenotype when dASPP is removed (see figure 20 C-C” ) is almost fully 
rescued if dASPP expression is restored by driving a UAS-dASPP construct in the ptc  
domain (see figure 20 D-D” ). This suggests that the enhancement o f the dCsk RNAi 
phenotype is indeed due to loss o f dASPP. Due to the nature of the cross scheme used to 
generate the dASPP rescue genotype only 50% of the progeny are expected to have the 
UAS-dASPP transgene. Therefore I also stained the discs with a dASPP antibody 
(dASPP39, see materials and methods) to distinguish those that over-express dASPP 
(see figure 20 E-E” -  an apical section through the same disc shown in figure 20 D- 
D” ). The enhanced phenotype was clearly rescued in all discs expressing dASPP within 
the ptc  domain. Furthermore, I found that dASPP over-expression rescues the pupal 
stage lethality caused by dCsk RNAi expression in the ptc  domain. Therefore, the 
specific phenotypes of dCsk RNAi boundary cells are sensitive to dASPP levels.
dCsk RNAi cells move to a basal position within epithelia and spread amongst wild- 
type cells. This can be visualised by taking transversal (XZ) sections through the wing 
disc (see figure 21 A). Note that apoptotic cells are observed basally and some cells are 
migrating away from the ptc  domain. Loss of dASPP enhances both the number of 
dying cells and the distance those cells move away from the ptc  domain (see figure 21
B). Interestingly, not all of the migrating cells of this genotype are Caspase 3 labelled 
(see figure 21 B) suggesting that Caspase activation may not be absolutely required for 
the migratory phenotype. In an attempt to address this question I co-expressed DIAP1 in 
the ptc domain and asked whether this rescues the defects observed. Expression of 
DIAP1, as expected, largely blocks the apoptosis induced by dCsk RNAi in a dASPP 
mutant background (compare figure 22 A-A” to figure 22 B-B’, the bracket indicates 
the equivalent region of the disc). Expression of DIAP1 also seems to largely inhibit the 
migratory phenotype; the number of individual cells moving away from the ptc  domain 
is reduced (compare figure 22 A to figure 22 B). However, the morphology of the 
boundary is abnormal and appears ‘ruffled’ compared to wild-type boundaries (compare 
figure 22 A to figure 20 A). This suggests that these cells may still possess migratory
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Figure 21: dASPP/dCsk deficient boundary cells delaminate and m igrate through 
the basal layer. (A and B) Transversal (XZ) sections through wing discs to show that 
dCsk deficient cells delaminate, undergo apoptosis and spread through the basal layer. 
Anti Discs-Large (Dig) staining (blue) is used to distinguish apical from basal. B shows 
the enhancement of the phenotype by dASPP loss of function.
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HFigure 22: The apoptosis and cell spreading phenotypes of dASPP/dCsk deficient 
boundary cells are largely rescued by DIAP1 expression. (A-A”) The enhanced dCsk 
boundary phenotype when flies are also mutant for dASPP. Cells at the boundary move 
away from the ptc domain whilst simultaneously undergoing apoptosis, as visualised by 
anti cleaved Caspase 3 staining (C3) (red). (B-B” ) If DIAP1 is co-expressed apoptosis 
and cell spreading are largely blocked, compare the region indicated by the bracket in A 
and B. However, the interface between the GFP expressing and non-GFP expressing cells 
is ruffled compared to control discs.
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properties but as apoptosis is blocked individual cells are prevented from dissociating 
from their neighbours and moving away from the ptc  domain.
3.5 dASPP physically interacts with dCsk
As dASPP genetically interacts with dCsk it is possible that the two proteins bind to 
each other. This was tested by Julien Colombani using co-immunoprecipitation and 
GST-pulldown experiments. HA-tagged dASPP (dASPP-PA) and Myc-tagged dCsk 
(dCsk-PB) were transfected into cultured Drosophila Kcl67 cells (a haemocyte derived 
cell line). dCsk-Myc was detected in HA but not control (GFP) immunoprecipitates 
suggesting that dASPP and dCsk physically interact (see figure 23 A).
To carry out the GST (Glutathione-S-Transferase) pulldown, K cl67 cells were 
transfected with HA-tagged dASPP and cell lysates were used for pull-down 
experiments using bacterially produced GST or GST-dCsk. dASPP-HA is pulled down 
by GST-dCsk but not GST (see figure 23 B), which is in agreement with the co- 
immunoprecipitation result suggesting that dASPP and dCsk physically interact. 
Subsequent GST pulldown experiments using truncated forms of dASPP (GST-dASPP 
N-term (amino acids 1-484 of dASPP-PA) or GST dASPP C-term) and bacterially 
expressed dCsk suggest than dASPP and dCsk directly bind to each other and that the 
dASPP N-terminal region mediates binding to dCsk (data not shown). These 
biochemical results strongly suggest the dASPP binds to dCsk and support our view 
based on the genetic data that dASPP and dCsk function in the same signalling 
pathway.
3.6 dASPP promotes dCsk kinase activity on its target dSrc42A
As dASPP and dCsk physically interact and dCsk is a tyrosine kinase, it was possible 
that dASPP functions as a regulator of dCsk kinase activity. This hypothesis was tested 
by Julien Colombani using in vitro kinase assays to determine dCsk activity either in the 
presence or absence o f transfected dASPP. First, a kinase-dead form of dSrc42A 
(dSrcK276R) was produced as a GST fusion protein in E.coli. This form of dSrc42A 
contains a mutation within the ATP-binding site and thus prevents autophosphorylation.
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Figure 23: dASPP physically interacts with and enhances the kinase activity of 
dCsk. (A) Co-immunoprecipitations between dASPP and dCsk. Drosophila Kcl67 cells 
were transfected with pAc5.1-dCsk-Myc and pAc5.1-dASPP-HA. HA and control (GFP) 
immunoprecipitates and input (1/10) were probed with anti-Myc (top) and anti-HA 
(bottom) antibodies. dCsk-Myc is detected in HA but not control immunoprecipitates. (B) 
Drosophila Kcl67 cells were transfected with pAc5.1-dASPP-HA. Cell lysates were used 
for pull-down experiments using GST and GST-dCsk. Precipitated fractions and input 
(1/10) were probed with anti-HA. dASPP is pulled down by GST-dCsk but not GST 
suggesting that dASPP and dCsk physically interact. The coomassie blue-stained gel 
shows the immunoprecipitated fusion proteins. (C) Immunoprecipitations followed by 
kinase assays were used to monitor the kinase activity o f a tagged form of dCsk (dCsk- 
Myc) on a bacterial dSrc substrate (GST-dSrc42AK276R). dCsk-alone and a negative 
control (mock immunoprecipitation with GFP antibody, marked by the asterisk) are 
shown (lanes 1-2 respectively). Input (1/5) and immunoprecipitated protein levels are 
shown by Western blots. GSTdSrc*276* levels are shown after coomassie blue staining. 
dCsk phosphorylation activity was quantified on a phosphorimager. Signals were normal­
ized according to immunoprecipitated kinase levels (see experimental procedures) and 
fold changes are indicated at the top of each lane. As expected, dASPP was detected in 
dCsk immunoprecipitates. Cotransfection of Kcl67 cells with dCsk-Myc and increasing 
quantity of dASPP-HA results in an enhancement of dCsk activity (lanes 3-5, 125, 250 
and 375pg transfected DNA respectively). The data and figure were generated by Julien 
Colombani.
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This makes dSrc a suitable substrate for dCsk in kinase assays as the 
phosphorylation status of this substrate is influenced only by dCsk kinase activity and 
not by autophosphorylation. Myc-tagged dCsk was immunoprecipitated from 
Drosophila Kcl67 cells and an in vitro kinase assay was performed using GST- 
dSrcK267R as a substrate.
The kinase activity of dCsk immunoprecipitated from Kcl67 cells is potentiated by co­
transfection of dASPP in a dose dependent manner (see figure 23 C, compare lane 1 to
t  9
lanes 3, 4 and 5). The values given above each -P band represent the fold increase in 
dCsk activity in the presence of dASPP (see figure 23 C). The values were obtained by 
quantifying the phosphorylation signal and normalising according to the efficiency of 
dCsk immunoprecipitation (see materials and methods for further details). Therefore, in 
the presence of dASPP the kinase activity of dCsk may be increased by up to 1.7 fold. 
Although this is a modest increase, the result is highly reproducible as it was observed 
in five independent experiments (data not shown). Furthermore, dCsk phosphorylates a 
single dSrc42A tyrosine residue, which may limit the dynamic range of the assay. In 
further experiments in Drosophila D16 cells it was shown that dASPP RNAi reduces 
the kinase activity of dCsk by 2-fold (data not shown) (Langton et al., 2007).
Taken together these results suggest that dASPP binds to and enhances the kinase 
activity o f dCsk. The positive regulation of dCsk by dASPP in the in vitro kinase assays 
is supported by the genetic data, which shows that dASPP and dCsk have similar LOF 
phenotypes. Furthermore, the result showing that dASPP RNAi reduces dCsk kinase 
activity by 2-fold suggests that dASPP is not absolutely required for dCsk kinase 
activity. This is probably the reason why dASPP mutants have a considerably weaker 
phenotype than dCsk mutants. Overall, our data suggest that dASPP is an important 
regulator of dCsk activity.
Although the biochemical data suggest that dASPP enhances the kinase activity of 
dCsk, the mechanism by which this is achieved is not known. One tempting possibility 
is that dASPP regulates dCsk by controlling its sub-cellular localization. Unfortunately, 
without a dCsk antibody that recognises dCsk in fixed tissues, this theory is difficult to 
test. However, I checked whether dCsk regulates dASPP localisation/levels by staining 
eye-antennal imaginal discs bearing dCsk mutant clones with the dASPP38 antibody.
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dASPP expression appears normal in dCskIjd8 clones (see figure 24 A-A” ) indicating 
that dCsk does not control the levels or localization of dASPP.
3.7 dASPP is epistatic to dSrc64B
The in vitro kinase assays suggest that dASPP functions as a positive dCsk regulator, 
implying that dASPP functions upstream of the dCsk targets dSrc42A and dSrc64B. 
Therefore, mutations in dSrc42A and dSrc64B should rescue dASPP phenotypes. This 
was tested in the eye where loss of dASPP results in a large, rough eye phenotype (see 
figure 25 B-B’) compared to control eyes (see figure 25 A-A’). I have already shown 
that removing one copy of the Drosophila SFK target, btk, suppresses the apoptotic 
phenotype observed in dASPP/dCsk deficient wing discs. Therefore I asked whether 
compromising btk also rescued the eye phenotype of dASPP mutants. Introducing a btk 
mutation into the dASPP mutant background partially suppressed the eye phenotype 
(see figure 25 C-C’), further suggesting that Btk functions downstream of dASPP.
Complete loss of dSrc64B is not lethal; dSrc64BKO (O'Reilly et al., 2006) is a viable, 
null allele and homozygous flies have normal sized eyes (see figure 25 D-D’), although 
the shape of the eye seems slightly affected (compare figure 25 D-D’ to figure 25 A- 
A ’). Having a null allele for both dSrc64B and dASPP allowed me to perform epistasis 
experiments. Complete removal of dSrc64B strongly suppresses the dASPP eye 
phenotype and rescues the size and bristle patterning defects (see figure 25 E-E’). The 
dSrc64B-dASPP double mutant eye is phenotypically very similar to the dSrc64B 
mutant eye suggesting that dSrc64B is epistatic to dASPP. This is clear evidence that 
dASPP functions upstream of or in parallel to dSrc64B during eye development and that 
the observed phenotypes are due to increased Drosophila SFK signalling.
It has been shown that dCsk functions upstream of both dSrc42A and dSrc64B (Pedraza 
et al., 2004), therefore it is maybe surprising that removal of dSrc64B suppresses the 
dASPP eye phenotype so strongly. One likely explanation is that inhibition of dSrc64B 
by dCsk is important for normal eye development whereas inhibition o f dSrc42A is less 
important in this context. The extent to which dSrc42A mutations suppress the dASPP 
eye phenotype was not tested.
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Figure 24: dCsk does not regulate dASPP expression or localization. (A-A” ) A 3rd 
instar eye-antennal imaginal disc with dCskljd8 clones, marked by absence of GFP (A). 
dASPP protein staining (red) is normal within the clones (A’). The orientation of the disc 
is indicated in A” (A is anterior, P is posterior).
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Figure 25: The dASPP  eye phenotypes are rescued by btk or dSrc64B  mutations.
Scanning electron micrographs (SEMs) of adult eyes of the indicated genotypes. dASPP8 
eyes (B) are large and rough compared to control eyes (A). (A’ and B’) High magnifica­
tion SEMs, bristle clustering is evident in dASPP8 eyes (arrows in B’). (C and C ’) The 
dASPP8 eye phenotype is partially rescued by halving the btk gene dosage. (E and E’) The 
dASPP8 eye phenotype is almost fully suppressed by removal of dSrc64B. The dASPP- 
dSrc64B double mutant eye (E and E’) is highly similar to the dSrc64B mutant eye (D and 
D’) suggesting that dSrc64B is epistatic to dASPP.
btk* '-,
dASPP8
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CHAPTER 4 Characterization of Boa
4.1 Introduction to Boa (Binder of dASPP)
CG5053 is the gene that links CG18375/dASPP to wts in the Curagen yeast 2-hybrid 
data set (see figure 9A). A P-element insertion (GE27409) within the CG5053 locus 
dominantly suppresses the GMRsav,wts eye phenotype (data not shown), suggesting 
that CG5053 may function as a negative regulator of tissue size. By this stage o f the 
project, dASPP mutants had been generated and I had shown that dASPP is a negative 
regulator of tissue size. Therefore I was interested in characterizing CG5053 to 
determine whether it also functions in organ size control and if so whether it plays a role 
in the Hippo pathway and/or in a dASPP pathway.
CG5053 is a conserved gene and encodes a protein of 607 amino acids with an RA (Ras 
Association) domain at the N-terminus. The CG5053 product shows significant 
homology to RASSF8/HOJ-1 within the RA domain (70% amino acid identity) (see 
figure 26). RASSF8/HOJ-1 has been identified as a candidate lung tumour suppressor 
gene and its expression in A459 cells led to inhibition of anchorage-independent growth 
(Falvella et al., 2006), though its function remains unclear. Homologous proteins are 
also found in A.gambiae and C.elegans (see figure 26).
4.2 Boa binds to dASPP
The initial characterization of CG5053 was aimed at confirming the Curagen yeast 2- 
hybrid data, which suggests that the CG5053 product binds to both wts and dASPP. 
Julien Colombani carried out this work. Despite numerous attempts it was not possible 
to confirm the interaction between the CG5053 product and wts by co- 
immunoprecipitation suggesting that these two proteins do not bind to each other. 
Additionally, the ‘score’ given for this interaction, which represents the probability that 
the interaction is genuine, is only just above the cut-off value of 0.3. Therefore the 
predicted CG5053-Wts interaction may represent a false positive within the yeast 2- 
hybrid data. However, the interaction between the CG5053 product and dASPP was
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Figure 26: Domain structure of Boa and alignment with homologs from other 
species. Alignment of Boa with A.gambiae (XP 321770), C.elegans (NPOO 1033555) 
and human (RASSF8/HOJ-1) homologs. Boa/CG5053 has a conserved N-terminal RA 
(Ras Association) domain. Percentage amino acid identity within the RA domain is indi­
cated.
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confirmed by co-immunoprecipitation in Drosophila K cl67 cells (see below). 
Therefore the CG5053 product was renamed Boa (for binder of dASPP) and the 
CG5053 gene will be referred to as boa in the following text. Myc-tagged dASPP and 
HA-tagged Boa were transfected into cultured Drosophila K cl67 cells. dASPP-Myc 
was detected in HA immunoprecipitates but not in control (GFP) immunoprecipitates 
(see figure 27). Furthermore, Boa-HA was detected in Myc but not control (GFP) 
immunoprecipitates (see figure 27 right hand panel). The ‘score’ for the Boa-dASPP 
interaction is relatively high (0.78) and this interaction is classed as a ‘high confidence 
interaction’. The co-immunoprecipitation results strongly suggest that Boa and dASPP 
physically interact and confirm the Curagen 2-hybrid interaction. Taken together this 
data suggests that Boa physically interacts with dASPP but not Wts. The physical 
interaction between Boa and dASPP indicates that they may function in a common 
signalling pathway.
4.3 Mutagenesis of boa by imprecise P-element excision
boa is an uncharacterised Drosophila gene and thus mutants are not available from the 
public stock centres. Therefore, I generated boa mutants to determine whether this gene 
is involved in organ size control and whether its product functions in a common 
pathway to its binding partner dASPP. In addition to the P-element insertion (GE27409) 
identified as a suppressor of GMRsav.wts, I was able to obtain an additional P-element 
line (G15974) with an insertion 2bp upstream of the boa transcription start site (see 
figure 28 A).
G15974 is homozygous viable and fertile and adults show no obvious phenotype. This 
transposon was imprecisely excised to generate boa mutants. First, the P-element 
insertion site was confirmed by sequencing a PCR product amplified using a P-element 
specific primer and a genomic primer close to the reported insertion site (data not 
shown). A similar strategy to the one used for dASPP mutagenesis was employed, 
which involved initially screening by PCR, followed by screening for phenotype (see 
chapter 3.2.2). The cross scheme to excise G15974 was carried out (see materials and 
methods for cross scheme) and individual putative mutant males were crossed to third 
chromosome balancer virgins (TM3/TM6B). After a few days the males were lifted from
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Figure 27: dASPP and Boa physically interact. Co-immunoprecipitation between 
dASPP and Boa. Drosophila K cl67 cells were transfected with pAc5.1-dASPP-Myc and 
pAc5.1-Boa-HA. HA, Myc and control (GFP) immunoprecipitates and inputs (1/10) were 
probed with anti-HA (top) and anti-Myc (bottom). dASPP-Myc is detected in HA but not 
control immunoprecipitates (left hand panels). Boa-HA is detected in Myc but not control 
immunoprecipitates (right hand panels). The data and figure were generated by Julien 
Colombani.
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the cross and screened by PCR for genomic deletions in the boa locus using the primers 
Boa-5’a and Boa-3’a, which flank the insertion site (see primers table).
4.4 Description of the boa alleles generated
100 putative mutant chromosomes were screened by PCR, leading to the identification
of boa2, which is an 823bp deletion that removes the boa 5’UTR, the start codon and
the first coding exon (see figure 28 A). This deletion results in a downward shift when
• • 2  •amplifying a PCR product using primers spanning the excision site, boa is a 
homozygous viable mutation and adults present a visible rough eye phenotype (data not 
shown).
As boa2 is a small deletion and only removes the first exon of the gene it may not a null 
allele. Although only one transcript is predicted (RA) for boa it is possible that a second 
translation initiation codon exists that is not deleted by boa . Indeed, there are two 
methionine residues (amino acids 60 and 107) in the second boa exon that may be 
utilised as alternative translation start sites. This seems likely as boa transcript was 
detected following RT-PCR on boa2 templates (see figure 28 C). For this reason I 
screened more putative boa mutant chromosomes with the aim of obtaining an allele 
likely to be null. As boa2 has a rough eye phenotype, this could be used to screen for 
further alleles by crossing putative mutants to boa2 and screening for the rough eye 
phenotype.
Roughly 300 putative mutant males were crossed to boa2 and the most useful alleles 
identified were boa4 and boa6, boa4 is a re-insertion of G15974 into the boa 5’UTR (see 
figure 28 A). This allele is also homozygous viable and results in a slightly stronger eye 
phenotype than boa2. During this reinsertion event, deletion of P-element sequence 
must have occurred; boa4 mutants have white eyes and thus the mini-white gene within 
the P-element sequence has been disrupted or deleted. The exact nature of this allele has 
not been determined and it is not known how much of the P-element sequence was 
deleted. For this reason boa4 was not used for the characterisation of the boa phenotype.
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Figure 28: boa mutagenesis by imprecise P-element excision. (A) An illustration 
showing the boa locus and the alleles generated. G15974 is inserted 2bp upstream of the 
boa transcription start site. This P-element was excised to generate boa2, boa4 and boa6. 
boa2 and boa6 are deletions, boa2 removes the first exon and boa6 removes the first exon 
and part of the second, boa4 is a reinsertion of part o f the P-element sequence into the boa 
5’UTR. (B-B’) An eye-antennal disc with boa6 clones, marked by absence of GFP. A 
reduction in Boa antibody staining (red) is observed within boa6 clones. (C) RT-PCR 
analysis of boa, tankyrase, dASPP (RA and RB) and actin (act) transcript levels in boa 
mutants and controls (precise excision). The amount of boa transcript is reduced in all 
boa alleles and is not detected in boa6 samples (last lane). dASPP and tankyrase transcript 
levels are unaffected, actin transcript levels provide a positive control for the samples.
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boa6 is a deletion of 1.4kb, which removes genomic sequence on both sides of the P- 
element (see figure 28 A), boa6 deletes the first boa exon and part o f the second exon. 
boa6 is a homozygous viable allele and the eye phenotype (see below) is stronger than 
observed for either boa2 or boa4 (data not shown), boa6 homozygotes also have a wing 
phenotype and wings are large and broad compared to control wings (see below). As 
boa6 deletes more of the boa sequence than boa2, and has a stronger phenotype, it was 
used for further characterisation o f the gene. A precise excision line (to use as a control) 
was identified by sequencing PCR products spanning the insertion site, which were 
amplified from homozygous flies obtained from 10 different putative mutant lines. As 
expected, the precise excision line, boactrl, is homozygous viable with no phenotype.
The mutant phenotype (see below for details) suggests that Boa, like its binding partner 
dASPP, is a negative regulator of tissue size. The similarity of phenotype (mild 
overgrowth and rough eye) resulting from loss of boa or dASPP suggests that they may 
function in the same signalling pathway.
4.5 Confirmation of the boa alleles
boa6 was recombined onto an FRT82B chromosome for clonal analysis. When boa6 
mutant clones are generated in the eye-antennal imaginal disc a reduction in Boa protein 
is detected within the clones (see figure 28 B-B’) using an antibody directed against 
Boa (Boa803, see materials and methods). The Boa803 antibody was generated by 
Eurogentec and raised in Guinea pigs against a peptide corresponding to amino acids 
218-232 of Boa. The Boa antibody is probably not as specific as the dASPP antibody as 
considerable staining is still detected in boa6 clones. The alternative explanation is that 
boa6 is not a protein null, however this is probably not the case as no boa transcript is 
detected in boa6 mutant samples (see figure 28 C and below). Recently, we have 
generated a highly specific Boa antibody, and Boa protein is completely absent in boa6 
mutant tissues following Western blotting (Julien Colombani, personal communication), 
confirming that boa6 is likely to be a null allele.
RT-PCR analysis using cDNA prepared from whole fly extract templates revealed that 
boa transcript levels are reduced in all excision alleles generated. Interestingly, the
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reduction in transcript observed for each allele corresponds to the strength of the 
phenotype of that allele. For example, boa has the weakest phenotype and also the 
weakest reduction in transcript levels, whereas boa6 has the strongest phenotype and the 
strongest reduction in transcript levels (see figure 28 C). Although this method of RT- 
PCR analysis is only semi-quantitative (see materials and methods for description) this 
result was observed in several independent experiments. In fact, boa transcript is 
completely absent from boa6 samples suggesting that boa6 is a null allele.
boa6 deletes roughly lOObp of the 5’UTR of the neighbouring gene, tankyrase (see 
figure 28 A). This raises the possibility that boa6 is a double mutant for boa and 
tankyrase. To address this concern I examined the levels of tankyrase transcript in the 
boa mutants by RT-PCR (see figure 28 C). However, the level of tankyrase transcript is 
unaffected by the boa6 deletion suggesting that boa6 does not strongly affect tankyrase 
expression. Furthermore, a lethal P-element insertion within the tankyrase locus is 
viable when crossed to boa6 and progeny have no discernable phenotype (data not 
shown). Taken together, this data suggests that boa6 is not a strong tankyrase allele 
however, it cannot be ruled out that tankyrase expression may be mildly affected in 
boa6 mutants. What is clear is that the observed boa phenotypes are due to deletion of 
boa and not tankyrase because they are fully rescued by ubiquitous boa expression 
using the Gal4-UAS system (Julien Colombani, personal communication). dASPP 
transcript (RA and RB) levels were also examined in samples from boa mutants (see 
figure 28 C) but no difference was observed between control and mutants. This 
indicates that Boa does not regulate dASPP at the transcriptional level.
4.6 Boa loss of function results in a rough eye phenotype
boa6 homozygous mutant have large, rough eyes compared to controls (see figure 29 A 
and B). The observed eye phenotype is similar but not identical to the eye phenotype of 
dASPP mutants (compare figure 29 B to figure 13 B and C). boa mutant eyes are not as 
enlarged as dASPP mutant eyes but are rougher in appearance. High magnification 
SEMs o f boa6 eyes reveal a strong patterning defect and the ommatidial lattice is 
disrupted (see figure 29 A ’ and B’). As observed in dASPP mutant eyes, boa mutant 
eyes have a bristle clustering phenotype (arrow in figure 29 B’).
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Figure 29: boa mutants have enlarged, rough eyes and m ispatterned retinas. (A and
B) Scanning electron micrographs (SEMs) of bocf,rl (precise excision) (A) and boa6 (B) 
adult eyes, boa mutant eyes are large and rough compared to controls. (A’ and B’) High 
magnification SEMs of adult eyes, in boa6 mutant eyes the hexagonal lattice o f omma- 
tidia is disrupted and bristle clustering is observed. (A” and B” ) boactrl and boa6 pupal 
retinas at 40h after puparium formation (APF) stained with anti-Dlg to mark cell outlines. 
In control retinas (A” ) the interommatidial cells form a regular hexagonal lattice and 
bristle cells always contact three secondary interommatidial cells (inset). In boa6 retinas 
(B” ) the lattice is disrupted. The inset shows a bristle cell contacted by four interomma­
tidial cells and the arrow indicates bristle clustering. (C and D) Further examples of the 
phenotypes seen in boa6 mutant retinas. (C) shows a retina where each ommatidia has 4 
vertices instead of 6 and (D) shows a retina where a double layer of interommatidial cells 
is observed (arrows).
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The phenotype of boa6 eyes was also examined at the pupal stage using an anti-Discs 
large antibody to mark cell membranes. boactrl retinas at 40-44h APF show the regular 
crystalline arrangement of hexagonal units (see figure 29 A ” ). The bristle cells are 
evenly spaced and each one always contacts three secondary pigment cells (inset in 
figure 29 A” ), boa6 retinas at 40-44h APF are mis-patterned (see figure 29 B” , C and 
D). Ommatidia may have four or five vertices instead of six leading to a disruption of 
the hexagonal lattice. Bristle clustering is commonly observed (arrow in figure 29 B” ) 
and bristle cells may contact four or more inter-ommatidial cells (inset in figure 29 B” ).
A striking phenotype is commonly observed in boa6 mutant retinas where the 
organization of the lattice is severely altered and the ommatidia arrange into square 
rather than hexagonal lattice (see figure 29 C). It is not currently known why loss o f boa 
can result in the formation o f a square lattice although it is probably not due to dASPP 
mis-regulation as this phenotype is not observed in dASPP mutant retinas. Another 
striking phenotype of boa6 retinas is an increase in the number of inter-ommatidial cells, 
which can lead to the formation of a double layer of inter-ommatidial cells separating 
each ommatidium (see figure 29 D, arrows indicate double layer). An increase in the 
number of inter-ommatidial cells suggests either a delay in cell cycle exit after the MF 
and/or a defect in developmental apoptosis, which removes excess inter-ommatidial 
cells from the retina between 24h and 40h APF. These possibilities have not yet been 
tested. Although a few excess inter-ommatidial cells are detected in dASPP mutant 
retinas a double layer was never observed. This suggests that Boa could function to 
control the number of inter-ommatidial cells independently of dASPP.
4.7 Boa functions as a tumour suppressor
boa6 homozygous mutants, and to a lesser extent boa4 homozygous mutants, show a 
characteristic broad wing phenotype, boa6 mutant wings are shorter along the 
proximodistal axis and broader along the anteroposterior axis compared to boactrl wings 
(see figure 30 A-C). Julien Colombani quantified the adult wing size and body weight 
of boa6 mutants and controls (see figure 30 D). In density-controlled crosses the average 
wing area of boa6 homozygotes (n=20) is 9.8% larger than boactrl wings (n=15). 
Importantly, the wing hair density of boa6 mutants (n=12) is comparable to control
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Figure 30: Boa is a negative regulator of tissue size. Density controlled crosses were 
performed at 25°C to obtain the genotypes indicated and adult wing area was determined. 
(A-C) boa6 mutant wings (B) are larger than bocf,rl wings (A). (D) Quantification of body 
weight, wing area and wing hair density of boa0 and boa6 flies, boa6 flies are heavier 
than controls and have larger wings (** indicates the p<0.01, using a student’s t-test), the 
hair density is similar to controls suggesting that boa6 wings contain more cells rather 
than larger cells. The data and figure were done by Julien Colombani.
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wings (n=12) indicating that boa6 mutant wings are larger because they contain more 
cells rather than larger cells (see figure 30 D). This suggests that proliferation is 
increased in boa6 mutant wings and that Boa does indeed function as a tumour 
suppressor to negatively regulate the size of developing organs. Accordingly, the adult 
body weight of boa6 mutants (n=80) is higher than the weight of control flies (n=120) 
by 9.9%. Both the increased wing size and body weight was rescued by ubiquitous 
UAS-boa expression, indicating that the observed phenotypes are indeed specific to loss 
of boa (Julien Colombani, personal communication).
4.8 The relationship between Boa and dASPP
By carefully quantifying the adult wing area and body weight of mutants and their 
appropriate controls we have shown that both dASPP and Boa are negative regulators of 
tissue size. As dASPP and Boa bind to each other and have similar mutant phenotypes it 
is highly likely that they function in the same cellular process. However, there are subtle 
differences between the phenotypes, for example boa mutant wings are large and broad 
and dASPP mutant wings are large but the shape is not affected, boa mutants also have 
a more severe rough eye phenotype. These differences suggest that although Boa and 
dASPP likely function together in some processes, they may also have independent 
functions.
Boa binding to dASPP raises the possibility that Boa functions to regulate the stability 
or localization of dASPP. This was tested by generating boa6 clones in eye-antennal 
imaginal discs and examining dASPP protein using the dASPP38 antibody. 
Interestingly, a reduction in dASPP protein was observed within boa6 clones (see figure 
31 A-A” , arrows indicate examples), indicating that Boa regulates either the stability or 
localization of dASPP. These possibilities cannot be distinguished from this result as 
both would cause a reduction of apical dASPP staining. Ideally, the level of dASPP 
protein would be examined in boa mutant discs compared to controls by Western 
blotting. Unfortunately, this experiment was not possible as the dASPP antibodies 
generated do not recognise endogenous dASPP in protein extracts from either tissues or 
cultured cells (data not shown). However, it is possible to conclude that Boa is required 
to maintain high levels of dASPP at the apical membrane by controlling its stability or
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Figure 31: Boa regulates the levels or localization of dASPP. (A-A” ) A third instar 
eye-antennal disc with boa6 clones, marked by absence of GFP. A reduction in dASPP 
antibody staining (red) is observed in boa6 clones (arrows). This suggests that Boa regu­
lates dASPP protein levels or dASPP sub-cellular localization.
localization. This implies that Boa is required for dASPP function and that the boa 
phenotype is at least partly due to de-regulation of dASPP. In support o f this idea, the 
boa6 phenotype can be partially rescued by ubiquitous expression of dASPP  using the 
Gal4-UAS system. For example, dASPP expression in a boa6 mutant background 
somewhat rescues the rough eye phenotype. The boa6 eye phenotype is only partially
o
rescued by dASPP expression whereas the dASPP eye phenotype is completely rescued 
by dASPP expression (Julien Colombani, unpublished observation). Therefore it is 
likely that Boa has functions that are independent of dASPP.
4.9 boa genetically interacts with dCsk
As Boa is partially required for dASPP function and dASPP is required for maximal 
dCsk activity it is likely that dCsk activity is reduced in boa mutants. Therefore one 
would expect boa to genetically interact with dCsk, although more weakly than dASPP 
interacts with dCsk. To address this I compromised dCsk function in a boa6 mutant 
background by introducing a copy of the strong dCsk,jd8 allele. This resulted in 
moderate patches of ectopic apoptosis in wing discs (see figure 32 B-B’) indicating that 
dCsk and boa genetically interact. The level of apoptosis occurring in boa-dCsk 
compromised wing discs is considerably lower than the level of apoptosis occurring in 
dASPP-dCsk compromised wing discs and accordingly notching of adult wings is not 
observed (see figure 32 B” ). However, removing one copy of dCsk does enhance the 
large wing phenotype of boa6 mutants (compare figure 32 A ’ to B’ and A ” to B” ) 
although the enhancement of wing area is yet to be quantified. This suggests that the 
proliferation defect observed in boa6 wings is at least partially caused by a reduction in 
dCsk activity.
4.10 Boa, dASPP and d C S k - three proteins functioning in a common 
pathway?
Taken together these results suggest a model whereby Boa and dASPP function 
upstream of dCsk and SFKs to negatively regulate the organ size. Boa is required to 
maintain high levels of dASPP at the apical membrane and dASPP is required for 
maximal dCsk activity. The phenotypes observed suggest that minor increases in SFK
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Figure 32: Genetic interactions between boa and dCsk. Cleaved Caspase 3 immunos- 
tainings (C3) (red) of third instar wing imaginal discs and the corresponding adult wings 
o f the indicated genotypes. (B-B”) Reducing dCsk function in a boa mutant background 
leads to ectopic apoptosis in wing discs. This level of apoptosis does not however result 
in notched adult wings (B”). (A-A”) Little apoptosis is observed in boa6 mutant wings or 
in dCsk heterozygous wings (see figure 14).
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activity (for example, in a boa or dASPP mutant) results in organ overgrowth as a 
consequence of increased proliferation and possibly reduced cell death. The data 
generated in this work also suggest that high levels of SFK signalling (for example in 
dCsk mutants or dASPP-dCsk compromised wings) lead to induction of apoptosis. This 
is in agreement with previous work showing that mild over-expression o f dSrc42A or 
dSrc64B results in overgrowth and strong over-expression of dSrc42A or dSrc64B leads 
to apoptosis (Pedraza et al., 2004; Vidal et al., 2007).
It is not clear whether Boa, dASPP and dCsk form a complex in vivo, however, 
complexes containing all three proteins are observed in cultured cells. If all three 
proteins are overexpressed in Kcl67 cells, Boa can be detected in dCsk 
immunoprecipitates and dCsk can be detected in Boa immunoprecipitates (Julien 
Colombani, personal communication). This does not necessarily mean that all three 
proteins form a complex in vivo as high expression levels may force complex formation. 
It is equally possible that 2 separate complexes exist, one containing Boa and dASPP 
and the other containing dASPP and dCsk. Ideally, one would examine the complexes 
formed in cultured cells following immunoprecipitations of endogenous proteins but 
this was not possible due to the lack of suitable antibodies. Regardless, our data suggest 
that both Boa and dASPP are regulators of dCsk and provide a novel link between 
previously unrelated tumour suppressor genes. It will be interesting to discover whether 
mammalian RASSF8 interacts with ASPP1 and/or ASPP2 and whether ASPP proteins 
also regulate CSK in mammals.
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CHAPTER 5 The D I A P - L a c Z  project
5.1 Does the EGF/Ras/ERK pathway control DIAP1 at the 
transcriptional level ?
The EGF/Ras/ERK signalling pathway (the Ras pathway) carries out several important 
functions in the developing Drosophila eye. The Ras pathway promotes cell 
proliferation and cell survival and is re-iteratively utilised to control the differentiation 
of neuronal cells posterior to the MF, which become the light sensing photoreceptor 
cells (Raabe, 2000).
The Ras signalling pathway is known to promote cell survival in Drosophila by 
specifically inhibiting the activity of the pro-apoptotic protein, Hid (head involution 
defective) (Bergmann et al., 1998; Kurada and White, 1998). Hid is believed to be a 
phosphorylation target of MAPK/ERK and contains several MAPK consensus 
phosphorylation sites (Bergmann et al., 1998). Hid induces apoptosis by promoting the 
polyubiquitination and degradation of DIAP1, consequently relieving inhibition of 
Caspases (Yoo et al., 2002). Therefore Ras signalling promotes cell survival by 
indirectly increasing DIAP1 protein levels via Hid inhibition. Conversely, the Hippo 
signalling pathway promotes apoptosis by decreasing DIAP1 levels and this regulation 
occurs at both the post-translational and transcriptional level (Harvey and Tapon, 2007). 
Therefore, I was interested in examining the possibility that the Ras signalling pathway 
promotes cell survival by regulating DIAP1 at the transcriptional level.
5.2 The basis for examining whether Ras signalling upregulates 
DIAP1 transcription
In the third instar eye imaginal disc the Ras signalling pathway is highly active in the 
ommatidial preclusters, which are specified as cells exit the MF. This can be visualised 
using an antibody that recognises active ERK/MAPK (see figure 33 A ’). This pattern of 
ERK activation is highly reminiscent of the observed pattern of DIAP1 expression in 
eye discs following in-situ hybridization (Nic Tapon, personal communication). DIAP1
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Figure 33: Transcriptional control of DIAP1 by the EGF/Ras/ERK pathway. (A-A” ) 
A wildtype (w) eye-antennal disc immunostained with p-ERK (red) and Beta-Gal (green) 
(to visualise DIAP-LacZ reporter expression) antibodies. p-ERK is detected in omma- 
tidial preclusters as cells exit the morphogenetic furrow (MF). DIAP-LacZ expression is 
highest in the photoreceptor clusters posterior to the MF and is first detected in the row of 
cells directly posterior to p-ERK expressing cells suggesting that DIAP1 may be tran­
scriptionally regulated by the EGF/Ras/ERK pathway. (B-B” ) A eye-antennal disc bear­
ing activated EGF receptor (EGFRact) FLPout clones, labelled by GFP expression. DIAP- 
LacZ (red) is elevated within the EGFR overexpressing clones and within cells neigh­
bouring the clone.
transcript is observed in ‘tufts’ of cells directly posterior to the MF corresponding to the 
preclusters. ERK activation and DIAP1 transcription therefore occur concurrently in a 
spatial and temporal manner suggesting that DIAP1 may be a direct transcriptional 
target of the Ras pathway. This observation led me to examine this potential regulation 
mechanism in detail.
DIAP-LacZ is a transposon insertion into the first DIAP1 intron that places the LacZ  
gene under the control of the endogenous DIAP1 promoter. DIAP-LacZ can therefore be 
used to monitor levels of DIAP1 transcription. DIAP-LacZ expression is observed in all 
differentiating photoreceptor cells and is highest in the first few rows o f cells posterior 
to the MF (see figure 33 A). DIAP-LacZ is not detected in the ‘tufts’ of cells where 
ERK is active; its expression is first detected in the row of cells immediately posterior 
to the cells where ERK is active (see figure 33 A-A” ). The difference in time of onset 
of DIAPI transcription as visualised by in-situ hybridization or by using DIAP-LacZ is 
likely to be due to the time taken to accumulate LacZ and produce P-Galactosidase. 
Therefore the earliest induction of DIAPI transcription, directly posterior to the MF, 
may not be seen when using the DIAP-LacZ reporter. However, DIAP-LacZ is 
expressed at high levels directly posterior to the region of high Ras signalling 
suggesting that DIAPI may be a transcriptional target o f the Ras pathway.
5.3 Analysis of DIAP-LacZ in Ras pathway gain of function clones
To address whether DIAPI is a transcriptional target of the Ras pathway I used mosaic 
analysis and examined the expression of DIAP-LacZ in clones that were either gain or 
LOF for various Ras pathway components. Ras signalling is known to be activated 
following ligand binding and activation of the EGF receptor (EGFR). Therefore, I 
overexpressed an activated form of EGFR (EGFRact) in FLPout clones and asked 
whether the transcription of DIAPI is affected. I observed a strong induction of DIAP- 
LacZ expression in EGFRact expressing clones (see figure 33 B-B” ). This was the first 
indication that DIAPI may be a transcriptional target of the Ras pathway. Interestingly, 
the induction of DIAP transcription was observed within the clone and also in a ring of 
cells around the clone suggesting that the Ras pathway can non-autonomously regulate 
DIAPI transcription over a short distance. Next, I overexpressed an activated form of
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Ras (Rasv12) in FLPout clones. Like EGFRact expressing clones, RasV12 expressing 
clones showed an upregulation of DIAPI (data not shown) suggesting that the DIAP- 
LacZ expression observed in EGFRact FLPout clones is likely due to Ras activation.
Next, I wanted to determine which of the transcription factors known to function 
downstream of Ras could be responsible for regulating DIAPI expression. Pointed 
(Pnt), Yan and Tramtrack (Ttk) are transcription factors known to function downstream 
of Ras and MAPK to control photoreceptor differentiation (Brunner et al., 1994; Lai 
and Rubin, 1992; Li et al., 1997; O'Neill et al., 1994; Tang et al., 1997). Therefore, I 
tested whether gain or LOF for these transcription factors affected DIAP-LacZ 
expression. The pnt locus encodes 2 transcriptional activator proteins, PntPl and PntP2 
(O'Neill et al., 1994). The yan locus is encodes a single transcriptional repressor protein 
(Lai and Rubin, 1992; O'Neill et al., 1994). The ttk locus codes for 2 repressor proteins, 
Ttk69 and Ttk88 (Harrison and Travers, 1990; Read and Manley, 1992).
For gain of function analysis I was able to acquire UAS-pntPl, UAS-pntP2, UAS-ttk69 
and UAS-ttk88 transgenes and generated FLPout clones to examine their effects on 
DIAPI transcription. Unfortunately, I was not able to acquire a UAS-yan transgene. 
Over-expression of pnt P I or pntP2 did not affect expression of DIAP-LacZ (see figure 
34 A-A’”  and B-B’” ) suggesting that the transcriptional upregulation of DIAPI by the 
Ras signalling pathway does not occur via PntPlor PntP2. However, when I generated 
ttk69 overexpressing clones I observed a strong induction of DIAP-LacZ expression (see 
figure 34 C-C’” )- This effect was specific to Ttk69 as over-expression of ttk88 had no 
effect on DIAP-LacZ expression (see figure 34 D-D’” ).
As Ttk69 is a transcriptional repressor it was surprising that its over-expression resulted 
in an upregulation of DIAPI transcription. One possibility is that Ttk69 regulates 
DIAPI transcription indirectly, for example Ttk69 may represses expression of a protein 
that itself represses DIAPI transcription. If this were the case then Ttk69 over­
expression would alleviate DIAPI repression. Another possibility is that over­
expression of ttk69 has dominant negative effects. For example, excessive Ttk69 may 
titrate a co-repressor leading to a derepression of DIAPI transcription. In order to 
distinguish between these possibilities it would be necessary to firstly determine 
whether Ttk69 is able to bind to the DIAPI promoter.
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Figure 34: The effect of overexpressing transcription factors functioning down­
stream of the Ras pathway on DIAP-LacZ  expression. (A, B, C, D) FLPout clones, 
marked by GFP expression, overexpressing either pntP l, pntP2, ttk69 or ttk88 were 
generated in eye-antennal discs. (A’, B’, C \  D ’) The level of DIAP-LacZ reporter expres­
sion (red) within the clones was examined. Elevated DIAP-LacZ was observed in ttk69 
overexpressing clones (C’) but not in pntP l, pntP2 or ttk88 overexpressing clones. (A” , 
B” , C” , D” ) ELAV staining (blue) is used a marker of neuronal differentiation, ttk69 
over-expression (C”) resulted in abnormal neuronal differentiation posterior to the mor­
phogenetic furrow.
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5.4 Analysis of DIAP-LacZ in Ras pathway loss of function clones
Ttk69 was identified as a transcription factor downstream of Ras that might be 
responsible for promoting DIAPI transcription. Therefore I generated LOF ttk clones 
and asked whether DIAPI levels are reduced within the clones. ttkleJI is a mutation that 
disrupts expression of both Ttk isoforms and ttk1 specifically disrupts the Ttk88 isoform 
(Xiong and Montell, 1993). Therefore, if Ttk69 promotes DIAPI transcription, as 
suggested by gain of function analysis, it is expected that ttkfeI1 clones will show 
reduced DIAP protein and ttk1 clones will not affect DIAPI protein levels. However I 
observed no change in DIAPI staining in either ttkle11 clones (see figure 35 A-A’” ) or 
in ttk1 clones (see figure 35 B-B’” ). This result conflicts with the gain of function data 
and suggests that Ttk69 may not regulate DIAPI levels. Neither of the models proposed 
in the previous paragraph based on the gain of function data can account for this result. 
If the first model, suggesting that Ttk69 indirectly regulates DIAPI at the transcriptional 
level is true, then one would still expect to see reduced DIAPI protein in TtklelJ clones. 
The second model suggested that Ttk69 actually did repress DIAPI transcriptionally 
and that UAS-ttk69 acts as a dominant negative by titrating a co-repressor. If this is true 
then one expects to see an upregulation of DIAPI in ttkle11 clones as repression is lost.
One explanation that may reconcile the LOF and gain of function data is that Ttk69 
does upregulate DIAPI transcriptionally but acts redundantly with other transcription 
factors. In other words Ttk69 may be sufficient but not necessary for DIAPI 
transcription, which would explain the observed upregulation in gain-of-function clones 
and lack of effect in loss-of-function clones. Therefore, whether Ttk69 regulates DIAPI 
transcriptionally downstream of Ras remains and open question and further experiments 
would be needed to address this.
I was not able to obtain UAS-yan, which prevented gain of function analysis, but I was 
able to obtain a yan mutation (yanexI) recombined onto an FRT chromosome for LOF 
analysis. In yan clones I observed a reduction in DIAPI protein levels (see figure 35 C- 
C’” ) suggesting that Yan may regulate DIAPI. Yan is a transcriptional repressor so 
direct targets are expected to be elevated in mutant clones. The fact that I observed 
reduced DIAPI levels suggests that Yan may regulate DIAPI indirectly. Alternatively, 
the downregulation o f DIAPI observed may be due to very indirect effects as a
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Figure 35: DIAPI levels in ttk and yan  loss of function clones. 3rd instar eye-antennal 
discs with ttk or yan  mutant clones marked by absence of GFP were immunostained with 
an anti-DIAPl antibody (red) and the neuronal marker ELAV (blue). (A and B) DIAPI 
levels are normal in ttk le ll  (A-A’”) and ttkl (B-B”’) clones and neuronal differentiation 
is unaffected. (C) A reduction in DIAPI protein is observed in yan clones (arrows in C’). 
Excessive neuronal differentiation is observed in yan clones (arrows in C” ).
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consequence of abnormal cell behaviours induced by loss o f Yan. Yan is a general 
inhibitor of differentiation and, as expected, I observed overproduction o f neuronal cells 
in yan mutant clones as visualised using an antibody against the neuronal marker, 
ELAV (see figure 35 C” , arrows indicate position o f clones). The level o f DIAP-LacZ 
in yan loss-of-function clones has not been examined.
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CHAPTER 6 Discussion
6.1 dASPP regulates dCsk activity
6.1.1 Summary of findings
The work presented provides evidence that dASPP, the homolog of the human ASPP 
proteins, has a previously uncharacterized role as a regulator of SFKs in Drosophila, by 
binding to and potentiating the kinase activity of the SFK inhibitor, dCsk. The genetic 
and biochemical data complement each other and suggest that dASPP is a positive 
regulator of dCsk (Langton et al., 2007).
Firstly, dASPP and dCsk mutants show similar phenotypes. They both function as 
tumour suppressors and LOF mutations lead to increased proliferation, which results in 
an increase in the size o f organs and animals. dASPP and dCsk mutants also show 
developmental delay, which is approximately one day for dASPP mutant adults. The 
developmental delay is more prolonged in dCsk mutants; the emergence of wandering 
larvae is delayed by about four days. dASPP and dCsk mutants show an alteration in 
cell-cell adhesion properties, which results in mis-patterning of the retina and 
compromises epithelial integrity in the wing. The similarity of phenotype suggests that 
dASPP and dCsk may function in the same signalling pathway. dCsk has a stronger 
phenotype than dASPP. For example, dCsk hypomorphic mutants die as giant pupae, 
whereas dASPP mutants are homozygous viable and show a more modest increase in 
organ and animal size. This suggests that dASPP is not absolutely required for dCsk 
function but rather it is necessary for maximal signalling.
Secondly, dASPP mutants enhance the dCsk RNAi phenotype, as would be expected for 
a positive regulator of dCsk. It is likely that dCsk function is partially compromised in 
dASPP mutant flies and therefore this genetic background confers extreme sensitivity to 
further loss of dCsk function. For example, reducing the gene dosage of dCsk in a 
dASPP mutant background leads to considerable apoptosis in the developing wing, 
which results in notched adult wings. Importantly, the wing disc apoptosis phenotype is 
observed for dCsk homozygous mutants suggesting that it is indeed the result of
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reduced dCsk function. Furthermore, the interaction was specific to dASPP and dCsk as 
the phenotype is not observed when a null allele for wts, another tumour suppressor, is 
introduced into a dASPP mutant background. The fact that multiple dASPP alleles 
(dASPPd and dASPP8) show this genetic interaction with multiple dCsk alleles (dCsk1Jd8 
and dCsk?017909), strengthens the argument that dASPP and dCsk genetically interact 
and that the phenotype observed is not due to secondary mutations on either 
chromosome. In addition dASPP mutants strongly enhance the specific phenotypes of 
dCsk RNAi boundary cells providing further evidence that dASPP positively regulates 
dCsk. The enhanced phenotype is rescued by expressing dASPP transgenically showing 
that the enhancement is specifically caused by loss of dASPP. Taken together the 
genetic data for dASPP and dCsk strongly suggests that dASPP has a positive role in a 
dCsk-signalling pathway that acts to maintain epithelial integrity.
Thirdly, dASPP and dCsk physically interact as shown by co-immunoprecipitation and 
GST-pulldown experiments, which supports the hypothesis that dASPP functions in a 
dCsk-signalling pathway. Furthermore, dASPP is able to enhance the kinase activity of 
dCsk on one of its physiological substrates, dSrc42A. Taken together with the genetic 
data this provides compelling evidence that dASPP functions as a positive regulator o f 
dCsk and hence, a negative regulator of SFKs in Drosophila. Genetic epistasis 
experiments also suggest that dASPP functions upstream of SFKs. The dASPP null 
phenotype (dASPP8) is almost completely suppressed by loss of dSrc64B (using the 
dSrc64BKO null allele) showing that dSrc64B is required for the dASPP phenotype.
6.1.2 dASPP and p53
Human ASPP proteins have been shown to directly bind to and regulate the apoptotic 
function of p53 (Samuels-Lev et al., 2001). However, several lines of evidence suggest 
that dASPP does not function as a regulator of Dmp53. Firstly, dASPP mutants show 
overgrowth phenotypes and Dmp53 is not implicated in the control of tissue growth. 
This does not exclude the possibility that dASPP regulates Dmp53 but does suggest that 
the overgrowth phenotype of dASPP mutants is not due to Dmp53 mis-regulation. 
Secondly, dASPP and Dmp53 do not physically interact in co-immunoprecipitation 
experiments (Julien Colombani, personal communication). Additionally, neither the
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four human p53 residues (His178, Arg181, Met243 and Asn247) shown in crystallography 
studies to contact ASPP2 (Gorina and Pavletich, 1996) nor the proline-rich region 
shown to be a second site for binding between the two proteins (Bergamaschi et al.,
2006) are conserved in Dmp53. Thirdly, dASPP is not required for radiation-induced 
cell death; dASPP clones in the wing disc show similar levels of apoptosis to wild-type 
tissue following irradiation (Julien Colombani, personal communication). Radiation- 
induced apoptosis is known to require Dmp53 (Brodsky et al., 2000; Ollmann et al., 
2000), suggesting that dASPP is not required for Dmp53 to induce apoptosis in 
response to DNA damage. Taken together this suggests that p53 activating function of 
ASPP proteins is not conserved in Drosophila and may have evolved later. It will be 
interesting to see whether human ASPP proteins function as regulators o f CSK as this 
work on Drosophila ASPP suggests; one possibility is that human ASPP regulates both 
p53 and CSK.
6.1.3 dASPP largely functions to regulate dCsk rather than the Hippo pathway
The aim at the start of this project was to identify novel components of the Hippo 
pathway by conducting a candidate-based genetic screen for modifiers of a Hippo 
pathway over-expression phenotype (GMRsav,wts). The strongest suppressor (dASPP) 
identified did have the expected overgrowth phenotype, however I subsequently showed 
that this is probably largely attributable to increased SFK signalling rather that reduced 
Hippo signalling. Combining dASPP mutations with Hippo pathway mutations either 
results in no enhancement of the large wing phenotype (in the case of hpo42'47) or 
additive effects (in the case of wtsxl). However, combining dASPP mutations with dCsk 
mutations results in a synergistic interaction that gives rise to ectopic apoptosis in the 
developing wing. Therefore, the strong genetic interaction suggests that dASPP 
functions to negatively regulate growth in a dCsk-SFK pathway rather than in the Hippo 
pathway.
6.1.4 Caveats of the genetic modifier screen
The dASPP mutants I generated did not show a convincing genetic interaction with the 
Hippo pathway. This was surprising as GE13722, which presumably represents a very
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weak dASPP allele, strongly suppresses the GMRsav,wts phenotype. This suggests that 
GE13722 represented a ‘false positive’ in my screen and that the suppression of 
GMRsav,wts observed is not due to loss of dASPP function but instead due to secondary 
mutation(s) on the GE13722 chromosome. This highlights the importance o f following 
up modifier screens with secondary screens to confirm hits and eliminate false positives 
arising from background effects.
Another potential caveat of the screen was that the majority of P-element insertions 
tested likely constituted weak LOF alleles as they were inserted either within the 
promoter region or within introns of genes of interest. This reduced the sensitivity of the 
screen since I was searching for dominant modifiers of the GMRsav.wts phenotype. 
Thus, the false negative rate of the screen was probably high. Furthermore, the intrinsic 
variability of the GMRsav.wts phenotype makes assessing the extent of suppression or 
enhancement difficult.
6.1.5 dASPP may have a minor and indirect role in the Hippo pathway
Despite the fact that merely additive effects on wing growth are observed when dASPP 
and wts mutations are combined, it is still possible the dASPP has some input to the 
Hippo pathway. Firstly, some of the genetic data presented suggests that in fact dASPP 
does genetically interact with the Hippo pathway. For example, wts mutations 
convincingly enhance the eye phenotype of dASPP mutants. In this case it cannot be 
said that the interaction is additive as heterozygosity for wts does not result in an eye 
phenotype. In addition, a deficiency for dASPP does partially suppress GMRsav.wts.
One possibility is that dASPP indirectly regulates the Hippo pathway via dCsk and 
Drosophila SFKs. Indeed, Wts was shown to be a phosphorylation target o f dCsk and 
dCsk mutants are partially rescued by wts expression suggesting that dCsk functions 
upstream of Wts (Stewart et al., 2003). Another group recently showed that the rough 
eye induced by mild dSrc64B expression is suppressed by wts mutation (Vidal et al.,
2007). This result indicates that the effects dCsk has on Wts are mediated indirectly via 
the SFKs and that Wts may not be a direct target o f dCsk. Therefore, the relationship 
between dCsk and the Wts is not clear at present. It is unlikely to be a straightforward as
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Hippo pathway readouts are not affected in dCsk clones. However, the Hippo and 
dCsk/SFK pathways genetically interact suggesting that there is crosstalk between the 
two. Regardless of whether dCsk regulates Wts directly or indirectly, this data, along 
with my own, suggests that the overgrowth phenotype of dASPP mutants is primarily 
due to decreased dCsk function, which may indirectly result in mild reductions in Hippo 
pathway activity.
6.1.6 dASPP, dCsk and epithelial integrity
dCsk mutant cells have been shown to be only susceptible to apoptosis when in contact 
with wild-type tissue (Vidal et al., 2006). I confirmed this result and found that dCsk 
LOF in discrete areas of the wing disc (using ptcGal4>dCskIR) does induce apoptosis 
of mutant cells. However, I found that broad loss of dCsk in wing discs also results in 
considerable apoptosis (for example in dCsk homozygous discs). This has not been 
previously described for dCsk mutant wing discs and suggests that epithelial extrusion 
and cell death may not only occur at mutant/wild-type boundaries but instead is a more 
general phenotype of dCsk mutant cells. This idea is supported by results from a recent 
paper, which shows that different levels of Drosophila SFK signalling have different 
outcomes; mild increases in SFK signalling lead to overgrowth and inhibit apoptosis, 
whereas strong increases in SFK signalling leads to apoptosis. The authors used a dCsk 
null allele to completely remove dCsk function in the eye and found that this leads to 
eye ablation by apoptosis (Vidal et al., 2007). Therefore, broad loss of dCsk can either 
protect against or induce apoptosis depending on the strength of the allele in question.
It has been suggested that specific interactions occur at mutant/wild-type boundaries 
that lead to the exclusion and death of dCsk mutant cells (Vidal et al., 2006). However, 
this conclusion was based on the effects of driving a dCsk RNAi construct using Gal4 
drivers that express in the whole wing (Eg. 765-Gal4) or in discrete areas of the wing 
(Eg. ptc-Gal4) (Vidal et al., 2006). One possibility is that the ptc-Gal4 driver simply 
expresses more strongly than the 756-Gal4 driver, leading to apoptosis only when the 
former controls dCsk RNAi expression. The fact that apoptosis largely occurs at the 
posterior boundary of the ptc  expression domain may not be due to the presence of a 
sharp boundary between mutant and wild-type cells as suggested, but instead because
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ptc is expressed more strongly towards the posterior side o f its expression domain. 
Additionally, the authors could not explain why apoptosis occurs several cell diameters 
away from the boundary when the strongly expressing sd-Gal4 driver was used (Vidal 
et al., 2006).
Vidal et al showed that the ptcGal4>dCskIR phenotype (discrete loss, leading 
apoptosis) but not the GMRGal4>dCskIR phenyotype (broad loss, leading to 
overgrowth) is suppressed by heterozygosity for pl20-catenin. This suggests that p i 20- 
catenin is specifically required for the boundary phenotype. However, I believe that the 
phenotype of dCsk in the eye and wing should not be compared. For example, c14SPP- 
dCsk compromised animals show a strong apoptotic wing phenotype and only a mild 
enhancement of the rough eye phenotype (data not shown), suggesting that the wing 
epithelium is more sensitive to loss of dCsk than the eye epithelium. It is not understood 
at present why the wing is more sensitive to loss of dCsk-dASPP.
Therefore, I speculate that broad loss of dCsk can result in apoptosis depending on the 
strength of LOF and the tissue examined. An interesting question arises from this study: 
is the extrusion and cell death caused by either discrete or broad loss of dCsk the result 
of the same phenomenon? The fact that broad loss and discrete loss result in a similar 
phenotype suggests that this is the case. However, clones o f hypomorphic dCsk 
mutations in the eye do not survive to adulthood, whereas when the whole eye is 
mutant, the adult eye is often overgrown (Vidal et al., 2006). This cannot be easily 
explained unless there is a boundary-specific effect caused by loss of dCsk, which 
eliminates clonal tissue. One possibility is that dCsk mutant clones are eliminated by 
cell competition, which could be tested by examining the survival of dCsk clones in a 
minute background. More work will be needed to address whether there is indeed a 
specific boundary effect induced by loss of dCsk and to identify the responsible cellular 
components and behaviours.
6.1.7 Loss of dASPP / dCsk promotes extrusion, apoptosis and migration
dASPP-dCsk deficient wing disc cells undergo apoptosis, move to a basal position 
within the epithelium and adopt a ‘migratory’ like behaviour. These events are likely to
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be the consequence of ectopic SFK activation, which has been shown to induce 
apoptosis in Drosophila imaginal discs (Pedraza et al., 2004; Tateno et al., 2000; Vidal 
et al., 2007), and is known to disrupt cell adhesions and promote migratory behaviour in 
mammalian cells (Yeatman, 2004).
6.1.7.1 Apoptosis of dASPP-dCsk mutant cells
I have shown that the ectopic apoptosis in dASPP-dCsk compromised wings is sensitive 
to the dosage of Btk, which is known to function downstream of SFKs in Drosophila 
and mammals (Guarnieri et al., 1998; Roulier et al., 1998; Saouaf et al., 1994; Tateno et 
al., 2000). Furthermore, I have shown that the cell death is mediated via the JNK 
signalling pathway, which induces cell death in many contexts, and is known to 
function downstream of SFKs in Drosophila and mammals (Dolfi et al., 1998; Read et 
al., 2004; Tateno et al., 2000). Therefore, it is highly likely that the apoptosis phenotype 
is the result of abnormal SFK activation. Indeed, over-expression of constitutively 
active dSrc42A has been shown to induce apoptosis in the wing disc via the JNK 
pathway (Tateno et al., 2000) and over-expression of activated forms of either 
Drosophila SFK in the eye leads to its ablation (Pedraza et al., 2004).
Since btk is required for the dCsk apoptosis phenotype, it is possible that SFKs activate 
Btk, which in turn directly or indirectly activates the JNK pathway, leading to cell 
death. It would be interesting to examine this possibility, as Btk has not previously been 
implicated in the induction of cell death by Drosophila or mammalian SFKs. Firstly, it 
would be necessary to confirm that btk LOF rescues the apoptosis phenotype using 
other dCsk and btk alleles. For, example it has recently been shown that dCsk null eyes 
are ablated by apoptosis; one could test whether btk mutants rescue this phenotype. 
UAS-btk transgenic lines could be generated to assess whether btk over-expression, like 
SFK over-expression, induces apoptosis. Once the result is confirmed it would be 
interesting to delineate the pathway responsible for inducing apoptosis. For example, it 
is not known whether Btk is regulated by both Drosophila SFKs. This could be 
addressed by assessing whether btk mutations suppress phenotypes resulting from over­
expression of either of the Drosophila SFKs. Also, if Btk is responsible for inducing 
JNK signalling, then how is this achieved? One could examine which known
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components of the JNK cascade are required for SFK/Btk induced apoptosis; this may 
provide clues as to where Btk functions within the JNK pathway.
In mammals active c-SRC has been shown to activate the JNK pathway in collaboration 
with FAK (Hauck et al., 2002; Hsia et al., 2003). The role of dFAK in SFK signalling is 
not well characterized and it would be interesting to test whether it is required for SFKs 
to activate the JNK pathway in Drosophila.
6.1.7.2 Loss of cell adhesions in dASPP-dCsk mutant cells
Mammalian c-SRC is known to have dramatic effects on both adherens junctions and 
focal adhesions (Yeatman, 2004). Therefore, it seems likely that dASPP-dCsk 
compromised wing disc cells move to a basal position within the epithelium as a result 
of altered adhesion properties induced by SFK activation. However, this is purely 
speculative, and was not directly examined in this work. Loss of cell-cell adhesions 
probably also contributes to the migratory phenotype as cells must detach from their 
neighbours to spread through the basal layer.
Interestingly, the phenotype of dCsk deficient boundary cells is suppressed by reducing 
the gene dosage of shg {Drosophila E-Cadherin) (Vidal et al., 2006), implying that an 
alteration in cell-cell adhesion properties is important for both basal extrusion and cell 
migration following SFK activation. However, this is a surprising result; it is expected 
that reducing shg levels would enhance rather than suppress the phenotype, as SFK 
activation is known to inhibit E-Cadherin function in mammals. One proposed 
explanation is that Shg has an autonomous role in the pathway responsible for 
promoting the removal of dCsk boundary cells; Shg may be required for JNK activation 
by SFKs. It would be interesting to see whether Shg is also required for the basal 
extrusion and apoptosis resulting from broad loss of dCsk in wing discs. Such 
experiments may reveal whether the phenotypes resulting from broad or discrete loss of 
dCsk are the result of the same cellular response.
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6.1.7.3 Migration of dASPP-dCsk mutant cells
Activated c-SRC is implicated in the metastasis o f tumour cells and has been shown to 
induce migratory behaviour using in vitro metastasis models (Hauck et al., 2002). 
Therefore, it is likely that the movement of dCsk boundary cells away from their 
original position occurs by active migration. In support of this view the migratory 
phenotype is sensitive to modulations in JNK pathway activity and is suppressed by 
heterozygosity for matrix-metalloprotease 2 (MMP-2) (Vidal et al., 2006). The JNK 
pathway is known to induce expression of MMPs in mammals (Hauck et al., 2002), 
which are required to degrade the ECM, allowing cells to become migratory. The fact 
that dASPP mutations enhance the distance that dCsk RNAi cells migrate suggests that 
human ASPP LOF may contribute to tumour cell metastasis. Interestingly, ASPP2 has 
been reported to be downregulated in invasive and metastatic breast carcinoma cells 
(Sgroi et al., 1999). The results presented in this work provide a potential mechanism 
for ASPP’s role in tumour cell invasion.
An alternative explanation for the movement of dCsk RNAi cells away from the ptc  
domain is that they are simply diffusing within the basal layer. However, dCsk null 
clones that also express RasV12 are highly invasive and mutant cells metastasize to
• • V 1 2distant secondary locations; a diffusion model cannot explain this result. Ras also 
rescues the apoptosis o f dCsk mutant cells suggesting that the movement of such cells is 
not simply the result of apoptosis and basal extrusion (Vidal et al., 2007).
6.1.7.4 Does loss of polarity lead to apoptosis or vice versa?
Previous work has shown that loss of polarity precedes JNK activation and cell death. 
For example, mutants for apico-basal polarity genes such as scribble lead to E-Cadherin 
down-regulation and JNK dependent apoptosis (Bilder and Perrimon, 2000; Brumby 
and Richardson, 2003). In fact scribble and dCsk phenotypes are highly similar; both 
result in overgrowth in a homotypic environment whereas clones are eliminated by JNK 
dependent apoptosis (Brumby and Richardson, 2003; Vidal et al., 2006). Therefore, it 
is possible that SFK activation in dCsk mutant cells disrupts apico-basal polarity 
complexes, leading to mis-localization of adherens junction components, JNK
179
activation and cell death. Alternatively, SFK activation may directly affect adherens 
junctions, leading to JNK activation and cell death. Both of these possible models 
suggest that loss o f polarity / adhesion precedes apoptosis.
Interestingly, my results indicate that cell death may contribute to extrusion and 
migration of dCsk RNAi cells. I found that blocking cell death in dCsk RNAi cells by 
over-expressing DIAP1 largely prevents the migration of individual cells away from the 
ptc domain. One possibility is that Caspase activation may be required for disruption of 
cell-cell adhesions, which is likely to be necessary for dCsk mutant cells to detach from 
their neighbours and migrate. An alternative possibility is that Caspases have a more 
direct role in promoting migration. Interestingly, DIAP1 and the apical Caspase 
DRONC have been previously implicated in cell migration of the border cells during 
oogenesis (Geisbrecht and Montell, 2004). However, conversely to my result, it was 
shown that DIAP1 over-expression promoted rather than prevented cell migration. 
Therefore, whereas it seems likely that loss of polarity and / or cell-cell adhesions 
induces JNK signalling and apoptosis, it is also possible that cell death pathways 
contribute to loss of cell-cell adhesion and migration. The dCsk RNAi phenotype is 
likely to be a complex phenomenon involving numerous SFK targets.
6.1.8 Mechanism of activation of dCsk by dASPP
This study of dASPP has shown that dASPP is a positive regulator of dCsk and this is 
achieved through binding and enhancement of dCsk kinase activity. However, it is still 
not clear exactly by which mechanism this regulation is achieved. For example, dASPP 
binding may induce a conformational change, which renders dCsk more active. 
Alternatively, dASPP may function as a scaffold to mediate the recruitment of other 
proteins to dCsk (possibly binding to the dASPP C-terminal region), which act to 
increase its activity. A third possibility is that dASPP regulates dCsk activity by 
controlling its sub-cellular localization and/or binding to substrates. Mammalian CSK’s 
ability to inhibit SFKs is believed to be primarily determined by its translocation to lipid 
rafts, where c-SRC is tethered by virtue of its myristylated N-terminus (Cole et al., 
2003). The transmembrane protein Cbp (CSK binding protein or PAG) has been 
reported to recruit dCsk to lipid rafts (Kawabuchi et al., 2000), but there is not a clear
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Cbp homolog in flies. Therefore, it is possible that dASPP carries out an analogous 
function and regulates dCsk activity by causing its re-localization to parts of the cell 
where SFKs are active. Indeed, dASPP has a specific sub-cellular localization and is 
found at the apical membrane of epithelial cells, just above the adherens junction (data 
not shown). Therefore, dASPP may be important for localizing dCsk to the apical 
membrane either to promote its activation or to bring it in proximity to substrates. 
Ideally dCsk antibodies would be used to examine the sub-cellular localization of dCsk 
in dASPP mutant clones. We have not managed to produce a dCsk antibody that 
recognises dCsk in fixed tissues but experiments are currently underway to examine the 
localization of a dCsk-GFP fusion protein in dASPP clones. It will be important in the 
future to determine exactly how dASPP regulates dCsk.
6.2 Boa (Binder of dASPP) - a novel regulator of tissue growth
6.2.1 Boa and dASPP function in the same signalling pathway
In this work the initial characterization of another tumour suppressor, Boa (Binder of 
dASPP), was carried out. Boa is the Drosophila homolog of RASSF8, a member o f the 
RASSF family, which all possess an RA (Ras Association) domain. Boa was identified 
as a suppressor in the GMRsav.wts modifier screen and links dASPP to Wts in the 
Curagen 2-hybrid data. The predicted interactions were tested by co- 
immunoprecipitation and this showed that Boa binds to dASPP but not Wts. As the 
characterization of dASPP suggests that it primarily regulates dCsk and not the Hippo 
pathway, it is likely that Boa also functions upstream of SFKs, rather than as a 
component of the Hippo pathway. Several lines of evidence suggest that Boa is a 
positive regulator of its binding partner, dASPP. Firstly, boa and dASPP phenotypes are 
similar; homozygous mutants are viable and show an increase in organ size and body 
size, suggesting that both genes are tumour suppressors. Also, boa and dASPP 
mutations result in mis-patterning of the ommatidial lattice, presumably as a 
consequence of altered cell-cell adhesion properties. Secondly, Boa is required to 
maintain high levels of dASPP at the apical membrane by either regulating its stability 
or localization. This is likely to be achieved through post-transcriptional mechanisms, as
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dASPP transcript levels are not affected by loss of Boa. Thirdly, knockdown o f 
endogenous Boa in cultured cells by RNAi prevents dASPP from enhancing the kinase 
activity of dCsk (Julien Colombani, personal communication). Taken together, this data 
suggests that Boa is a positive dASPP regulator and is important for dASPP to enhance 
the kinase activity of dCsk.
6.2.2 Boa is not absolutely required for dASPP function
Several pieces of data suggest that dASPP function is compromised but not abolished 
by Boa LOF. Boa maintains high levels of dASPP at the apical membrane but is not 
absolutely required for dASPP localization as small amounts of dASPP protein still 
detectable at the apical membrane in boa mutant clones. Additionally, boa shows a 
weak genetic interaction with dCsk. Reducing the dCsk gene dosage by 50% in a boa 
mutant background results in ectopic apoptosis in the wing disc. However, the level of 
apoptosis observed is considerably less than is observed in dASPP-dCsk compromised 
wing discs, and does not result in notching of adult wings. These results suggest that 
Boa is partially required for dASPP function, by regulating dASPP protein stability or 
dASPP localization. In agreement with this model, the boa6 rough eye phenotype is 
partially rescued by ubiquitous expression of dASPP under the control o f the 
daughterless promoter (M ien Colombani, unpublished observation). The rescue is 
incomplete suggesting that Boa has other functions during eye development that are 
independent of dASPP.
6.2.3 Boa has other roles besides maintaining dASPP regulation
Although dASPP and boa mutant phenotypes are similar, there are important 
differences suggesting that Boa has other functions besides dASPP regulation. For 
example, dASPP mutant wings are large but of normal shape, whereas boa mutant 
wings are large and broadened. Also, boa has a stronger eye phenotype than dASPP ; 
loss of boa can severely disrupt retinal patterning leading to the formation of a square, 
rather than hexagonal lattice, a phenotype not observed in dASPP mutant retinas, boa 
but not dASPP mutant retinas frequently show a double layer of inter-ommatidial cells, 
indicating that they contain considerably more inter-ommatidial cells. The number of
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excess cells in boa mutant retinas has not been quantified yet. It will be important to 
determine whether this is a result o f delayed cell cycle exit after the MF or reduced 
apoptosis between 24h and 40h APF, as this may give clues as to the ‘other’ function(s) 
of Boa. Therefore, while Boa is a regulator of dASPP it is likely to have additional, 
independent functions. Accordingly, while dASPP over-expression in the eye has no 
phenotype, boa over-expression results in a rough eye (data not shown). Furthermore, 
the dASPP-boa double mutant overgrowth phenotype is stronger than the dASPP 
overgrowth phenotype (Julien Colombani, personal communication). These two pieces 
of data strongly suggest that Boa has dASPP-independent functions.
The other function(s) of Boa may be related to its conserved RA domain. RA domain 
containing proteins are known to bind to Ras super-family proteins, raising the 
intriguing possibility the Boa may regulate the Ras pathway. However, heterozygosity 
for a Rasl null allele does not obviously affect the boa phenotype (data not shown). 
One explanation is that Boa regulates another member of the Ras family. Alternatively, 
Boa may have a minor role in the Hippo pathway; as Boa and Wts do not co- 
immunoprecipitate it is unlikely to function at the level of Wts. Over-expression of fa t  
results in a broad wing phenotype, which is highly reminiscent of boa mutant wings, 
raising the possibility that Fat regulates Boa or vice versa. These possibilities remain to 
be tested.
In summary Boa has been identified as a tumour suppressor gene in Drosophila, which 
acts to maintain high levels of dASPP at the apical membrane. This appears to be 
important for dASPP to carry out its role as a positive regulator of dCsk.
6.3 Potential impact of the work on dASPP and Boa
This work has provided the initial characterization if two Drosophila genes of 
previously unknown function. We have shown that dASPP and Boa function as tumour 
suppressors in vivo and are likely to function upstream of SFKs. The discovery that 
dASPP regulates dCsk suggests that ASPP proteins could be regulators of CSK, and 
hence SFKs in mammals.
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As c-SRC activation is associated with metastasis, which is frequently the cause of 
death in cancer patients, it is important to fully understand how SFKs are regulated. The 
discovery that dASPP and Boa are positive regulators of dCsk broadens our 
understanding of SFK regulation. If the interactions between these proteins are 
conserved in mammals and RASSF8 and ASPP proteins function upstream of SFKs, 
this work could have implications for the development of novel cancer treatments.
6.4 Future directions
The next stage of this project will involve completing the characterisation of the boa 
phenotype, confirming interactions between boa and dASPP /  dCsk and attempting to 
pinpoint the ‘other’ functions of Boa. Careful analysis of the phenotypes resulting from 
both over-expression and loss of boa in the eye will be carried out. I plan to quantify the 
number of excess inter-ommmatidial cells per ommatidium in dASPP and boa mutant 
retinas. If, as expected, there are excess inter-ommatidial cells in dASPP and boa 
mutant retinas I will examine whether this is due to delayed cell cycle exit (using BrdU 
labelling of discs with boa clones) or reduced apoptosis at 40h AFP (using TUNEL 
staining of pupal retinas with boa clones).
I also plan to make sections of boa adult eyes to examine whether there are defects in
planar cell polarity (PCP), which regulates ommatidial rotation, or in photoreceptor
differentiation. Additionally, live imaging of developing pupal retinas will be carried
out for control, boa6 mutant, and boa over-expressing retinas to try and understand the 
cell-sorting defect that leads to the severe patterning defects. A useful tool for this will
be E-Cadherin-GFP and pi20-catenenin-GFP, which have been previously used for 
live imaging of the developing retina (Vidal et al., 2006). Irregular Chiasm / Roughest
is known to be important for inter-ommatidial cell-sorting in the pupal retina, and 
mutant eye phenotypes are similar to boa eye phenotypes. Early in pupal development 
(~20h APF) Roughest accumulates at the membrane of primary pigment cells where 
they contact inter-ommatidial cells (Reiter et al., 1996). I plan to examine the 
localization of Roughest in boa clones in pupal retina to see whether the observed cell- 
sorting defect is due to Roughest mis-localization. Hopefully, this analysis of the boa 
eye phenotype will give clues as the other role(s) of Boa.
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In the future it will be interesting to carry out genetic or cell based screens for novel 
interactors of Boa, dASPP and dCsk. In particular, as boa and dASPP are viable 
mutations, they provide sensitized backgrounds to screen for novel genes involved in 
SFK signalling. This may reveal other factors functioning in the dASPP-dCsk-SFK 
pathway or identify new components of Boa signalling pathways.
It will be important to map the region of Boa required for binding dASPP and vice 
versa. The co-immunoprecipitation experiments suggest that Boa binds to dASPP and 
dASPP binds to dCsk. Boa does not bind to dCsk unless dASPP is also expressed 
(Julien Colombani, personal communication). This suggests that all three proteins may 
form a complex in vivo. However, this is based on experiments where proteins are over­
expressed and binding between endogenous proteins would need to be examined to 
address this possibility. Alternatively, two separate complexes may exist, one 
containing Boa and dASPP and the other containing dASPP and dCsk. The N-terminus 
of dASPP is required for binding to dCsk but it has not been determined which region 
of dCsk bind dASPP.
Future experiments will also include further analysis of the mechanism of regulation of 
dASPP by Boa. It will be interesting to determine whether Boa regulates dASPP protein 
stability or regulates it localization. Ideally, antibodies that recognize endogenous 
dASPP on Western blots would be used to examine levels o f dASPP protein in boa 
mutant versus control wing discs. This will reveal whether Boa regulates dASPP 
stability or localization. Additionally, the mechanism by which dASPP regulates dCsk 
will be investigated.
6.5 DIAP-LacZ project discussion
In addition to characterizing dASPP and Boa, I have also examined the transcriptional 
regulation of DIAP1 by the Ras pathway. The onset of Ras pathway signalling in the 
ommatidial preclusters posterior to the MF, as visualized using a phospho-MAPK 
antibody, is accompanied by the onset o f D1AP1 transcription, as visualised by in-situ 
hybridization (Nic Tapon, personal communication). I have presented results that 
suggest that the Ras pathway transcriptionally regulates DIAP1 to promote cell survival.
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This has not been described before and is likely to be independent o f the 
posttranslational regulation of DIAP1 by the Ras pathway via Hid. Therefore, although 
this study is incomplete due to lack of time, it could potentially provide a novel 
mechanism of survival signalling by the Ras pathway.
I have shown that DIAP1 is transcriptionally upregulated by the Ras pathway. The EGF 
receptor and Ras are likely to be involved and Ttk69 may be the downstream 
transcription factor responsible for controlling DIAP1 transcription. EGFR and Ras are 
known to regulate a wide variety of cellular processes, so it can be argued that the effect 
on DIAP1 transcription may be very indirect. However, Ttk69 over-expression 
upregulates DIAP1 transcription suggesting that the mechanism may be more direct, as 
Ttk69 is targeted for degradation by the Ras pathway.
Ttk69 is known to function as a transcriptional repressor (Harrison and Travers, 1990; 
Read and Manley, 1992); therefore it was surprising that its over-expression led to an 
upregulation of DIAP-LacZ. One possibility is that high levels of Ttk69 titrate a co­
repressor required for DIAP1 repression, and in this way act like a dominant negative. If 
this is true then it is expected that ttk69 LOF clones would show the same phenotype. 
However, I observed no modification of DIAP1 protein levels in LOF clones. Another 
possibility is that Ttk69 can function as a transcriptional activator is some 
circumstances. Interestingly, whereas the literature mainly describes Ttk69 as a 
transcriptional repressor, it has been shown to strongly activate transcription o f a f tz  
reporter when expressed in yeast cells (Yu et al., 1999). This is proposed to be due to 
the fact that yeast cells lack a necessary Drosophila co-repressor but nevertheless 
suggests that Ttk has the potential to activate transcription. However, if  Ttk69 does 
function as an activator of DIAP1 transcription it is not easy to explain why I did not 
observe less DIAP1 protein in ttkleN clones. It is plausible that Ttk69 regulates DIAP1 
transcription redundantly with another transcription factor, which can compensate for 
loss of Ttk69. A third possible explanation is that Ttk69 indirectly upregulates DIAP1 
transcription by repressing expression of a negative regulator. However, if this model 
were correct, I would expect loss of Ttk69 to reduce DIAP1 protein levels, which was 
not the case. Therefore, preliminary results suggest that Ttk69 may regulate 
transcription of DIAP1 downstream of Ras, but how this is achieved is not yet clear.
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Further work will be required to distinguish what effect Ttk69 has on DIAP1 
transcription.
I have also shown that DIAP1 protein levels are reduced in yan  LOF clones suggesting 
that Yan may play a role in regulating DIAP levels. However, DIAP1 levels may be 
downregulated very indirectly as a consequence of apoptosis occurring in response to 
loss of Yan. This is likely to be the case for two reasons. Firstly, Yan is a transcriptional 
repressor (O'Neill et al., 1994). Therefore direct transcriptional targets are expected to 
be elevated rather than reduced in mutant clones. Secondly, the result suggests that Yan 
promotes cell survival (as there is less DIAP1 in clones). This does not make sense with 
respect to its role in the Ras pathway, as Ras signalling is known to promote survival 
and inhibit Yan.
Yan is a general inhibitor of differentiation and, as expected, excess photoreceptor 
differentiation was observed in yan clones. As yan  clones have less DIAP1 protein this 
suggests that DIAP1 is not upregulated posterior to the MF simply as a consequence of 
photoreceptor differentiation. In order to address whether Yan regulates DIAP1 
transcription it would be necessary to examine the level of DIAP-LacZ in yan  over­
expression and LOF clones.
In order to determine whether Ttk69 regulates the DIAP1 promoter it will be necessary 
to first confirm that Ttk69 regulates DIAP1 using another system, for example a cell- 
based reporter assay. If this reveals that Ttk69 regulates DIAP1 transcription (either 
positively or negatively), the next step will be to search for Ttk69 consensus binding 
site(s) within the DIAP1 promoter. Mutation of these sites should clarify the effect of 
Ttk69 on DIAP1 transcription. If Ttk69 is a regulator of DIAP1 transcription it will be 
interesting to determine whether this only occurs in the eye or whether it is a general 
mechanism of survival signalling by the Ras pathway. Future work would also include 
further analysis of the effect of Yan on DIAP1 levels.
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